<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006968" GROUP_ID="ORAL" ID="470407050819355343" MERGED_FROM="" MODIFIED="2012-11-13 17:28:45 +0000" MODIFIED_BY="Philip Riley" REVIEW_NO="0198" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.4">
<COVER_SHEET MODIFIED="2012-11-13 13:52:27 +0000" MODIFIED_BY="Philip Riley">
<TITLE MODIFIED="2012-11-12 10:09:05 +0000" MODIFIED_BY="Zbys Fedorowicz">Local interventions for the management of alveolar osteitis (dry socket)</TITLE>
<CONTACT>
<PERSON ID="D807EB6282E26AA20144426CC4B3281C" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Blánaid</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Daly</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer/Academic Lead Special Care Dentistry</POSITION>
<EMAIL_1>blanaid.daly@kcl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dental Practice &amp; Policy</DEPARTMENT>
<ORGANISATION>King's College London Dental Institute</ORGANISATION>
<ADDRESS_1>Denmark Hill Campus</ADDRESS_1>
<ADDRESS_2>Bessemer Road</ADDRESS_2>
<CITY>London</CITY>
<ZIP>SE5 9RW</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 2033299 4455</PHONE_1>
<PHONE_2>+44 2033299 4942</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2012-11-13 13:52:27 +0000" MODIFIED_BY="Philip Riley">
<PERSON ID="D807EB6282E26AA20144426CC4B3281C" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Blánaid</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Daly</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer/Academic Lead Special Care Dentistry</POSITION>
<EMAIL_1>blanaid.daly@kcl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dental Practice &amp; Policy</DEPARTMENT>
<ORGANISATION>King's College London Dental Institute</ORGANISATION>
<ADDRESS_1>Denmark Hill Campus</ADDRESS_1>
<ADDRESS_2>Bessemer Road</ADDRESS_2>
<CITY>London</CITY>
<ZIP>SE5 9RW</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 2033299 4455</PHONE_1>
<PHONE_2>+44 2033299 4942</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="A5F7A9EE82E26AA2003ED3F5E0FBD283" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Mohammad</FIRST_NAME>
<MIDDLE_INITIALS>O</MIDDLE_INITIALS>
<LAST_NAME>Sharif</LAST_NAME>
<SUFFIX/>
<POSITION>Dentist</POSITION>
<EMAIL_1>mohammad.owaise.sharif@googlemail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Dentistry</DEPARTMENT>
<ORGANISATION>The University of Manchester</ORGANISATION>
<ADDRESS_1>Coupland III Building, Oxford Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Manchester</CITY>
<ZIP>M13 9PL</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="E47F5AD082E26AA2014D8C0189339A28" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Tim</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Newton</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Psychology as Applied to Dentistry</POSITION>
<EMAIL_1>tim.newton@kcl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Division of Health and Social Care Research</DEPARTMENT>
<ORGANISATION>KCL Dental Institute</ORGANISATION>
<ADDRESS_1>Bessemer Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>SE5 9RW</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 (0)203 299 3481</PHONE_1>
<PHONE_2/>
<FAX_1>+44 (0)203 299 3409</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="D809CE0C82E26AA20144426CA6664FCE" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Kate</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Jones</LAST_NAME>
<SUFFIX/>
<POSITION>Consultant in Dental Public Health</POSITION>
<EMAIL_1>kate.jones@nhs.net</EMAIL_1>
<EMAIL_2>kate.jones@nhs.net</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>NHS Sheffield</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Sheffield</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="8328" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Helen</FIRST_NAME>
<MIDDLE_INITIALS>V</MIDDLE_INITIALS>
<LAST_NAME>Worthington</LAST_NAME>
<SUFFIX/>
<POSITION>Co-ordinating Editor</POSITION>
<EMAIL_1>helen.worthington@manchester.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Oral Health Group</DEPARTMENT>
<ORGANISATION>School of Dentistry, The University of Manchester</ORGANISATION>
<ADDRESS_1>Coupland III Building, Oxford Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Manchester</CITY>
<ZIP>M13 9PL</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 161 306 0237</PHONE_1>
<PHONE_2>+44 161 275 7819</PHONE_2>
<FAX_1>+44 161 275 7815</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2012-11-12 10:24:52 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="7" MONTH="11" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="29" MONTH="10" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="12" MONTH="10" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2008"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2012-11-12 10:25:05 +0000" MODIFIED_BY="[Empty name]"/>
<HISTORY/>
<SOURCES_OF_SUPPORT MODIFIED="2012-11-13 12:09:12 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-11-13 12:09:12 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-11-13 12:07:52 +0000" MODIFIED_BY="[Empty name]">
<NAME>The University of Manchester</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-11-13 12:09:12 +0000" MODIFIED_BY="[Empty name]">
<NAME>Manchester Academic Health Sciences Centre (MAHSC)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The Cochrane Oral Health Group is supported by the MAHSC and the NIHR Manchester Biomedical Research Centre.</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-11-13 12:07:05 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-11-13 12:06:09 +0000" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Oral Health Group Global Alliance</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>All reviews in the Cochrane Oral Health Group are supported by Global Alliance member organisations (British Orthodontic Society, UK; British Society of Paediatric Dentistry, UK; National Center for Dental Hygiene Research &amp; Practice, USA and New York University College of Dentistry, USA) providing funding for the editorial process (<A HREF="http://ohg.cochrane.org">http://ohg.cochrane.org</A>).</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2012-11-13 12:07:05 +0000" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>All reviews in the Cochrane Oral Health Group are supported by NIHR Systematic Reviews Programme infrastructure funding.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-11-13 17:08:04 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-11-13 16:13:23 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-11-08 17:35:52 +0000" MODIFIED_BY="[Empty name]">What treatments can be used to prevent and treat alveolar osteitis (dry socket)?</TITLE>
<SUMMARY_BODY MODIFIED="2012-11-13 16:13:23 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket is a condition that sometimes arises when teeth have been extracted and is more likely to occur following extraction of wisdom teeth in the lower jaw. It is thought to be linked to the loss of some or all of the blood clot that forms at the bottom of a socket after a tooth is taken out, although other factors are probably also involved. Dry socket can be very painful for several days after an extraction and people with this condition can also experience bad breath. The condition can result in more visits to the dentist or dental hospital and other inconveniences such as time lost from work.</P>
<P>This review looked at existing research with the aim of assessing what treatments can be used to prevent and to treat alveolar osteitis (dry socket). The search for existing studies was done on 29 October 2012.</P>
<P>The review team identified 21 trials which met the inclusion criteria for this review: 18 trials (2376 participants) looking at different ways to prevent dry socket and three trials (194) on the treatment of dry socket.</P>
<P>The studies looked at adults over 18 years of age and included (amongst others) people who smoked and took oral contraceptives (both possible risk factors). However, studies involving people who were extremely ill or who had compromised immune systems were not included. Studies which looked at the use of antibiotics to manage dry socket were also not included.</P>
<P>
<B>Prevention</B>
</P>
<P>It was found that there is some evidence to show that rinsing both before and after tooth extraction with chlorhexidine gluconate rinse (at 0.12% and 0.2% strength) reduced the risk of having a dry socket. Placing chlorhexidine gel (0.2% strength) in the socket of an extracted tooth also reduced the risk of having dry socket.</P>
<P>The risk of developing dry socket depends on many factors, some of which are unknown. Your dentist or dental care professional (DCP) should be able to advise you of your own risk status.</P>
<P>To illustrate the effectiveness of chlorhexidine treatment as a preventive measure: if the risk of contracting alveolar osteitis (dry socket) was 1% (one in a hundred) then 232 people undergoing tooth extractions would need to be treated to prevent one case of dry socket; if the risk was 5%, then the number needed to be treated to prevent one case of dry socket would be 47; if the risk rises to 30%, the number needed to be treated to prevent one case of dry socket would be 8.</P>
<P>In these trials no serious side effects or reactions by patients due to chlorhexidine were reported. However, two serious events associated with the use of chlorhexidine mouthwash for irrigation of dry socket have been reported in the UK. If people have a history of allergies or have had adverse reactions previously to the use of chlorhexidine mouthwashes they should tell their dentist or DCP before using chlorhexidine. They should also tell their dentist or DCP if they experience any unusual symptoms such as rashes, itching or swelling of the lips whilst using chlorhexidine.</P>
<P>It is recommended that all members of the dental team prescribing chlorhexidine products are aware of the potential for both minor and serious side effects, are competent to manage a medical emergency associated with anaphylaxis (toxic shock) and warn patients of the potential for adverse events.</P>
<P>
<B>Treatment</B>
</P>
<P>There was insufficient evidence to conclude whether any treatments relieved established dry socket or not. <I> </I>   </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-11-13 16:50:59 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-11-12 10:29:03 +0000" MODIFIED_BY="[Empty name]">
<P>Alveolar osteitis (dry socket) is a complication of dental extractions and occurs more commonly in extractions involving mandibular molar teeth. It is associated with severe pain developing 2 to 3 days postoperatively, a socket that may be partially or totally devoid of blood clot and in some patients there may be a complaint of halitosis. It can result in an increase in postoperative visits.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-11-12 10:28:47 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effects of local interventions for the prevention and treatment of alveolar osteitis (dry socket) following tooth extraction.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-11-01 15:05:35 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>The following electronic databases were searched: the Cochrane Oral Health Group Trials Register (to 29 October 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2012, Issue 10), MEDLINE via OVID (1946 to 29 October 2012) and EMBASE via OVID (1980 to 29 October 2012). There were no restrictions regarding language or date of publication. We also searched the reference lists of articles and contacted experts and organisations to identify any further studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-11-12 11:19:47 +0000" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials of adults over 18 years of age who were having permanent teeth extracted or who had developed dry socket post-extraction. We included studies with any type of local intervention used for the prevention or treatment of dry socket, compared to a different local intervention, placebo or no treatment. We excluded studies reporting on systemic use of antibiotics or the use of surgical techniques for the management of dry socket because these interventions are evaluated in separate Cochrane reviews.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-11-12 12:28:25 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently undertook risk of bias assessment and data extraction in duplicate for included studies using pre-designed proformas. Any reports of adverse events were recorded and summarised into a table when these were available. We contacted trial authors for further details where these were unclear. We followed The Cochrane Collaboration statistical guidelines and reported dichotomous outcomes as risk ratios (RR) and calculated 95% confidence intervals (CI) using random-effects models. For some of the split-mouth studies with sparse data it was not possible to calculate RR so we calculated the exact odds ratio instead. We used the GRADE tool to assess the quality of the body of evidence.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-11-13 16:50:53 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty-one trials with 2570 participants met the inclusion criteria; 18 trials with 2376 participants for the prevention of dry socket and three studies with 194 participants for the treatment of dry socket. The risk of bias assessment identified six studies at high risk of bias, 14 studies at unclear risk of bias and one studies at low risk of bias. When compared to placebo, rinsing with chlorhexidine mouthrinses (0.12% and 0.2% concentrations) both before and after extraction(s) prevented approximately 42% of dry socket(s) with a RR of 0.58 (95% CI 0.43 to 0.78; P &lt; 0.001) (four trials, 750 participants, moderate quality of evidence). The prevalence of dry socket varied from 1% to 5% in routine dental extractions to upwards of 30% in surgically extracted third molars. The number of patients needed to be treated with (0.12% and 0.2%) chlorhexidine rinse to prevent one patient having dry socket (NNT) was 232 (95% CI 176 to 417), 47 (95% CI 35 to 84) and 8 (95% CI 6 to 14) for control prevalences of dry socket of 1%, 5% and 30% respectively.</P>
<P>Compared to placebo, placing chlorhexidine gel (0.2%) after extractions prevented approximately 58% of dry socket(s) with a RR of 0.42 (95% CI 0.21 to 0.87; P = 0.02) (two trials, in 133 participants, moderate quality of evidence). The number of patients needed to be treated with chlorhexidine gel to prevent one patient having dry socket (NNT) was 173 (95% CI 127 to 770), 35 (95% CI 25 to 154) and 6 (95% CI 5 to 26) for control prevalences of dry socket of 1%, 5% and 30% respectively.</P>
<P>A further 10 intrasocket interventions to prevent dry socket were each evaluated in single studies, and therefore there is insufficient evidence to determine their effects. Five interventions for the treatment of dry socket were evaluated in a total of three studies providing insufficient evidence to determine their effects.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-11-13 16:50:59 +0000" MODIFIED_BY="[Empty name]">
<P>Most tooth extractions are undertaken by dentists for a variety of reasons, however, all but three studies included in the present review included participants undergoing extraction of third molars, most of which were undertaken by oral surgeons. There is some evidence that rinsing with chlorhexidine (0.12% and 0.2%) or placing chlorhexidine gel (0.2%) in the sockets of extracted teeth, provides a benefit in preventing dry socket. There was insufficient evidence to determine the effects of the other 10 preventative interventions each evaluated in single studies. There was insufficient evidence to determine the effects of any of the interventions to treat dry socket. The present review found some evidence for the association of minor adverse reactions with use of 0.12%, 0.2% and 2% chlorhexidine mouthrinses, though most studies were not designed to detect the presence of hypersensitivity reactions to mouthwash as part of the study protocol. No adverse events were reported in relation to the use of 0.2% chlorhexidine gel placed directly into a socket (though previous allergy to chlorhexidine was an exclusion criterion in these trials). In view of recent reports in the UK of two cases of serious adverse events associated with irrigation of dry socket with chlorhexidine mouthrinse, it is recommended that all members of the dental team prescribing chlorhexidine products are aware of the potential for both minor and serious adverse side effects.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-11-13 16:59:03 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-11-12 20:50:20 +0000" MODIFIED_BY="[Empty name]">
<P>Teeth are routinely extracted in general dental practice because they are affected by tooth decay or periodontal disease. In spite of the generalised overall improvements in oral health, it is estimated that European dentists in general dental practice extract up to seven teeth per week (<LINK REF="REF-McCaul-2001" TYPE="REFERENCE">McCaul 2001</LINK>). Alveolar osteitis (dry socket) is a complication that may follow tooth extraction (<LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>). It tends to occur when the blood clot in an extraction socket is disrupted prematurely leaving bone unprotected and exposed to the oral environment. The socket may become packed with food and bacteria and breakdown products from these are said to lead to further dissolution of the blood clot (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). Dry socket typically presents as postoperative pain of increasing severity in and around the extraction site at 1 to 3 days after the extraction. The socket may be partially or totally devoid of a blood clot and the patient may also complain of halitosis (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="2">Aetiology and prevalence</HEADING>
<P>Dry socket is a complication associated with 0.5% to 5% of routine extractions (<LINK REF="STD-Field-1988" TYPE="STUDY">Field 1988</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>), and is reported to occur more often after the extraction of mandibular molars, especially impacted wisdom teeth (1% to 37.5%) (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="REF-Fridrich-1990" TYPE="REFERENCE">Fridrich 1990</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). The aetiology of dry socket is not fully understood and a number of mechanisms and factors have been postulated that include: flap extent and design, surgical trauma, experience of the surgeon, perioperative patient stress factors and focal fibrinolytic activity (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="REF-Fazakerley-1991" TYPE="REFERENCE">Fazakerley 1991</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). The focal fibrinolytic activity mechanisms were postulated to occur through plasminogen mediated fibrinolysis, non-plasminogen mediated fibrinolysis and leukocyte mediated fibrinolysis (<LINK REF="REF-Fazakerley-1991" TYPE="REFERENCE">Fazakerley 1991</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). Women appear to be at higher risk from dry socket compared to men. A number of explanations for this gender difference in prevalence have been suggested e.g. changes that occur in the blood clotting mechanism during the menstrual cycle and the use of oral contraceptives (<LINK REF="REF-Garcia-2003" TYPE="REFERENCE">Garcia 2003</LINK>; <LINK REF="REF-Muhonen-1997" TYPE="REFERENCE">Muhonen 1997</LINK>). The highest incidence of dry socket is reported in the fourth decade of life (<LINK REF="REF-Rood-1981" TYPE="REFERENCE">Rood 1981</LINK>; <LINK REF="REF-Rud-1970" TYPE="REFERENCE">Rud 1970</LINK>), but this figure may be artefactual in view of the increased likelihood of tooth loss in later life (<LINK REF="STD-Butler-1977" TYPE="STUDY">Butler 1977</LINK>). There is some evidence that people who have experienced dry sockets previously may be at greater risk to experiencing dry socket compared to those who have never had a dry socket (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>).</P>
<P>Several reviews have suggested a causal relationship between the complexity of the dental extraction and the occurrence of dry socket (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>; <LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). Smoking is considered to be another factor that may increase the risk of developing dry socket after tooth extraction (<LINK REF="REF-Sweet-1978" TYPE="REFERENCE">Sweet 1978</LINK>). Additional risk factors include: infection around the tooth to be extracted, inadequate oral hygiene (<LINK REF="STD-Tjernberg-1979" TYPE="STUDY">Tjernberg 1979</LINK>), and poor after care (<LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>). There is very limited supportive evidence for some of the other reasons that may account for the loss of blood clot from a socket which include forceful spitting, sucking through a straw, coughing or sneezing (<LINK REF="STD-Bloomer-2012" TYPE="STUDY">Bloomer 2012</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). While bacterial breakdown and fibrinolysis is widely accepted as a major contributor to the loss of the blood clot, no studies have convincingly demonstrated an unequivocal bacterial cause for dry socket (<LINK REF="REF-Alexander-2000" TYPE="REFERENCE">Alexander 2000</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Symptoms and diagnosis</HEADING>
<P>Two of the key challenges when conducting this review were the multitude of terminologies used for dry socket and the classification of signs and symptoms that were accepted as determining the presence of dry socket. Dry socket was frequently conflated with an infected socket in some studies. A continuous throbbing pain that radiates to the ear, temple and neck is the most common symptom of dry socket (<LINK REF="STD-Swanson-1989" TYPE="STUDY">Swanson 1989</LINK>). Classically, this starts 1 to 3 days post-extraction and may be accompanied by other signs and symptoms e.g. foul taste, bad breath, localised swelling and lymph-node involvement (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>; <LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). The symptoms can persist for up to 10 days after extraction and may include pain so severe that it is not relieved by even the strongest of analgesic medications (<LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>).</P>
<P>Clinical history and examination are the principal methods of reaching a diagnosis. The clinical picture is of an extraction socket that is visually devoid of a blood clot but other causative factors for severe postoperative pain should be excluded e.g. infected retained roots (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>; <LINK REF="REF-Kolokythas-2010" TYPE="REFERENCE">Kolokythas 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Prevention</HEADING>
<P>There have been a number of theories as to the aetiology of dry socket and a range of preventative agents have been advocated according to the prevailing theory of causation at the time including: plaque control, antiseptic rinses, preoperative systemic antibiotics and direct placement of medicaments into the socket (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="STD-Goldman-1973" TYPE="STUDY">Goldman 1973</LINK>; <LINK REF="STD-Hall-1971" TYPE="STUDY">Hall 1971</LINK>; <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK>; <LINK REF="REF-Kolokythas-2010" TYPE="REFERENCE">Kolokythas 2010</LINK>; <LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). Several studies have reported that preoperative and postoperative antiseptic chlorhexidine rinses can be effective in reducing the incidence of dry socket (<LINK REF="STD-Berwick-1990" TYPE="STUDY">Berwick 1990</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Tjernberg-1979" TYPE="STUDY">Tjernberg 1979</LINK>). Other studies have reported on the use of intrasocket antibiotic medicaments (<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>), and intrasocket antifibrinolytic agents (<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>). Studies have also reported upon the use of flap design to minimise trauma and risk of dry socket (<LINK REF="STD-Bello-2011" TYPE="STUDY">Bello 2011</LINK>; <LINK REF="STD-Haraji-2010" TYPE="STUDY">Haraji 2010</LINK>; <LINK REF="STD-Kirk-2007" TYPE="STUDY">Kirk 2007</LINK>). The prophylactic use of systemic antibiotics is not generally advocated and there is a consensus that these measures should be reserved for individual patients reporting a history of multiple incidents of dry socket or for the immunocompromised patient (<LINK REF="REF-Epstein-2000" TYPE="REFERENCE">Epstein 2000</LINK>; <LINK REF="REF-Fazakerley-1991" TYPE="REFERENCE">Fazakerley 1991</LINK>). A recent Cochrane review concluded that there is moderate quality evidence that antibiotics may reduce the risk of dry socket by 38% (risk ratio (RR) 0.62; 95% confidence interval (CI) 0.41 to 0.95; P = 0.03) in pooled data of 1429 participants who had surgical removal of third molars (<LINK REF="REF-Lodi-2012" TYPE="REFERENCE">Lodi 2012</LINK>). This should be balanced against the increased risk of mild and transient adverse events associated with prescribing antibiotics compared to placebo (RR 1.98; 95% CI 1.10 to 3.59; P = 0.02) (<LINK REF="REF-Lodi-2012" TYPE="REFERENCE">Lodi 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Treatment</HEADING>
<P>Forty-five percent of patients with dry socket require multiple postoperative visits, which could have significant consequences for the individual patient as well as societal costs including time off work (<LINK REF="REF-Nusair-2007" TYPE="REFERENCE">Nusair 2007</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). Treatment options tend to focus on symptomatic relief, which may include the removal of debris from the socket by irrigation with saline or sterile local anaesthetic, and the use of analgesic medication (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>). Alternative options include the placement of intrasocket medicaments including antibacterials, topical anaesthetics and obtundents or combinations of all three (<LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK>). These intrasocket medications include zinc oxide and eugenol impregnated cotton pellets (<LINK REF="STD-Bloomer-2000" TYPE="STUDY">Bloomer 2000</LINK>), alvogyl (eugenol, iodoform and butamen) (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>), dentalone, bismuth subnitrate and iodoform paste (BIPP) on ribbon gauze and metronidazole and lidocaine ointment (<LINK REF="REF-Silva-2006" TYPE="REFERENCE">Silva 2006</LINK>). Some studies have also reported the use of lasers for the treatment of dry socket (<LINK REF="STD-Jovanovic-2011" TYPE="STUDY">Jovanovic 2011</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>).</P>
</SUBSECTION>
<IMPORTANCE MODIFIED="2012-11-12 13:50:42 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket is a complication of dental extractions that is associated with severe pain and can result in an increase in postoperative visits. Prevention of dry socket as well as the effective management of its sequelae can help in reducing postoperative morbidity for the individual as well as societal costs, for example, lost time from work and healthcare costs. A systematic review of the current best evidence for the effects of the available interventions could help to inform clinical decision making for the prevention and management of dry socket.</P>
<P>This systematic review will summarise the evidence of local interventions for the management of dry socket. Another Cochrane review summarises the evidence of the effects of systemic antibiotics prescribed to prevent infectious complications following tooth extraction which includes dry socket as one of the primary outcomes (<LINK REF="REF-Lodi-2012" TYPE="REFERENCE">Lodi 2012</LINK>). A further ongoing Cochrane review will evaluate the evidence for surgical techniques (such as surgical drains, wound irrigation and different flap designs) for the removal of mandibular wisdom teeth, which also includes dry socket as a primary outcome (<LINK REF="REF-Coulthard-2003" TYPE="REFERENCE">Coulthard 2003</LINK>). In order to avoid duplication this review evaluates other 'local' interventions for the prevention and treatment of dry socket.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-10-10 20:12:46 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>To assess the effects of local interventions used for the prevention and treatment of alveolar osteitis (dry socket).</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-11-13 16:51:37 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-11-12 15:53:34 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-11-12 15:53:34 +0000" MODIFIED_BY="[Empty name]">
<P>We only considered randomised controlled trials (RCTs) for inclusion in this review. All studies included in this review utilised and reported explicit and validated criteria that were used in the diagnosis of dry socket. The diagnosis of dry socket was based on the <LINK REF="REF-Blum-2002" TYPE="REFERENCE">Blum 2002</LINK> criteria i.e. a continuous throbbing pain starting 1 to 3 days post-extraction, a socket that may be partially or totally devoid of blood clot and which may be accompanied by other signs and symptoms such as foul taste, bad breath, localised swelling and lymph-node involvement.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-11-12 14:05:30 +0000" MODIFIED_BY="[Empty name]">
<P>We considered studies that included adults over the age of 18 years who had undergone an extraction (routine or more complex surgical) of one or more permanent teeth under local anaesthesia with or without sedation or under general anaesthesia. We included studies that included participants who were smokers. We excluded participants who were immunocompromised, had any co-morbidities or medical conditions that might influence the healing of oral tissues.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-11-12 14:08:33 +0000" MODIFIED_BY="[Empty name]">
<P>We considered studies that included any type of local intervention used for the management of dry socket compared to a different local intervention, placebo or no treatment. We included studies that permitted the use of concomitant pain medication provided it was made available equally to both groups. We excluded studies that examined the effectiveness of local interventions to prevent dry socket and then subsequently to treat dry sockets.</P>
<P>We excluded studies which reported upon the use of systemic antibiotics because these are covered in a separate Cochrane review (<LINK REF="REF-Lodi-2012" TYPE="REFERENCE">Lodi 2012</LINK>). Likewise, we excluded studies evaluating the use of different surgical procedures (including drains and lavage volume) to manage dry socket because these interventions are part of another ongoing Cochrane review (<LINK REF="REF-Coulthard-2003" TYPE="REFERENCE">Coulthard 2003</LINK>)</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-11-12 14:10:53 +0000" MODIFIED_BY="[Empty name]">
<P>We considered studies that included outcome measures that were reported according to clinically important time-points i.e. at the end of the intervention and during a follow-up period of up to 2 weeks.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<P>For prevention of dry socket.</P>
<OL>
<LI>Proportion of participants presenting with a dry socket within 1 week post-treatment.</LI>
</OL>
<P>For treatment of established dry socket.</P>
<OL>
<LI>Time to heal dry socket.</LI>
<LI>Pain: its severity and duration from time of administration of intervention to relief of pain assessed using any patient-reported validated pain scale.</LI>
<LI>Swelling: assessed using photography or digital morphometry.</LI>
<LI>Limitation of chewing or swallowing and time to resumption of normal feeding.</LI>
<LI>Fever.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<P>Secondary outcomes assessed were for the treatment of dry sockets.</P>
<OL>
<LI>Quality of life as assessed by a validated questionnaire.</LI>
<LI>Patient satisfaction assessed by any validated measure.</LI>
<LI>Costs.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse effects</HEADING>
<P>Any specific adverse effects related to any clinically diagnosed reactions to any of the active interventions were noted and reported as an additional table.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-11-13 12:19:05 +0000" MODIFIED_BY="[Empty name]">
<P>Detailed search strategies for each database searched were developed to identify relevant trials. The search strategies were based on the search strategy developed for MEDLINE (OVID) but revised appropriately for each database. The search strategy used a combination of controlled vocabulary and free text terms and was linked with the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials (RCTs) in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the <I>Cochrane Handbook for</I> <I>Systematic Reviews of Interventions</I> Version 5.1.0 [updated March 2011] (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>)<I>.</I> Details of the MEDLINE search are provided in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The search of EMBASE was linked to the Cochrane Oral Health Group filter for identifying RCTs.</P>
<ELECTRONIC_SEARCHES MODIFIED="2012-11-13 12:19:05 +0000" MODIFIED_BY="[Empty name]">
<P>The following electronic databases were searched.</P>
<UL>
<LI>The Cochrane Oral Health Group Trials Register (to 29 October 2012) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>)</LI>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I>, 2012, Issue 10) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>)</LI>
<LI>MEDLINE via OVID (1946 to 29 October 2012) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>)</LI>
<LI>EMBASE via OVID (1980 to 29 October 2012) (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>)</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Language</HEADING>
<P>There was no language restriction on included studies. Any non-English papers that were identified were translated and assessed for eligibility.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-11-12 14:18:09 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Handsearching</HEADING>
<P>We did not conduct any additional handsearching outside the Cochrane Collaboration's worldwide handsearching programme (see the Cochrane <A HREF="http://us.cochrane.org/master-list">Master List</A> of journals that have been searched). We examined the reference lists of any potential clinical trials to help identify additional studies not identified by the electronic searches.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Unpublished studies</HEADING>
<P>To identify possible unpublished or ongoing studies, we contacted investigators of several included studies and other researchers, experts and organisations known in this field.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-11-13 16:51:37 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-11-12 14:21:02 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the abstracts of retrieved studies. We obtained full copies of studies deemed to be relevant, potentially relevant i.e. those appearing to meet the inclusion criteria, or for which there was insufficient information in the title and abstract to make a clear decision. Two review authors then assessed full text papers independently and any disagreements on the eligibility of included studies were resolved through discussion and consensus. If necessary, a third review author was consulted.<BR/>
<BR/>We excluded any studies that did not match the inclusion criteria at this stage or at subsequent stages and noted the reasons for exclusion in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table. <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> presents the study flow diagram.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-11-12 14:24:49 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors collected study details and outcomes data independently and in duplicate using a predetermined form designed for this purpose. These were entered into the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table and outcome data were entered into additional tables or as forest plots in RevMan and any disagreements were discussed. Data were only included if there was an independently reached consensus. If necessary a third review author was consulted to resolve inconsistencies.</P>
<P>We extracted the following details.</P>
<OL>
<LI>Trial methods:<I> </I>(a) method of allocation; (b) masking of participants, operators and outcomes; (c) exclusion of participants after randomisation and proportion of losses at follow-up and number analysed.</LI>
<LI>Participants: (a) country of origin; (b) sample size and sample size calculation; (c) age; (d) gender; (e) inclusion and exclusion criteria.</LI>
<LI>Intervention and control: type and procedural information including dose, mode of local use, time of administration relative to extraction details of any other concomitant medication.</LI>
<LI>Outcomes: primary and secondary outcomes, methods of assessment and completeness of reporting as outlined in the <A HREF="https://mail.google.com/mail/html/compose/static_files/CRIT_OUTCOMES">Types of outcome measures</A> section of this review.</LI>
</OL>
<P>If stated, we recorded the sources of funding of any of the included studies.</P>
<P>This information was used to help assess the clinical diversity and generalisability of any included trials.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-11-12 14:33:05 +0000" MODIFIED_BY="[Empty name]">
<P>Studies identified for inclusion in this review were assessed independently by two review authors who graded them using the Cochrane risk of bias tool described in Chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The independent evaluations were compared and discussed and any disagreements were resolved.<BR/>
</P>
<P>We assessed each trial for the following domains.</P>
<OL>
<LI>Sequence generation (selection bias)</LI>
<LI>Allocation concealment (selection bias)</LI>
<LI>Blinding of participants and personnel (performance bias)</LI>
<LI>Blinding of outcome assessors (performance bias)</LI>
<LI>Completeness of outcome data</LI>
<LI>Risk of selective outcome reporting</LI>
<LI>Risk of other bias</LI>
</OL>
<P>For each domain a description of what occurred as reported in the journal article was described and a judgement made on the risk of bias: high, unclear or low risk of bias. The judgement was determined using guidance as described in Chapter 8 of the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>The assessments for each included study are reported in the corresponding section of the risk of bias tables in RevMan 5 (<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Overall risk of bias</HEADING>
<UL>
<LI>Low risk of bias: all domains are judged to be at low risk of bias.</LI>
<LI>Unclear risk of bias: one or more domains judged to be at unclear risk of bias.</LI>
<LI>High risk of bias: one or more domains judged to be at high risk of bias.</LI>
</UL>
<P>Th overall risk of bias assessment was undertaken without blinding of review authors to the study authors' names or organisations, or the journal type. The independent evaluations were compared and discussed and any disagreements were resolved.</P>
<P>The results of the risk of bias assessment are presented graphically both by domain and by study (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-11-13 16:51:28 +0000" MODIFIED_BY="[Empty name]">
<P>The primary measure of intervention effect for the prevention of dry socket was the reduction in incidence of dry socket between the control and intervention groups i.e. proportion of participants presenting with a dry socket within 1 week post-treatment. For the treatment of dry socket the primary measure of intervention effect was the reduction in the time to heal of the socket and reduction in the incidence of pain, swelling, functional limitation (chewing, swallowing and time to resumption of normal feeding) and fever.</P>
<P>Secondary measures of intervention effect for the prevention and treatment of dry socket were: quality of life, patient satisfaction and costs between the intervention group and the control.</P>
<P>For each intervention, we recorded data on each patient in both the control and intervention group who experienced the event and the total number of patients involved in both control and intervention arms.</P>
<P>For dichotomous data, we calculated the risk ratio (relative risk), which is the ratio of the risk of an event occurring in the experimental and control group, together with the 95% confidence interval. For the split-mouth studies with sparse data, the risk ratio could sometimes not be calculated, and we calculated the exact odds ratio instead. For continuous outcomes, we used the mean differences and 95% confidence intervals to summarise the data for each group where the mean difference and standard deviations were calculable from the data presented.</P>
<P>If we had identified any data obtained from visual analogue scales and any categorical outcomes we would have converted them into dichotomous data if appropriate prior to analysis.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-11-12 20:07:05 +0000" MODIFIED_BY="[Empty name]">
<P>The outcomes specified for this review necessitated repeated observations on the participants over a comparatively short period of time during and after the interventions. Therefore, depending on sufficient data being available, we grouped the outcomes and analysed them according to clinically important time-points; at the end of the intervention and during the follow-up period. We analysed the split-mouth studies using 'paired' methods such as those outlined in <LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>. We calculated risk ratios for the paired differences for whether the site had a dry socket or not, together with the appropriate standard errors and 95% confidence intervals using Stata software version 12.0.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-11-12 14:40:22 +0000" MODIFIED_BY="[Empty name]">
<P>We contacted authors of included studies to obtain missing trial details and data from the reports.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-11-12 14:42:33 +0000" MODIFIED_BY="[Empty name]">
<P>We assessed clinical heterogeneity by examining the characteristics of the studies, the similarity between the types of participants, the interventions and the outcomes as specified in the criteria for included studies. We assessed statistical heterogeneity using a Chi<SUP>2</SUP> test and the I<SUP>2</SUP> statistic where I<SUP>2</SUP> values over 50% indicate moderate to high heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>). The Cochrane Handbook also gives a rough guide to heterogeneity measured by I<SUP>2 </SUP>as follows: 0-40% may not be important, 30 to 60% represents moderate heterogeneity, 50 to 90% may be classified as substantial heterogeneity and 75 to 100% represents considerable heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>In the event that there were insufficient clinically homogeneous trials for any specific intervention or insufficient study data that could be pooled, a narrative synthesis was presented</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-11-12 14:46:27 +0000" MODIFIED_BY="[Empty name]">
<P>If sufficient trials had been identified for inclusion in this review, we would have assessed publication bias according to the recommendations on testing for funnel plot asymmetry (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>), as described in section 10.4.3.1 of the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and if asymmetry was identified, other possible causes would have been assessed.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-11-12 15:17:29 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors analysed the data and reported them as specified in Chapter 9 of the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Analysis was conducted at the same level as the allocation. The data for effects related to prevention were analysed and presented separately to those which considered treatment only.</P>
<P>We undertook pooling of data to provide estimates of the efficacy of the interventions if included studies were clinically and statistically homogeneous. We used risk ratios to pool the dichotomous outcomes where possible.</P>
<P>We calculated number needed to treat (NNT) for the pooled estimates using control prevalence rates for dry socket. Dry socket is a complication associated with 0.5% to 5% of routine extraction of teeth affected by periodontal disease and dental decay (<LINK REF="STD-Field-1988" TYPE="STUDY">Field 1988</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>), however, the prevalence of dry socket post-extraction of mandibular molars, especially impacted wisdom teeth is much higher (1% to 37.5%) (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="REF-Fridrich-1990" TYPE="REFERENCE">Fridrich 1990</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). For the assumed risk of dry socket in the control group for the 'Summary of findings' table, we set prevalence rates to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%).</P>
<P>In general, for the synthesis of any quantitative data, we used the random-effects model unless there were less than three studies, where we used fixed-effect model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-11-12 15:18:11 +0000" MODIFIED_BY="[Empty name]">
<P>The following subgroup analyses were planned if sufficient studies were identified: complexity of the extraction (surgical removal or simple extraction), whether or not prophylactic systemic antibiotics were prescribed and, different types of teeth (third molars, molars, premolars). However, there were insufficient studies to undertake subgroup analyses.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-11-13 16:51:37 +0000" MODIFIED_BY="[Empty name]">
<P>If a sufficient number of studies with similar characteristics had been included in the review, we would have undertaken sensitivity analyses to assess the robustness of the results by excluding studies at high risk of bias.</P>
<SUBSECTION>
<HEADING LEVEL="3">Presentation of the main results</HEADING>
<P>We used GRADEPro software to prepare two 'Summary of findings' tables for the main outcomes of this review. We used the mean risk of the outcome in the placebo or the control group as the assumed risk for each outcome and we then calculated the corresponding risk using the risk ratio (or the mean difference) estimate from the meta-analysis. In addition, we assessed the overall quality of the studies using the GRADE approach. In this approach, the quality of a body of evidence involves consideration of within-study risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias, as described in section 12.2.2 of the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The quality of the evidence was assessed as: high, moderate, low or very low.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-11-13 16:58:04 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-11-13 16:51:47 +0000" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2012-11-12 20:50:20 +0000" MODIFIED_BY="[Empty name]">
<P>The electronic and other searches retrieved 395 references to studies. <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> presents the study flow diagram. After examination of the titles and abstracts of these references, we eliminated all of those that did not match the inclusion criteria and were clearly ineligible. Full text copies of the remaining studies (n = 102) were obtained and these were then subjected to further evaluation. Several studies were translated; three (<LINK REF="STD-Birke-1970" TYPE="STUDY">Birke 1970</LINK>; <LINK REF="STD-Neugebauer-2004" TYPE="STUDY">Neugebauer 2004</LINK>; <LINK REF="STD-Neuner-1969" TYPE="STUDY">Neuner 1969</LINK>) were in German and one each was in Japanese (<LINK REF="STD-Anonymous-1966" TYPE="STUDY">Anonymous 1966</LINK>), Russian (<LINK REF="STD-Butylin-1977" TYPE="STUDY">Butylin 1977</LINK>), Serbian (<LINK REF="STD-Jovanovic-2011" TYPE="STUDY">Jovanovic 2011</LINK>), French (<LINK REF="REF-Turcotte-1997" TYPE="REFERENCE">Turcotte 1997</LINK>), Polish (<LINK REF="STD-Banach-1973" TYPE="STUDY">Banach 1973</LINK>) and three were in Chinese (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Wen-2004" TYPE="STUDY">Wen 2004</LINK>). We also examined the bibliographical references of all potentially eligible studies and two potentially relevant additional citations were identified (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Kirk-2007" TYPE="STUDY">Kirk 2007</LINK>). The full details of <LINK REF="STD-Babar-2012" TYPE="STUDY">Babar 2012</LINK> were not available at the time of publication of this review.</P>
<P>The search also retrieved two reviews: two with meta-analysis (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK>) and the remaining five were narrative reviews (<LINK REF="REF-Kolokythas-2010" TYPE="REFERENCE">Kolokythas 2010</LINK>; <LINK REF="STD-Neuner-1969" TYPE="STUDY">Neuner 1969</LINK>; <LINK REF="REF-Noroozi-2009" TYPE="REFERENCE">Noroozi 2009</LINK>; <LINK REF="REF-Turcotte-1997" TYPE="REFERENCE">Turcotte 1997</LINK>; <LINK REF="REF-Vezeau-2000" TYPE="REFERENCE">Vezeau 2000</LINK>). <LINK REF="REF-Yengopal-2012" TYPE="REFERENCE">Yengopal 2012</LINK> was published while the present review was at the editorial stage. All reviews were examined for potentially eligible studies.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-11-13 16:51:47 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty-one studies were included in this review. The majority (n = 18) evaluated interventions for the prevention of dry sockets (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). The three remaining included studies examined treatment strategies for dry sockets occurring after dental extraction (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>).<BR/>
</P>
<P>All the prevention trials comprehensively addressed the single (primary) outcome of whether a dry socket occurred or not. However, the three treatment trials only provided a limited amount of useable data for the primary and secondary outcomes of this review.</P>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the trial setting and investigators</HEADING>
<P>Thirteen of the studies had been conducted in college/university oral surgery departments: <LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK> (UK); <LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK> (China); <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK> (USA); <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK> (Denmark); <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK> (Spain); <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK> (China); <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> (Turkey); <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK> (Sweden); <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK> (Turkey); <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK> (UK); <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK> (Denmark); <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK> (Spain) and <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK> (Spain). Military clinics were the settings for three of the studies (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). One was a multi-centre study conducted in three dental practices in the UK (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>). The settings of the remaining four studies were not stated (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>).</P>
<P>The providers of care for thirteen of the included studies were not stated (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). The skill level and number of operators providing care where stated was variable. Single operators provided care in three of the included studies (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>). Either oral and maxillofacial surgeons, general dentists or general dentistry residents provided care for patients in three studies (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>). <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK> stated that "multiple surgeons with varying levels of experience" with "formal training in third molar removal" were responsible for provision of care. <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK> stated that four general dental practitioners were providers of care.</P>
<P>There were 18 studies of prevention and three on the treatment of dry socket. Three of the prevention studies were designed as split-mouth studies (<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>), and the remainder were parallel group design. Trials in the treatment review will always be of parallel group design as there would be insufficient patients with more than one dry socket to undertake this type of study design.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the participants</HEADING>
<P>The majority of the prevention studies (n = 16) involved sockets of mandibular third molar teeth in adults. Nine studies reported on mandibular third molars which were extracted under local anaesthesia with/without intravenous sedation (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>). A further three studies involved third molar teeth where the patients ages were not specified (<LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>). Three studies investigated prevention of dry socket after mandibular third molar extraction, however, patients below the age of 18 years were enrolled in: <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK> (age 17 to 46 years); <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK> (age 17 to 61 years) and <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK> (age 16 to 32 years). One further study investigated prevention of dry socket after mandibular third molar extraction, however, patient age was not stated (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>).</P>
<P>
<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK> investigated prevention of dry socket after non-surgical extraction of one or more molar/premolar teeth under local anaesthetic in adult patients (age 18 to 90 years), while <LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK> also reported on teeth other than third molars.</P>
<P>In the treatment studies, <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> reported on treatment of dry socket after mandibular third molar extraction, <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK> reported on premolars and molars and no specific tooth was identified in <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>. <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK> investigated the treatment of diagnosed dry socket in 17 to 58 year old patients, <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> investigated the treatment of diagnosed dry sockets in adults over 18 years of age and <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK> investigated the treatment of diagnosed dry socket, however, age and gender were unspecified.</P>
<P>The number of participants in the prevention studies ranged from 19 to 400 with a median of 86. The number of participants in the treatment studies ranged from 35 to 55 with a median of 52.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the interventions</HEADING>
<P>This section is divided into two main parts: the characteristics of the interventions for the 18 studies looking at the prevention of dry socket and the characteristics of the three trials looking at the treatment of dry socket.</P>
<SUBSECTION>
<HEADING LEVEL="5">Prevention</HEADING>
<P>The potentially active interventions in this section have been divided into two broad categories: antiseptics and intrasocket interventions.</P>
<SUBSECTION>
<HEADING LEVEL="6">Antiseptics (rinses)</HEADING>
<UL>
<LI>Chlorhexidine rinse (pre and post) versus placebo or saline (post) (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>)   <B> </B>
</LI>
<LI>Chlorhexidine rinse (pre) versus chlorhexidine rinse (post) (<LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>)  </LI>
<LI>Chlorhexidine gel versus chlorhexidine rinse (both post) (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>)</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Intrasocket interventions</HEADING>
<P>The following interventions were evaluated but only one comparison, intrasocket chlorhexidine gel, was evaluated in more than one trial.</P>
<UL>
<LI>Acellular dermal matrix patch (1 x 1 cm) versus no treatment (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>)</LI>
<LI>Apernyl versus placebo (<LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>)</LI>
<LI>Artemisia desertorum spreng (Shahaosan or Yunnan) versus placebo control (<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>)</LI>
<LI>Chlorhexidine gel versus placebo/no treatment (<LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>
</LI>
<LI>Clindamycin phosphate antibiotic solution patch versus saline patch (<LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>)</LI>
<LI>Glucocorticosteroid antibiotic agent versus normal saline (<LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>)</LI>
<LI>Heal-all tissue patch (2 x 2.5 cm) versus no treatment (<LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>)</LI>
<LI>Metronidazole gel versus placebo gel (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>)</LI>
<LI>P-hydroxybenzoic acid versus placebo (<LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>)</LI>
<LI>Platelet rich plasma versus control (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>)</LI>
<LI>Tranexamic acid versus placebo (<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>)</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Treatment</HEADING>
<UL>
<LI>Alvogyl versus no treatment  (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>)</LI>
<LI>Alvogyl versus SaliCept  (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>)  </LI>
<LI>Metronidazole versus placebo (<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>)               </LI>
<LI>SaliCept versus no treatment (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>)      </LI>
<LI>Topical anaesthetic gel (prilocaine-lidocaine) versus eugenol (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>)</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the outcome measures</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Prevention</HEADING>
<P>The primary (and only) outcome measure for prevention was the presence/absence of a dry socket. This was clearly reported in all 18 studies for prevention. Minor adverse events were reported in eight of the prevention studies (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Treatment</HEADING>
<P>Although three trials were looking at the treatment of dry socket, there was very little usable data reported. The data from <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> were unusable as medians and error bars for pain were presented in graphs. There was no evidence of a difference in pain at 48 hours in <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK> (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>
<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK> provided raw data on the duration of treatment and there was a statistically significant reduction in duration of treatment in the metronidazole group (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>
<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> (p1574) stated in the text: "The differences in the changes in the clinical signs and symptoms between the control group and all 3 treatment groups were statistically significant (P&lt;0.05) on the third day after treatment" and "Regardless of the treatment the VAS scores changed during the follow-up period (P&lt;0.001); however the intensity of the pain decreased more rapidly in all the treatment groups than for the control group (P&lt;0.05)".</P>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-11-12 20:59:37 +0000" MODIFIED_BY="[Empty name]">
<P>Eighty-one studies were excluded from this review and the reasons for their exclusion are summarised below:</P>
<UL>
<LI>Not a randomised controlled trial/inadequate method of sequence generation (n = 45): <LINK REF="STD-Annibali-2012" TYPE="STUDY">Annibali 2012</LINK>; <LINK REF="STD-Anonymous-1966" TYPE="STUDY">Anonymous 1966</LINK>; <LINK REF="STD-Banach-1973" TYPE="STUDY">Banach 1973;</LINK> <LINK REF="STD-Bloomer-2000" TYPE="STUDY">Bloomer 2000</LINK>; <LINK REF="STD-Bloomer-2012" TYPE="STUDY">Bloomer 2012</LINK>; <LINK REF="STD-Birke-1970" TYPE="STUDY">Birke 1970</LINK>; <LINK REF="STD-Brignardello-2012" TYPE="STUDY">Brignardello 2012</LINK>; <LINK REF="STD-Butylin-1977" TYPE="STUDY">Butylin 1977</LINK>; <LINK REF="STD-Christensen-2012" TYPE="STUDY">Christensen 2012</LINK>; <LINK REF="STD-Cooper-2012" TYPE="STUDY">Cooper 2012</LINK>; <LINK REF="STD-Field-1988" TYPE="STUDY">Field 1988</LINK>; <LINK REF="STD-Fotos-1992" TYPE="STUDY">Fotos 1992</LINK>; <LINK REF="STD-Garibaldi-1995" TYPE="STUDY">Garibaldi 1995</LINK>; <LINK REF="STD-Goldman-1973" TYPE="STUDY">Goldman 1973</LINK>; <LINK REF="STD-Goldsmith-2012" TYPE="STUDY">Goldsmith 2012</LINK>; <LINK REF="STD-Goyal-2012" TYPE="STUDY">Goyal 2012</LINK>; <LINK REF="STD-Hall-1971" TYPE="STUDY">Hall 1971</LINK>; <LINK REF="STD-Johnson-1988" TYPE="STUDY">Johnson 1988</LINK>; <LINK REF="STD-Jovanovic-2011" TYPE="STUDY">Jovanovic 2011</LINK>; <LINK REF="STD-Julius-1982" TYPE="STUDY">Julius 1982</LINK>; <LINK REF="STD-Keskitalo-1973" TYPE="STUDY">Keskitalo 1973</LINK>; <LINK REF="STD-Krekmanov-1986" TYPE="STUDY">Krekmanov 1986</LINK>; <LINK REF="STD-Kudiyirickal-2012" TYPE="STUDY">Kudiyirickal 2012</LINK>; <LINK REF="STD-Lao-2012" TYPE="STUDY">Lao 2012</LINK>; <LINK REF="STD-Liu-2011" TYPE="STUDY">Liu 2011</LINK>; <LINK REF="STD-Long-2012" TYPE="STUDY">Long 2012</LINK>; <LINK REF="STD-Malkawi-2011" TYPE="STUDY">Malkawi 2011</LINK>; <LINK REF="STD-MacGregor-1975" TYPE="STUDY">MacGregor 1975</LINK>; <LINK REF="STD-Mishra-2012" TYPE="STUDY">Mishra 2012</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Neugebauer-2004" TYPE="STUDY">Neugebauer 2004</LINK>; <LINK REF="STD-Neuner-1969" TYPE="STUDY">Neuner 1969</LINK>; <LINK REF="STD-Qi-2012" TYPE="STUDY">Qi 2012</LINK>; <LINK REF="STD-Ritzau-1978" TYPE="STUDY">Ritzau 1978</LINK>; <LINK REF="STD-Sanchis-2004" TYPE="STUDY">Sanchis 2004</LINK>; <LINK REF="STD-Sorensen-1987" TYPE="STUDY">Sorensen 1987</LINK>; <LINK REF="STD-Swanson-1989" TYPE="STUDY">Swanson 1989</LINK>; <LINK REF="STD-Sweet-1985" TYPE="STUDY">Sweet 1985</LINK>; <LINK REF="STD-Syrjanen-1981" TYPE="STUDY">Syrjanen 1981</LINK>; <LINK REF="STD-Tjernberg-1979" TYPE="STUDY">Tjernberg 1979</LINK>; <LINK REF="STD-Tong-2012" TYPE="STUDY">Tong 2012</LINK>; <LINK REF="STD-Vedtofte-1974" TYPE="STUDY">Vedtofte 1974</LINK>; <LINK REF="STD-Wen-2004" TYPE="STUDY">Wen 2004</LINK>; <LINK REF="STD-Yue-2012" TYPE="STUDY">Yue 2012</LINK>; <LINK REF="STD-Zanetta_x002d_Barbosa-1994" TYPE="STUDY">Zanetta-Barbosa 1994</LINK>.</LI>
<LI>Dry socket not defined (n = 11): <LINK REF="STD-Arakeri-2011" TYPE="STUDY">Arakeri 2011</LINK>; <LINK REF="STD-Arenaz_x002d_Bua-2010" TYPE="STUDY">Arenaz-Bua 2010</LINK>; <LINK REF="STD-Daniels-2011" TYPE="STUDY">Daniels 2011</LINK>; <LINK REF="STD-Hooley-1995" TYPE="STUDY">Hooley 1995</LINK>; <LINK REF="STD-Kirk-2007" TYPE="STUDY">Kirk 2007</LINK>; <LINK REF="STD-MacGregor-1973" TYPE="STUDY">MacGregor 1973</LINK>; <LINK REF="STD-Majid-2010" TYPE="STUDY">Majid 2010</LINK>; <LINK REF="STD-Mehlisch-2010a" TYPE="STUDY">Mehlisch 2010a</LINK>; <LINK REF="STD-Mehlisch-2010b" TYPE="STUDY">Mehlisch 2010b</LINK>; <LINK REF="STD-Nordenram-1973" TYPE="STUDY">Nordenram 1973</LINK>; <LINK REF="STD-Zuniga-2011" TYPE="STUDY">Zuniga 2011</LINK>.</LI>
<LI>Irrelevant outcomes (n = 1): <LINK REF="STD-Betts-1995" TYPE="STUDY">Betts 1995</LINK>.</LI>
<LI>Wrong interventions, comparisons or other inclusion criteria (n = 18): <LINK REF="STD-Akota-1998" TYPE="STUDY">Akota 1998</LINK>; <LINK REF="STD-Altman-2011" TYPE="STUDY">Altman 2011</LINK>; <LINK REF="STD-Al_x002d_Sukhun-2011" TYPE="STUDY">Al-Sukhun 2011</LINK>; <LINK REF="STD-Baqain-2012" TYPE="STUDY">Baqain 2012</LINK>; <LINK REF="STD-Bello-2011" TYPE="STUDY">Bello 2011</LINK>; <LINK REF="STD-Berwick-1990" TYPE="STUDY">Berwick 1990</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-Butler-1977" TYPE="STUDY">Butler 1977</LINK>; <LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-Haraji-2010" TYPE="STUDY">Haraji 2010</LINK>; <LINK REF="STD-Hill-2006" TYPE="STUDY">Hill 2006</LINK>; <LINK REF="STD-Krekmanov-1981" TYPE="STUDY">Krekmanov 1981</LINK>; <LINK REF="STD-Lopez_x002d_Cedrun-2011" TYPE="STUDY">Lopez-Cedrun 2011</LINK>; <LINK REF="STD-Mitchell-1986a" TYPE="STUDY">Mitchell 1986a</LINK>; <LINK REF="STD-Olusanya-2011" TYPE="STUDY">Olusanya 2011</LINK>; <LINK REF="STD-Schatz-1987" TYPE="STUDY">Schatz 1987</LINK>; <LINK REF="STD-Syrjanen-1981a" TYPE="STUDY">Syrjanen 1981a;</LINK> <LINK REF="STD-Torres_x002d_Lagares-2010" TYPE="STUDY">Torres-Lagares 2010</LINK>.</LI>
<LI>Study not related to dry socket (n = 1): <LINK REF="STD-Jolley-1972" TYPE="STUDY">Jolley 1972</LINK>.</LI>
<LI>Study unavailable or abstract available with insufficient information (n = 4): Study unobtainable: <LINK REF="STD-Nentwig-1985" TYPE="STUDY">Nentwig 1985</LINK>; <LINK REF="STD-Schlund-1968" TYPE="STUDY">Schlund 1968</LINK>. Abstracts available with insufficient information <LINK REF="STD-Olson-1987" TYPE="STUDY">Olson 1987</LINK>; <LINK REF="STD-Pichler-2001" TYPE="STUDY">Pichler 2001</LINK>.</LI>
<LI>Study awaiting classification (n = 1): <LINK REF="STD-Babar-2012" TYPE="STUDY">Babar 2012</LINK>.</LI>
</UL>
<P>Further information about the reasons for exclusion of these studies is available in the '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-11-13 14:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>For the prevention trials, the risk of bias assessment was undertaken for the primary outcome (whether or not the patient had a dry socket). As both the patients' and outcome assessors' assessment form part of the diagnosis of dry socket, the blinding assessment had to include both (both groups must be blinded for this category to have been assessed as being at low risk of bias). In studies where the operator was not blinded to group allocation, but the patient was blinded, it was difficult to assess the impact on performance bias as it was unclear if personnel had been told not to comment on the intervention being delivered, which could have resulted in inadvertent communication of group allocation.</P>
<ALLOCATION MODIFIED="2012-11-12 16:03:38 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Sequence Generation</HEADING>
<P>Random sequence generation was assessed at low risk of bias in nine studies (43%) (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>), and unclear in the remainder.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Allocation concealment was considered to be low risk of bias in seven trials (33%) (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>), and for the remainder of the studies it was deemed as either unclear (13 trials; 62%) or at high risk of bias (one trial; 5%) (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2012-11-12 16:05:01 +0000" MODIFIED_BY="[Empty name]">
<P>As both the patients' and outcome assessors' assessment form part of the diagnosis of dry socket, the blinding assessment has to include both (both groups must be blinded for this category to be assessed as being at low risk of bias).</P>
<P>Blinding was considered to be at low risk of bias for both performance and detection bias in five trials (24%) (<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). Blinding (performance bias) was judged as being unclear in 15 trials (71%) and at low risk of bias for six trials (29%). Blinding (detection bias) was judged as being at low risk in six trials (29%), unclear in 14 trials (67%) and at high risk in one trial.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-11-13 14:01:20 +0000" MODIFIED_BY="[Empty name]">
<P>We assumed that drop-outs in prevention of dry socket studies probably do not have dry socket as they would be returning for treatment. Fifteen (71%) of the trials were considered to be at low risk of bias with respect to incomplete outcome data (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). Four trials (19%) were considered to be at unclear risk with respect to incomplete outcomes (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>) and two studies were considered at high risk (<LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>). Twelve studies analysed the same number of patients as were analysed (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). Where reported, the range in the number of drop-outs was from three (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>) to 11 (<LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>). One study only assessed patients who returned with pain, so it was assumed that the other patients who did not return did not have dry socket (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-11-13 14:03:18 +0000" MODIFIED_BY="[Empty name]">
<P>Only the reporting of dry socket was considered for this item for the prevention trials. The majority of trials reported this well and were considered at low risk of bias. Two trials were unclear in their reporting (<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>), and three were considered to be at high risk of reporting bias (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>). <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK> only reported dry socket for extracted mandibular third molars although non-mandibular third molars were also extracted concurrently. <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK> as stated above only assessed patients who returned with pain, and <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK> did not report any data from the questionnaire completed by participants on day 7.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-11-13 14:10:16 +0000" MODIFIED_BY="[Empty name]">
<P>Two thirds of the trials (n = 14) were considered to be at low risk of bias from other sources. Five trials (24%) were deemed unclear in this respect (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>). The reporting in the <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK> trial in general was very poor and it was not possible to make a clear judgement in many domains. Two of the trials in this review were deemed to be at a high risk of bias from other sources. Of the high risk trials, investigators in the <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK> trial randomised at an individual participant level but subsequently analysed participants at an extraction site level; similarly <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK> randomised individuals, however, subsequent analyses were at tooth level.</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall assessment of bias</HEADING>
<P>All domains had to be assessed as being at low risk of bias for a study to be considered low risk of bias. If any domain was assessed as being at high risk of bias, the study was assessed as high risk of bias, the remainder were assessed as unclear. <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> presents the review authors' judgements about each risk of bias item presented as percentages across all included studies and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> presents review authors' judgements about each risk of bias item for each included study.</P>
<P>Only one study was assessed as being at low risk of bias overall (<LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>), 14 were deemed unclear (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>; <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>; <LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>; <LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>; <LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>; <LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>), and the six remaining studies were deemed as being at high risk of bias overall (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>).</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-11-13 16:58:04 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Prevention</HEADING>
<P>Forest plots have only been included when there was more than one study for a specific comparison.</P>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcome: prevention of dry socket</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Antiseptics (rinses) (comparison 1.1)</HEADING>
<P>Four trials, one at unclear risk of bias (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>) and three at high risk of bias (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>), compared rinsing with chlorhexidine at 0.12% concentration (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>) and 0.2% concentration (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>), both pre- and post-extraction, to rinsing with a placebo for the prevention of dry socket. The meta-analysis showed a clear benefit in rinsing with chlorhexidine with a risk ratio (RR) of 0.58 (95% confidence interval (CI) 0.43 to 0.78; P &lt; 0.001). There was no evidence of any heterogeneity (Chi<SUP>2</SUP> = 3.20, df = 3 (P = 0.36); I² = 6%). The number of patients needed to be treated by using the chlorhexidine rinse to prevent one patient having dry socket (NNT) was 232 (95% CI 176 to 417), 47 (95% CI 35 to 84) and 8 (95% CI 6 to 14) for control prevalences of dry socket of 0.01, 0.05 and 0.30 respectively (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>One single trial at unclear risk of bias compared rinsing with chlorhexidine (0.2% strength) both pre- and post-extraction, to rinsing just post-extraction (<LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>). A further single trial, at unclear risk of bias, compared inserting chlorhexidine gel (0.2%) into the socket with rinsing with chlorhexidine (0.12%) (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>). As these interventions were evaluated in single studies, there is insufficient evidence to determine their effects. The results for the placement of chlorhexidine gel directly in a socket are presented in the intrasocket section below.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Intrasocket interventions (comparison 1.2)</HEADING>
<P>The other 12 trials investigating intrasocket interventions all compared different interventions with placebo or no treatment as described below. </P>
<UL>
<LI>Acellular dermal matrix patch (1 x 1 cm) versus no treatment (<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>)</LI>
<LI>Apernyl versus placebo (<LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>)</LI>
<LI>Artemisia desertorum spreng (Shahaosan or Yunnan) versus placebo control (<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>)</LI>
<LI>Chlorhexidine gel versus placebo/no treatment (<LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>)</LI>
<LI>Clindamycin phosphate antibiotic solution patch versus saline patch (<LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>)</LI>
<LI>Glucocorticosteroid antibiotic agent versus normal saline (<LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>)</LI>
<LI>Heal-all tissue patch (2 x 2.5 cm) versus no treatment (<LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>)</LI>
<LI>Metronidazole gel versus placebo gel (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>)</LI>
<LI>P-hydroxybenzoic acid versus placebo (<LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>)</LI>
<LI>Platelet rich plasma versus control (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>)</LI>
<LI>Tranexamic acid versus placebo (<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>)</LI>
</UL>
<P>Two trials, one at low risk (<LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>) and one at high risk of bias (<LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>), compared placing chlorhexidine gel in the extracted socket with placebo or no treatment. The meta-analysis showed a benefit for chlorhexidine gel with a RR of 0.42 (95% CI 0.21 to 0.87; P = 0.02), with no evidence of heterogeneity (P = 0.60, I<SUP>2 </SUP>= 0%). The number of patients needed to be treated by chlorhexidine gel to prevent one patient having dry socket (NNT) was 173 (95% CI 127 to 770), 35 (95% CI 25 to 154) and 6 (95% CI 5 to 26) for control prevalences of dry socket 0.01, 0.05 and 0.30 respectively (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>The remaining 10 intrasocket interventions to prevent dry socket were each evaluated in single studies, and therefore there is insufficient evidence to determine their effects. The results are shown in 'Additional <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>'.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events reported in prevention studies</HEADING>
<P>'Additional <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>' summarises the adverse events reported in studies for prevention of dry socket. In the 21 trials included in this review, 10 trials with 1267 participants used chlorhexidine either in gel form or as a mouthwash (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). Four trials used 0.2% chlorhexidine rinse (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>), and three trials reported using 0.12% chlorhexidine rinse (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>). Adverse reactions in relation to the use of chlorhexidine mouthwash were reported in four trials (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>; <LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>). Adverse reactions included: staining of teeth, altered taste and bad taste, gastrointestinal complaints, numbness and paraesthesia. <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK> reported bad taste and stomach upset, though no staining of the teeth was noted. One person in the placebo group of this trial was reported to have had a "severe surgical infection" which the authors concluded was not attributable to the medication received. In contrast, neither <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991;</LINK> <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK> nor <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK> reported any adverse events associated with the use of chlorhexidine rinse, though it should be noted that <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK> specifically excluded participants with a previous history of chlorhexidine allergy from the trial. <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK> prescribed dexamethasone (glucocorticoid) IV for all patients immediately before surgery, which could have suppressed allergic symptoms to chlorhexidine but patients were instructed to rinse for 7 days from the day after surgery, so the protective effect of the steroid would have been expected to have reduced over time. In <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>, all patients were required to rinse with 0.2% chlorhexidine postoperatively three times daily. A foreign body reaction was noted, which the authors attributed to the delivery vehicle of the cones used to deliver the intrasocket medicament. No specific adverse events were reported in relation to the mouthwash, though the authors report that overall 42 patients (36.8%) stated that they experienced an unpleasant taste, general malaise was recorded in 31 patients (25.8%), 19 felt dizzy (16.1%) and 15 (12.5%) felt nausea. It is unclear from the reporting in this study whether these adverse effects were attributable to the after effects of third molar surgery, the delivery vehicle used in the experimental and control group or to the 0.2% mouthwash that was prescribed for all patients. Intrasocket medicaments containing chlorhexidine gels have been developed that are postulated to increase the bioavailability of chlorhexidine in the application (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>). No adverse events were reported in the three trials for prevention of dry socket using chlorhexidine 0.2% gels placed in the socket immediately after extraction of the third molar tooth (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008;</LINK> <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>). Participants in the <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK> trial who were allocated to the intrasocket gel group topped up the gel in the extraction socket twice daily for 7 days after the extraction. In two trials by <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK> and <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>, participants received only one application of the bio-adhesive gel during surgery. All three studies were derived from the same research group and all three excluded participants with a previous history of chlorhexidine allergy.</P>
<P>Of the other trials investigating intrasocket interventions, two reported adverse events: pain and burning sensation associated with apernyl (<LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>), and hematoma and rash associated with the use of P-hydroxybenzoic acid (<LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Treatment</HEADING>
<P>Three trials investigated the treatment of dry sockets (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>; <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>; <LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>) with the following: topical anaesthetic gel (prilocaine-lidocaine), alvogyl, SaliCept, and metronidazole. They were compared to no treatment or eugenol. A single study provided data for each comparison, with <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> having four arms. The data reported in <LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> cannot be used as medians are presented with error bars. The treatment comparisons were:</P>
<UL>
<LI>topical anaesthetic gel (prilocaine-lidocaine) versus eugenol  (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>);</LI>
<LI>alvogyl versus no treatment  (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>);      </LI>
<LI>SaliCept versus no treatment (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>);</LI>
<LI>alvogyl versus SaliCept  (<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK>); and     </LI>
<LI>metronidazole versus placebo (<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>).    </LI>
</UL>
<P>There was no evidence of a difference in pain levels at 48 hours in <LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK> (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>
<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK> provided raw data on the duration of treatment and there was a statistically significant reduction in duration of treatment in the metronidazole group (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<P>
<LINK REF="STD-Kaya-2011" TYPE="STUDY">Kaya 2011</LINK> (p1574) stated in the text: "The differences in the changes in the clinical signs and symptoms between the control group and all 3 treatment groups were statistically significant (P&lt;0.05) on the third day after treatment... Regardless of the treatment, the VAS (visual analogue scale) scores changed during the follow-up period (P&lt;0.001); however the intensity of the pain decreased more rapidly in all 3 treatment groups than for the control group (P&lt;0.05)".</P>
<P>No other outcomes included in the review were reported.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events reported in treatment studies</HEADING>
<P>None of the three studies that reported on the treatment of dry sockets reported any adverse events.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-11-13 16:59:03 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-11-13 16:58:42 +0000" MODIFIED_BY="[Empty name]">
<P>There were 21 studies included in this review that recruited 2570 patients and reported on 17 different interventions. Of the 21 included studies, 18 were for prevention and three for the treatment of dry socket. Although 18 trials were included that looked at interventions for the prevention of dry socket, only two interventions were considered in more than one trial: chlorhexidine rinse and intrasocket chlorhexidine gel. The quality of the trials was mixed.</P>
<P>There was evidence for the effectiveness of rinsing both pre- and post-extraction with 0.12% and 0.2% chlorhexidine compared to placebo with a risk ratio (RR) of 0.58 (95% confidence interval (CI) 0.43 to 0.78; P &lt; 0.001; 750 participants) based on moderate evidence from four trials, one at unclear and three at high risk of bias, but with no evidence of heterogeneity. The number of patients needed to be treated to prevent one patient having dry socket (NNT) varied considerably depending on the prevalence of dry socket. For a 30% prevalence, as in the included studies, the NNT was 8 (95% CI 6 to 14) but if the control prevalence is 1% then the NNT increased to 232 (95% CI 176 to 417) (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>There was moderate evidence from two studies with 133 participants, one at low risk of bias and one at high risk of bias, with no evidence of heterogeneity that chlorhexidine gel (0.2%) placed in an extraction socket is an effective preventative therapy (RR 0.42; 95% CI 0.21 to 0.87; P = 0.02). Once again the NNT varied considerably from 6 (95% CI 5 to 26) for control prevalences of 30% to 173 (95% CI 127 to 770) for control prevalence of 1% (<LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>).</P>
<P>The remaining interventions for the prevention of dry socket and the interventions for the treatment of dry socket were only looked at in single studies and therefore there is insufficient evidence to determine their effects.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-11-13 16:21:09 +0000" MODIFIED_BY="[Empty name]">
<P>A comprehensive search strategy was employed and it is likely that the majority of published trials are included in this review. It is uncertain how many unpublished trials there are as some of the interventions identified were developed by industry and findings from these trials were not always reported in the past.</P>
<P>Only two studies reported on the prevention of dry socket in molars and premolars (<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>), all other trials reported on prevention following extraction of third molars. The <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK> trial was also notable in that it was conducted in four general dental practice settings. Trials included in the present review tended to include extractions undertaken by experienced oral surgeons in hospital or military minor oral surgery clinics. However, most extractions in dentistry are undertaken in primary dental care, by general dental practitioners on teeth other than lower third molars. Most extractions do not involve surgical removal of the tooth. It is important that future well designed trials of interventions to treat and prevent dry socket are conducted in primary dental care settings. Such studies should recruit patients who are having a range of tooth type extractions including molar and premolar teeth. It is also important that power calculations inform the sample size of the proposed study to ensure trials are large enough to detect clinically important effects of interventions including hypersensitivity reactions and adverse events.</P>
<P>Three of the trials in this review employed a split-mouth design, with no trials employing a cross-over design. Split-mouth designs are appropriate when the disease is stable and uniformly distributed and the effects of the intervention are short lived or reversible (<LINK REF="REF-Antczak_x002d_Bouckoms-1990" TYPE="REFERENCE">Antczak-Bouckoms 1990</LINK>). There is evidence from one trial that development of dry socket increases the risk of developing dry socket in the future (<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>), therefore this could compromise the use of cross-over studies, however, split-mouth studies appear to be appropriate for looking at the prevention of dry socket. It is also important that participants and observers are blind to the intervention allocation if possible.</P>
<P>There was considerable variation in the design of trials, inclusion and exclusion criteria, definition of dry socket, presurgical regimens, intraoperative procedures and postoperative medications. The generalisability of the trials was compromised in some trials by excluding smokers and women on oral contraceptive therapy. Also, most teeth were third molars. In most trials, the existence of pericoronitis and infection was a cause for exclusion. These exclusion criteria have the potential for studies to include patient groups where the risk factors for dry socket are reduced so dry socket is less likely to happen. This effect was balanced by the predominance of studies that largely reported on extraction of third molars where the prevalence of dry socket is higher compared to extraction of other teeth. Many studies were conducted in a hospital setting with operators who were undertaking these procedures frequently and had high levels of skill. The results may be different from general dental practice where the dentists have less time, are undertaking fewer of these procedures, and so outcomes may be less predictable.</P>
<P>Dry socket is a common consequence of tooth extraction and it is important that this review presents the latest evidence for prevention and treatment. A range of interventions reported in this review reflect prevailing theories of dry socket causation at the time the study was undertaken. This meant that many of the comparisons for the prevention and treatment included small single studies making it difficult to provide strong evidence for any of the interventions used. There is a dearth of evidence in relation to the treatment of dry socket. Recent work has reported on the use of lasers and obtundents in the treatment of dry socket. The studies show promise, though problems with the design of the studies and reporting precluded their inclusion in this review.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-11-13 16:59:03 +0000" MODIFIED_BY="[Empty name]">
<P>Although the criteria for assessing overall risk of bias were strict (all domains assessed had to be at low risk of bias for the trial to be deemed at low risk of bias), only one study was assessed as being at low risk of bias. Of the remainder, 14 (67%) were assessed as being at unclear risk of bias and six (29%) were assessed at high risk of bias. The quality of reporting could be improved by authors reporting their studies in line with CONSORT and, where possible, undertaking double blind trials with adequate outcome assessment. Some studies had to be excluded as they did not have an adequate definition of dry socket and some appeared to conflate infection with dry socket. There was also variation in the secondary outcomes reported in the trials and many did not match the ones included in the protocol for the present review. There was also generally inadequate reporting of adverse events.</P>
<SUBSECTION>
<HEADING LEVEL="2">Adverse Effects</HEADING>
<P>Three of the four studies included in the meta-analysis reported some adverse effects associated with the use of 0.12% chlorhexidine (<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>; <LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>; <LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>) and 0.2% chlorhexidine (<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>) mouthwash. Adverse effects included: staining of teeth, altered taste, bad taste, numbness and stomach upsets. The use of 0.2% chlorhexidine mouthwash was reported in three further trials (<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>; <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>; <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>). In the trial by <LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>, a range of adverse effects were reported but it was not possible to attribute these with confidence to either the surgery undertaken, the vehicle delivering the intrasocket medicament or the use of 0.2% chlorhexidine mouthwash. <LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK> reported altered taste and numbness. <LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK> reported no adverse effects. No adverse effects were reported in the three included studies for prevention of dry socket that used chlorhexidine 0.2% gels inserted immediately post-extraction of third molar teeth (<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>). All three studies, however, were derived from the same research group, had small sample sizes and all three excluded participants with a previous history of chlorhexidine allergy.</P>
<P>Immunoglobulin E (IgE) mediated allergic reactions associated with chlorhexidine use have been reported including: urticaria, angioedema and anaphylaxis (<LINK REF="REF-Nagendran-2009" TYPE="REFERENCE">Nagendran 2009</LINK>). Anaphylactic symptoms associated with the use of chlorhexidine have been reported in dental settings (<LINK REF="REF-Gagari-1995" TYPE="REFERENCE">Gagari 1995</LINK>; <LINK REF="REF-Sharma-2009" TYPE="REFERENCE">Sharma 2009</LINK>), and other healthcare settings (<LINK REF="REF-Nagendran-2009" TYPE="REFERENCE">Nagendran 2009</LINK>). Immediate hypersensitivity is rare, though late onset hypersensitivity and eczema are well documented events in healthcare settings (<LINK REF="REF-Beaudouin-2004" TYPE="REFERENCE">Beaudouin 2004</LINK>). There have been two recent cases in the UK of anaphylaxis associated with irrigation of dry socket with chlorhexidine mouthrinse that have been reported in Coroners' reports and the media but not in the scientific literature (<LINK REF="REF-Edwards-2011" TYPE="REFERENCE">Edwards 2011</LINK>; <LINK REF="REF-Reissner-2011" TYPE="REFERENCE">Reissner 2011</LINK>). The present review found some evidence for the association of minor adverse reactions with 0.12% and 0.2% chlorhexidine mouthrinses, though no allergic reactions were reported. All studies in relation to the use of 0.2% chlorhexidine gel excluded participants with a history of chlorhexidine allergy. Most studies in the present review were not designed to detect the presence of hypersensitivity reactions to mouthwash as part of the study protocol. Future trials of chlorhexidine mouthrinses should consider using chlorhexidine-specific IgE serological testing to reduce the risk of allergic reactions (<LINK REF="REF-Beaudouin-2004" TYPE="REFERENCE">Beaudouin 2004</LINK>), and to estimate the prevalence of chlorhexidine allergy in the study population. While serious adverse effects and events attributable to rinses are rare, the decision to recommend rinsing with chlorhexidine should be balanced against reported adverse effects of tooth staining, taste alteration and nausea. A recent review of the effect of chlorhexidine mouthrinse on plaque and gingival inflammation concluded that staining was the most common adverse effect, followed by increased calculus formation and change in taste sensation (<LINK REF="REF-Van-Strydonck-2012" TYPE="REFERENCE">Van Strydonck 2012</LINK>). It was also reported that burning sensations, hypersensitivity, mucosal lesions and an anaesthetised sensation were less frequent events (<LINK REF="REF-Van-Strydonck-2012" TYPE="REFERENCE">Van Strydonck 2012</LINK>). While serious adverse effects and events are rare, it is recommended that all members of the dental team prescribing chlorhexidine mouthwashes and gels for the management of dry socket are aware of the potential for side effects, are competent to manage a medical emergency associated with anaphylaxis and warn their patients of the potential for adverse events.</P>
</SUBSECTION>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2012-11-13 16:45:31 +0000" MODIFIED_BY="[Empty name]">
<P>Two systematic reviews concluded that rinsing perioperatively with 0.12% chlorhexidine gluconate was effective in preventing dry socket after the extraction of third molar teeth (<LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK>; <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK>). The findings from the present review are consistent with the findings reported in both these reviews. <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK> concluded that while it could not be determined that perioperative rinsing with 0.12% chlorhexidine prevented dry socket in all extractions, there was evidence that perioperative rinsing with chlorhexidine could prevent dry sockets in lower third molar extractions. <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK> also concluded that there was strong evidence that local treatment with tetracycline seemed to have a clinically relevant effect on dry socket and reported on three trials in this grouping. These three studies did not meet the inclusion criteria for the present review. <LINK REF="REF-Yengopal-2012" TYPE="REFERENCE">Yengopal 2012</LINK> included a different group of studies to the present review. In contrast to our review, <LINK REF="REF-Yengopal-2012" TYPE="REFERENCE">Yengopal 2012</LINK> concluded that chlorhexidine had not been conclusively shown to be significantly better than placebo for reducing the incidence of alveolar osteitis (dry socket) after tooth extraction.</P>
<P>The present review reported new findings not reported on in three previous systematic reviews relating to evidence for the effectiveness of 0.2% chlorhexidine gels in the prevention of dry sockets. The three trials on which this new evidence was based were all published after <LINK REF="REF-Caso-2005" TYPE="REFERENCE">Caso 2005</LINK> and <LINK REF="REF-Hedstrom-2007" TYPE="REFERENCE">Hedstrom 2007</LINK>. The review by <LINK REF="REF-Yengopal-2012" TYPE="REFERENCE">Yengopal 2012</LINK> used different inclusion criteria compared to the present review.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-11-13 16:48:46 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-11-13 16:46:50 +0000" MODIFIED_BY="[Empty name]">
<P>There is moderate evidence that rinsing perioperatively with 0.12% and 0.2% chlorhexidine gluconate is beneficial in preventing dry socket. There is moderate evidence that chlorhexidine gel placed in the socket post-extraction may also be beneficial in preventing dry socket. The decision to recommend rinsing with chlorhexidine should be balanced against reported adverse effects of tooth staining, taste alteration and nausea. Adverse events attributable to the rinses were rare but patients need to be aware and informed of the potential for adverse events associated with the use of chlorhexidine. There have been two reported cases of serious adverse event in the UK attributed to rinsing with chlorhexidine mouthwash for established dry socket. It is recommended that all members of the dental team prescribing chlorhexidine mouthwashes and chlorhexidine gels are aware of the potential for adverse effects, are competent to manage a medical emergency associated with anaphylaxis and warn their patients of the potential for adverse events. While an allergic reaction can occur despite a history of previous uneventful use of the allergen, it is also recommended that a full allergy history is taken before the prescription of chlorhexidine mouthwash and gels.</P>
<P>There was no evidence to support any of the interventions included for the treatment of dry socket.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-11-13 16:48:46 +0000" MODIFIED_BY="[Empty name]">
<P>More well designed trials in general dental practice settings with teeth other than third molars and including non-surgical extractions are needed. Further studies comparing rinsing with chlorhexidine with intrasocket chlorhexidine gel to prevent dry socket would help to determine whether one intervention is better than another. Clinicians and researchers in this area need to decide collectively what outcomes should be measured in both prevention and treatment studies. All studies should carefully present data on any adverse events, even if none were observed. More research is required into the effectiveness of treatment of dry sockets.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-11-13 12:11:44 +0000" MODIFIED_BY="[Empty name]">
<P>The review authors would like to acknowledge the assistance they have received from members of the Cochrane Oral Health Group and for the helpful comments on this review from the referees. In addition, the authors would like to thank Marina Gallagher and Natalie John of King's College London Dental Institute who obtained many of the references. The authors are grateful to the following: Prof Vasiliy Vlassov, Prof Ken Yaegaki , Dr Nian Fang and Ms Mona Nasser who kindly translated several papers into the English language which enabled assessment of their eligibility for this review. The authors would also like to thank Zbys Fedorowizc and Mona Nasser for their contribution to protocol development, and also thanks to Zbys Fedorowizc for his contribution to information retrieval and screening of search results in earlier drafts of this review. Our thanks also to Dr Torres-Lagares who confirmed that the three included studies that he was involved in each involved completely different participants.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-02-20 17:19:33 +0000" MODIFIED_BY="[Empty name]">
<P>There are no financial conflicts of interest and the review authors declare that they do not have any associations with any parties who may have vested interests in the results of this review.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-11-13 12:14:22 +0000" MODIFIED_BY="[Empty name]">
<P>Conceiving the idea: Blánaid Daly (BD).<BR/>Writing the protocol: BD, Mohammad O Sharif (MOS), Tim Newton (TN), and Kate Jones (KJ).<BR/>Organising retrieval of papers: BD, MOS, TN.<BR/>Writing to authors of papers for additional information: BD, MOS.<BR/>Providing additional data about papers: BD.<BR/>Data collection for the review: BD, MOS.<BR/>Screening search results: BD, MOS, TN, KJ, Helen Worthington (HW).<BR/>Screening retrieved papers against inclusion criteria: BD, MOS, TN, KJ, HW.<BR/>Appraising quality of papers: BD, MOS, KJ.<BR/>Extracting data from papers: BD, MOS, HW.<BR/>Obtaining and screening data on unpublished studies: MOS, HW.<BR/>Entering data into RevMan: BD, MOS, HW.<BR/>Analysis of data: BD, MOS, HW.<BR/>Writing the review: BD, MOS, HW, TN, KJ.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-11-13 17:08:04 +0000" MODIFIED_BY="[Empty name]">
<UL>
<LI>The original protocol was only for the treatment of dry socket. We have expanded the scope of the review to incorporate the prevention of dry socket.</LI>
<LI>We added the primary outcome for treatment of dry socket: time to heal.</LI>
<LI>We reworded 'type of participant' to clarify the inclusion of any extracted teeth.</LI>
<LI>We changed analyses from fixed-effect to random-effects as requested by referee.</LI>
</UL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-11-13 16:35:10 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-11-12 21:07:48 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-11-12 19:39:00 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Alissa-2010" MODIFIED="2012-11-12 19:31:05 +0000" MODIFIED_BY="[Empty name]" NAME="Alissa 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-12 19:31:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alissa R, Esposito M, Horner K, Oliver R</AU>
<TI>The influence of platelet-rich plasma on the healing of extraction sockets: an explorative randomised clinical trial</TI>
<SO>European Journal of Oral Implantology</SO>
<YR>2010</YR>
<VL>3</VL>
<NO>2</NO>
<PG>121-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bai-2011" MODIFIED="2012-11-12 19:32:45 +0000" MODIFIED_BY="[Empty name]" NAME="Bai 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:32:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bai Z-C, Shi S-G, Li Li-L, Niu Z-Y, Zhang Y-R</AU>
<TI>Application of accellular dermal matrix embedded in socket after wisdom tooth extraction</TI>
<SO>Journal of Clinical Rehabilitative Tissue Engineering Research</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>34</NO>
<PG>6457-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burgoyne-2010" MODIFIED="2010-10-22 21:40:24 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Burgoyne 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-10-22 21:40:24 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burgoyne CC, Giglio JA, Reese SE, Sima AP, Laskin DM</AU>
<TI>The efficacy of a topical anesthetic gel in the relief of pain associated with localized alveolar osteitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2010</YR>
<VL>68</VL>
<PG>144-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delilbasi-2002" MODIFIED="2012-11-12 19:33:40 +0000" MODIFIED_BY="[Empty name]" NAME="Delilbasi 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-11-12 19:33:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delilbasi C, Saracoglu U, Keskin A</AU>
<TI>Effects of 0.2% chlorhexidine gluconate and amoxicillin plus clavulanic acid on the prevention of alveolar osteitis following mandibular third molar extractions</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radioloy, and Endodontics</SO>
<YR>2002</YR>
<VL>94</VL>
<NO>3</NO>
<PG>301-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-03-14 15:17:39 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gersel_x002d_Pedersen-1979" MODIFIED="2010-07-12 09:39:56 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Gersel-Pedersen 1979" YEAR="1979">
<REFERENCE MODIFIED="2010-07-12 09:39:56 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gersel-Pedersen N</AU>
<TI>Tranexamic acid in alveolar sockets in the prevention of alveolitis sicca dolorosa</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1979</YR>
<VL>8</VL>
<NO>6</NO>
<PG>421-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hermesch-1998" MODIFIED="2012-11-12 19:35:41 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Hermesch 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-11-12 19:35:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hermesch C, Hilton T, Baker R, Biesbrock A, Hamlin J, McClanahan S et al</AU>
<TI>Prophylactic use of Peridex® reduces the incidence of alveolar osteitis following third molar extraction</TI>
<SO>Journal of Dental Research</SO>
<YR>1997</YR>
<VL>76</VL>
<NO>1 Suppl IADR Abstracts</NO>
<PG>243 (Abs No 1835)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-12 19:35:41 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hermesch CB, Hilton TJ, Biesbrock AR, Baker RA, Cain-Hamlin J, McClanahan SF et al</AU>
<TI>Perioperative use of 0.12% chlorhexidine gluconate for the prevention of alveolar osteitis: efficacy and risk factor analysis</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics</SO>
<YR>1998</YR>
<VL>85</VL>
<NO>4</NO>
<PG>381-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hita_x002d_Iglesias-2008" MODIFIED="2010-07-12 10:06:13 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Hita-Iglesias 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-07-12 10:06:13 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hita-Iglesias P, Torres-Lagares D, Flores-Ruiz R, Magallanes-Abad N, Basallote-Gonzalez M et al</AU>
<TI>Effectiveness of chlorhexidine gel versus chlorhexidine rinse in reducing alveolar osteitis in mandibular third molar surgery</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2008</YR>
<VL>66</VL>
<NO>3</NO>
<PG>441-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Huang-2011" MODIFIED="2012-11-12 19:36:05 +0000" MODIFIED_BY="[Empty name]" NAME="Huang 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:36:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huang D-Y, Nie E-M, Guo J-B, Ji L</AU>
<TI>Application of HEAL-ALL patch on the prevention of dry socket syndrome after tooth extraction</TI>
<SO>Journal of Clinical Rehabilitative Tissue Engineering Research</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>29</NO>
<PG>5409-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaya-2011" MODIFIED="2012-11-12 19:36:25 +0000" MODIFIED_BY="[Empty name]" NAME="Kaya 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:36:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaya G&#350;, Yapici G, Sava&#351; Z, Güngörmü&#351; M</AU>
<TI>Comparison of alvogyl, SaliCept patch, and low-level laser therapy in the management of alveolar osteitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>6</NO>
<PG>1571-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kjellman-1973" MODIFIED="2012-11-12 19:36:45 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Kjellman 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:36:45 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjellman O</AU>
<TI>Apernyl as alveolar inlay in connection with the removal of impacted third molars of the lower jaw. A clinical double blind investigation of 100 patients</TI>
<SO>Svensk Tandlakare Tidskrift</SO>
<YR>1973</YR>
<VL>6</VL>
<NO>2</NO>
<PG>197-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Larsen-1991" MODIFIED="2010-07-11 10:18:28 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Larsen 1991" YEAR="1991">
<REFERENCE MODIFIED="2010-07-11 10:18:28 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen PE</AU>
<TI>The effect of a chlorhexidine rinse on the incidence of alveolar osteitis following the surgical removal of impacted mandibular third molars</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1991</YR>
<VL>49</VL>
<NO>9</NO>
<PG>932-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Metin-2006" MODIFIED="2012-11-12 19:37:01 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Metin 2006" YEAR="">
<REFERENCE MODIFIED="2012-11-12 19:37:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Metin M, Tek M, Sener I</AU>
<TI>Comparison of two chlorhexidine rinse protocols on the incidence of alveolar osteitis following the surgical removal of impacted third molars</TI>
<SO>Journal of Contemporary Dental Practice</SO>
<YR>2006</YR>
<VL>7</VL>
<NO>2</NO>
<PG>79-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1984" MODIFIED="2010-07-11 11:04:22 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Mitchell 1984" YEAR="1984">
<REFERENCE MODIFIED="2010-07-11 11:04:22 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell L</AU>
<TI>Topical metronidazole in the treatment of 'dry socket'</TI>
<SO>British Dental Journal</SO>
<YR>1984</YR>
<VL>156</VL>
<NO>4</NO>
<PG>132-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ragno-1991" MODIFIED="2012-11-12 19:37:16 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Ragno 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-11-12 19:37:16 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ragno JR, Szkutnik AJ</AU>
<TI>Evaluation of 0.12% chlorhexidine rinse on the prevention of alveolar osteitis</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1991</YR>
<VL>72</VL>
<NO>5</NO>
<PG>524-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reekie-2006" MODIFIED="2012-11-12 19:37:30 +0000" MODIFIED_BY="[Empty name]" NAME="Reekie 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-11-12 19:37:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reekie D, Downes P, Devlin CV, Nixon GM, Devlin H</AU>
<TI>The prevention of 'dry socket' with topical metronidazole in general dental practice</TI>
<SO>British Dental Journal</SO>
<YR>2006</YR>
<VL>200</VL>
<NO>4</NO>
<PG>210-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ritzau-1977" MODIFIED="2012-11-12 19:38:24 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Ritzau 1977" YEAR="1977">
<REFERENCE MODIFIED="2012-11-12 19:38:24 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ritzau M, Swangsilpa K</AU>
<TI>The prophylactic use of propylic ester of p-hydrobenzoic acid on alveolitis sicca dolorosa. A preliminary report</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1977</YR>
<VL>43</VL>
<NO>1</NO>
<PG>32-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shi-2003" MODIFIED="2010-07-12 11:50:48 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Shi 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-07-12 11:50:48 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shi L, Hu K, Peng L</AU>
<TI>Effect evaluation of artemisia desertorum spreng</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>1</NO>
<PG>166-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torres_x002d_Lagares-2006" MODIFIED="2010-07-14 08:42:02 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Torres-Lagares 2006" YEAR="">
<REFERENCE MODIFIED="2010-07-14 08:41:29 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torres-Lagares D, Infante-Cossio P, Gutierrez-Perez JL, Romero-Ruiz MM, Garcia-Calderon M, Serrera-Figallo MA</AU>
<TI>Intra-alveolar chlorhexidine gel for the prevention of dry socket in mandibular third molar surgery. A pilot study</TI>
<SO>Medicina Oral, Patologia Oral y Cirugia Bucal</SO>
<YR>2006</YR>
<VL>11</VL>
<NO>2</NO>
<PG>179-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torres_x002d_Lagares-2006a" MODIFIED="2010-07-14 08:42:13 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Torres-Lagares 2006a" YEAR="2006">
<REFERENCE MODIFIED="2010-07-14 08:30:29 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torres-Lagares D, Gutierrez-Perez JL, Infante-Cossio P, Garcia-Calderon M, Romero-Ruiz MM, Serrera-Figallo MA</AU>
<TI>Randomized, double-blind study on effectiveness of intra-alveolar chlorhexidine gel in reducing the incidence of alveolar osteitis in mandibular third molar surgery</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2006</YR>
<VL>35</VL>
<NO>4</NO>
<PG>348-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trieger-1991" MODIFIED="2010-07-11 10:20:15 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Trieger 1991" YEAR="1991">
<REFERENCE MODIFIED="2010-07-11 10:20:15 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trieger N, Schlagel GD</AU>
<TI>Preventing dry socket. A simple procedure that works</TI>
<SO>Journal of the American Dental Association</SO>
<YR>1991</YR>
<VL>122</VL>
<NO>2</NO>
<PG>67-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Eeden-2006" MODIFIED="2012-11-12 19:39:00 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="van Eeden 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-11-12 19:39:00 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Eeden SP, Butow K</AU>
<TI>Post-operative sequelae of lower third molar removal: a literature review and pilot study on the effect of Covomycin D</TI>
<SO>SADJ Journal of the South African Dental Association</SO>
<YR>2006</YR>
<VL>61</VL>
<NO>4</NO>
<PG>154-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-11-12 21:07:23 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Akota-1998" MODIFIED="2012-10-09 16:50:52 +0100" MODIFIED_BY="[Empty name]" NAME="Akota 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-10-09 16:50:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akota I, Alvsaker B, Bjornland T</AU>
<TI>The effect of locally applied gauze drain impregnated with chlortetracycline ointment in mandibular third-molar surgery</TI>
<SO>Acta Odontologica Scandinavica</SO>
<YR>1998</YR>
<VL>56</VL>
<NO>1</NO>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Sukhun-2011" MODIFIED="2012-02-14 15:12:36 +0000" MODIFIED_BY="[Empty name]" NAME="Al-Sukhun 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-14 15:12:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Sukhun J, Penttila H</AU>
<TI>The cyclooxygenase-2 inhibitor celecoxib and alveolar osteitis</TI>
<SO>Journal of the Irish Dental Association</SO>
<YR>2011</YR>
<VL>57</VL>
<NO>1</NO>
<PG>50-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Altman-2011" MODIFIED="2012-11-12 20:59:05 +0000" MODIFIED_BY="[Empty name]" NAME="Altman 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 20:59:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Altman RD, Daniels S, Manvelian G</AU>
<TI>Acute pain relief by a proprietary, nano-formulated lower-dose oral indomethacin</TI>
<SO>Arthritis and Rheumatism</SO>
<YR>2011</YR>
<VL>63</VL>
<NO>S10</NO>
<PG>1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Annibali-2012" MODIFIED="2012-11-12 20:59:37 +0000" MODIFIED_BY="[Empty name]" NAME="Annibali 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 20:59:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Annibali S, De Biase A, Pippi R, Sfasciotti GL</AU>
<TI>A consensus conference on management of the lower third molar. Italian Society of Odontostomatological Surgery</TI>
<SO>Minerva Stomatologica</SO>
<YR>2012</YR>
<VL>60</VL>
<NO>10</NO>
<PG>509-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anonymous-1966" MODIFIED="2012-11-12 19:40:08 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Anonymous 1966" YEAR="1966">
<REFERENCE MODIFIED="2012-11-12 19:40:08 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anonymous</AU>
<TI>[Drug therapy for dry socket] [Japanese]</TI>
<SO>Nihon Shika Ishikai Zasshi - Journal of the Japan Dental Association</SO>
<YR>1966</YR>
<VL>19</VL>
<NO>8</NO>
<PG>653-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arakeri-2011" MODIFIED="2012-11-12 19:40:59 +0000" MODIFIED_BY="[Empty name]" NAME="Arakeri 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:40:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arakeri G, Brennan PA</AU>
<TI>Povidone-iodine: an anti-oedematous agent?</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>40</VL>
<NO>2</NO>
<PG>173-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-19 16:09:25 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arenaz_x002d_Bua-2010" MODIFIED="2012-11-12 19:42:15 +0000" MODIFIED_BY="[Empty name]" NAME="Arenaz-Bua 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-12 19:42:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arenaz-Búa J, Luaces-Rey R, Sironvalle-Soliva S, Otero-Rico A, Charro-Huerga E, Patiño-Seijas B et al</AU>
<TI>A comparative study of platelet-rich plasma, hydroxyapatite, demineralized bone matrix and autologous bone to promote bone regeneration after mandibular impacted third molar extraction</TI>
<SO>Medicina Oral, Patologia Oral y Cirugia Bucal</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>3</NO>
<PG>e483-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Banach-1973" MODIFIED="2012-11-12 19:42:38 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Banach 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:42:38 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Banach J, Malinowski J, Spychalska M, Zielinska B</AU>
<TI>[Clinical evaluation of Apernyl preparation] [Polish]</TI>
<SO>Czasopismo Stomatologiczne</SO>
<YR>1973</YR>
<VL>26</VL>
<NO>8</NO>
<PG>861-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baqain-2012" MODIFIED="2012-11-12 21:00:09 +0000" MODIFIED_BY="[Empty name]" NAME="Baqain 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:00:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baqain ZH, Al-Shafii A, Hamdan AA, Sawair FA</AU>
<TI>Flap design and mandibular third molar surgery: a split mouth randomized clinical study</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2012</YR>
<VL>41</VL>
<NO>8</NO>
<PG>1020-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bello-2011" MODIFIED="2012-11-12 19:43:09 +0000" MODIFIED_BY="[Empty name]" NAME="Bello 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:43:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bello SA, Olaitan AA, Ladeinde AL</AU>
<TI>A randomized comparison of the effect of partial and total wound closure techniques on postoperative morbidity after mandibular third molar surgery</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>6</NO>
<PG>e24-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berwick-1990" MODIFIED="2012-02-10 13:43:52 +0000" MODIFIED_BY="[Empty name]" NAME="Berwick 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-02-10 13:43:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berwick JE, Lessin ME</AU>
<TI>Effects of a chlorhexidine gluconate oral rinse on the incidence of alveolar osteitis in mandibular third molar surgery</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1990</YR>
<VL>48</VL>
<NO>5</NO>
<PG>444-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Betts-1995" MODIFIED="2012-11-12 19:43:31 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Betts 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-11-12 19:43:31 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Betts NJ, Makowski G, Shen YH, Hersh EV</AU>
<TI>Evaluation of topical viscous 2% lidocaine jelly as an adjunct during the management of alveolar osteitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1995</YR>
<VL>53</VL>
<NO>10</NO>
<PG>1140-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bezerra-2011" MODIFIED="2012-11-12 19:44:05 +0000" MODIFIED_BY="[Empty name]" NAME="Bezerra 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:44:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS</AU>
<TI>Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg)</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>11</NO>
<PG>e333-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Birke-1970" MODIFIED="2012-11-12 19:44:24 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Birke 1970" YEAR="1970">
<REFERENCE MODIFIED="2012-11-12 19:44:24 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Birke WP, Furtig W</AU>
<TI>[Drug therapy of post extraction pain] [German]</TI>
<SO>Deutsche Stomatologie</SO>
<YR>1970</YR>
<VL>20</VL>
<NO>5</NO>
<PG>370-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bloomer-2000" MODIFIED="2012-11-12 19:44:38 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Bloomer 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-11-12 19:44:38 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloomer CR</AU>
<TI>Alveolar osteitis prevention by immediate placement of medicated packing</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>2000</YR>
<VL>90</VL>
<NO>3</NO>
<PG>282-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bloomer-2012" MODIFIED="2012-11-12 21:00:35 +0000" MODIFIED_BY="[Empty name]" NAME="Bloomer 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:00:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloomer CR</AU>
<TI>Straws do not cause dry sockets when third molars are extracted</TI>
<SO>Texas Dental Journal</SO>
<YR>2012</YR>
<VL>129</VL>
<NO>1</NO>
<PG>25-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brignardello-2012" MODIFIED="2012-11-12 21:01:18 +0000" MODIFIED_BY="[Empty name]" NAME="Brignardello 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:01:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brignardello-Petersen R, Carrasco-Labra A, Araya I, Yanine N, Beyene J, Shah PS</AU>
<TI>Is adjuvant laser therapy effective for preventing pain, swelling, and trismus after surgical removal of impacted mandibular third molars? A systematic review and meta-analysis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2012</YR>
<VL>70</VL>
<NO>8</NO>
<PG>1789-801</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butler-1977" MODIFIED="2012-11-12 19:44:50 +0000" MODIFIED_BY="[Empty name]" NAME="Butler 1977" YEAR="1977">
<REFERENCE MODIFIED="2012-11-12 19:44:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butler DP, Sweet JB</AU>
<TI>Effect of lavage on the incidence of localized osteitis in mandibular third molar extraction sites</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1977</YR>
<VL>44</VL>
<NO>1</NO>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Butylin-1977" MODIFIED="2012-11-12 19:45:04 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Butylin 1977" YEAR="1977">
<REFERENCE MODIFIED="2012-11-12 19:45:04 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Butylin AM</AU>
<TI>[Effect of PC powder on the healing of the socket after tooth extraction] [Russian]</TI>
<SO>Stomatologiia</SO>
<YR>1977</YR>
<VL>56</VL>
<NO>2</NO>
<PG>95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bystedt-1980" MODIFIED="2012-11-12 19:45:39 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Bystedt 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-11-12 19:45:39 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bystedt H, Nord CE, Nordenram A</AU>
<TI>Effect of azidocillin, erythromycin, clindamycin and doxycycline on postoperative complications after surgical removal of impacted mandibular third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1980</YR>
<VL>9</VL>
<NO>3</NO>
<PG>157-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Christensen-2012" MODIFIED="2012-11-12 21:01:29 +0000" MODIFIED_BY="[Empty name]" NAME="Christensen 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:01:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Christensen JA, Matzen LH, Wenzel A</AU>
<TI>Should removal of lower third molars be included in the pre-graduate curriculum for dental students? An evaluation of post-operative complications after student operations</TI>
<SO>Acta Odontologica Scandinavica</SO>
<YR>2012</YR>
<VL>70</VL>
<NO>1</NO>
<PG>42-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cooper-2012" MODIFIED="2012-11-12 21:01:49 +0000" MODIFIED_BY="[Empty name]" NAME="Cooper 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:01:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cooper SA, Voelker M</AU>
<TI>Evaluation of onset of pain relief from micronized aspirin in a dental pain model</TI>
<SO>Inflammopharmacology</SO>
<YR>2012</YR>
<VL>20</VL>
<NO>4</NO>
<PG>233-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Daniels-2011" MODIFIED="2012-11-12 19:46:43 +0000" MODIFIED_BY="[Empty name]" NAME="Daniels 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:46:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Daniels SE, Bandy DP, Christensen SE, Boice J, Losada MC, Liu H et al</AU>
<TI>Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model</TI>
<SO>Clinical Journal of Pain</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>1</NO>
<PG>1-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Field-1988" MODIFIED="2010-07-12 09:28:39 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Field 1988" YEAR="1988">
<REFERENCE MODIFIED="2010-07-12 09:28:39 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Field EA, Nind D, Varga E, Martin MV</AU>
<TI>The effect of chlorhexidine irrigation on the incidence of dry socket: a pilot study</TI>
<SO>British Journal of Oral and Maxillofacial Surgery</SO>
<YR>1988</YR>
<VL>26</VL>
<NO>5</NO>
<PG>395-401</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fotos-1992" MODIFIED="2012-11-12 19:46:56 +0000" MODIFIED_BY="[Empty name]" NAME="Fotos 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-11-12 19:46:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fotos PG, Koorbusch GF, Sarasin DS, Kist RJ</AU>
<TI>Evaluation of intra-alveolar chlorhexidine dressings after removal of impacted mandibular third molars</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1992</YR>
<VL>73</VL>
<NO>3</NO>
<PG>383-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garibaldi-1995" MODIFIED="2012-11-12 19:47:11 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Garibaldi 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-11-12 19:47:11 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garibaldi JA, Greenlaw J, Choi J, Fotovatjah M</AU>
<TI>Treatment of post-operative pain</TI>
<SO>Journal of the California Dental Association</SO>
<YR>1995</YR>
<VL>23</VL>
<NO>4</NO>
<PG>71-2, 74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldman-1973" MODIFIED="2012-11-12 19:47:24 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Goldman 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:47:24 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldman DR, Kilgore DS, Panzer JD, Atkinson WH</AU>
<TI>Prevention of dry socket by local application of lincomycin in Gelfoam</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1973</YR>
<VL>35</VL>
<NO>4</NO>
<PG>472-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldsmith-2012" MODIFIED="2012-11-12 21:02:16 +0000" MODIFIED_BY="[Empty name]" NAME="Goldsmith 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:02:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goldsmith SM, De Silva RK, Tong DC, Love RM</AU>
<TI>Influence of a pedicle flap design on acute postoperative sequelae after lower third molar removal</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2012</YR>
<VL>41</VL>
<NO>3</NO>
<PG>371-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goyal-2012" MODIFIED="2012-11-12 21:02:52 +0000" MODIFIED_BY="[Empty name]" NAME="Goyal 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:02:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goyal M, Marya K, Jhamb A, Chawla S, Sonoo PR, Singh V et al</AU>
<TI>Comparative evaluation of surgical outcome after removal of impacted mandibular third molars using a Piezotome or a conventional handpiece: a prospective study</TI>
<SO>British Journal of Oral and Maxillofacial Surgery</SO>
<YR>2012</YR>
<VL>50</VL>
<NO>6</NO>
<PG>556-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1971" MODIFIED="2010-08-21 17:27:02 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Hall 1971" YEAR="1971">
<REFERENCE MODIFIED="2010-08-21 17:27:02 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall HD, Bildman BS, Hand CD</AU>
<TI>Prevention of dry socket with local application of tetracycline</TI>
<SO>Journal of Oral Surgery</SO>
<YR>1971</YR>
<VL>29</VL>
<NO>1</NO>
<PG>35-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haraji-2010" MODIFIED="2012-11-12 19:48:24 +0000" MODIFIED_BY="[Empty name]" NAME="Haraji 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-12 19:48:24 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2012-03-14 15:31:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;this is an electronic version need paper ref&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-11-12 19:48:24 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haraji A, Motamedi MH, Rezvani F</AU>
<TI>Can flap design influence the incidence of alveolar osteitis following removal of impacted mandibular third molars?</TI>
<SO>General Dentistry</SO>
<YR>2010</YR>
<VL>58</VL>
<NO>5</NO>
<PG>e187-9</PG>
<IDENTIFIERS MODIFIED="2012-11-12 19:47:41 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-2006" MODIFIED="2012-11-12 19:50:11 +0000" MODIFIED_BY="[Empty name]" NAME="Hill 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-11-12 19:50:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Michael Hill C, Sindet-Pederson S, Seymour RA, Hawkesford JE 2nd, Coulthard P, Lamey PJ et al</AU>
<TI>Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies</TI>
<SO>Clinical Therapeutics</SO>
<YR>2006</YR>
<VL>28</VL>
<NO>9</NO>
<PG>1279-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hooley-1995" MODIFIED="2012-11-12 19:50:22 +0000" MODIFIED_BY="[Empty name]" NAME="Hooley 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-11-12 19:50:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hooley JR, Golden DP</AU>
<TI>The effect of polylactic acid granules on the incidence of alveolar osteitis after mandibular third molar surgery. A prospective randomized study</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>1995</YR>
<VL>80</VL>
<NO>3</NO>
<PG>279-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-1988" MODIFIED="2012-11-12 19:50:31 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Johnson 1988" YEAR="1988">
<REFERENCE MODIFIED="2012-11-12 19:50:31 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson WS, Blanton EE</AU>
<TI>An evaluation of 9-aminoacridine/Gelfoam to reduce dry socket formation</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1988</YR>
<VL>66</VL>
<NO>2</NO>
<PG>167-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jolley-1972" MODIFIED="2012-11-12 19:50:57 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Jolley 1972" YEAR="1972">
<REFERENCE MODIFIED="2012-11-12 19:50:57 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jolley HM, Torneck CD, Siegel I</AU>
<TI>A topical choline salicylate gel for control of pain and inflammation in oral conditions -a controlled study</TI>
<SO>Journal of the Canadian Dental Association</SO>
<YR>1972</YR>
<VL>38</VL>
<NO>2</NO>
<PG>72-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jovanovic-2011" MODIFIED="2012-11-12 19:51:58 +0000" MODIFIED_BY="[Empty name]" NAME="Jovanovic 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:51:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jovanovi&#263; G, Uri&#263; N, Kruni&#263; N, Tijani&#263; M, Stojanovi&#263; S</AU>
<TI>Assessment of the effectiveness of low level laser in the treatment of alveolar osteitis [Slovenian]</TI>
<TO>Procena efikasnosti primene lasera male snage u terapiji alveolarnogosteitisa</TO>
<SO>Vojnosanitetski Pregled</SO>
<YR>2011</YR>
<VL>68</VL>
<NO>6</NO>
<PG>506-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Julius-1982" MODIFIED="2010-08-06 07:32:21 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Julius 1982" YEAR="1982">
<REFERENCE MODIFIED="2010-08-06 07:32:21 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Julius LL, Hungerford RW, Nelson WJ, McKercher TC, Zellhoefer RW</AU>
<TI>Prevention of dry socket with local application of Terra-Cortril in gelfoam</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1982</YR>
<VL>40</VL>
<NO>5</NO>
<PG>285-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keskitalo-1973" MODIFIED="2012-11-12 19:52:19 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Keskitalo 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:52:19 +0000" MODIFIED_BY="Zbys Fedorowicz" NOTES="&lt;p&gt;&lt;span modified=&quot;2012-03-14 15:45:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Was this tra&lt;/span&gt;&lt;span modified=&quot;2012-03-14 15:46:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;nslated?&lt;/span&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-11-12 19:52:19 +0000" NOTES_MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keskitalo E, Persson G</AU>
<TI>A clinical trial of Apernyl cones and tamponade with Ward's Wondr Pak in the treatment of dry socket</TI>
<SO>Svensk Tandlakare Tidskrift</SO>
<YR>1973</YR>
<VL>66</VL>
<NO>5</NO>
<PG>475-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirk-2007" MODIFIED="2012-11-12 19:52:59 +0000" MODIFIED_BY="[Empty name]" NAME="Kirk 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-11-12 19:52:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirk DG, Liston PN, Tong DC, Love RM</AU>
<TI>Influence of two different flap designs on incidence of pain, swelling, trismus, and alveolar osteitis in the week following third molar surgery</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>2007</YR>
<VL>104</VL>
<PG>e1-e6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krekmanov-1981" MODIFIED="2010-07-12 10:44:45 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Krekmanov 1981" YEAR="1981">
<REFERENCE MODIFIED="2010-07-12 10:44:45 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krekmanov L</AU>
<TI>Alveolitis after operative removal of third molars in the mandible</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1981</YR>
<VL>10</VL>
<NO>3</NO>
<PG>173-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krekmanov-1986" MODIFIED="2012-11-12 19:53:17 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Krekmanov 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-11-12 19:53:17 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krekmanov L, Nordenram A</AU>
<TI>Postoperative complications after surgical removal of mandibular third molars. Effects of penicillin V and chlorhexidine</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1986</YR>
<VL>15</VL>
<NO>1</NO>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kudiyirickal-2012" MODIFIED="2012-11-12 21:03:22 +0000" MODIFIED_BY="[Empty name]" NAME="Kudiyirickal 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:03:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kudiyirickal M, Hollinshead F</AU>
<TI>Clinical profile of orofacial infections: an experience from two primary care dental practices</TI>
<SO>Medicina Oral, Patologia Oral y Cirugia Bucal</SO>
<YR>2012</YR>
<VL>17</VL>
<NO>4</NO>
<PG>e533-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lao-2012" MODIFIED="2012-11-12 21:03:45 +0000" MODIFIED_BY="[Empty name]" NAME="Lao 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:03:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lao L, Huang Y, Feng C, Berman BM, Tan MT</AU>
<TI>Evaluating traditional Chinese medicine using modern clinical trial design and statistical methodology: application to a randomized controlled acupuncture trial</TI>
<SO>Statistics in Medicine</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>7</NO>
<PG>619-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2011" MODIFIED="2012-11-12 21:04:00 +0000" MODIFIED_BY="[Empty name]" NAME="Liu 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 21:04:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu W, Dutta S, Hosmane BS</AU>
<TI>Exposure-survival analysis to quantify the proportion of subjects with meaningful pain relief in dental pain</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>2011</YR>
<VL>51</VL>
<NO>51</NO>
<PG>1366-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Long-2012" MODIFIED="2012-11-12 21:04:31 +0000" MODIFIED_BY="[Empty name]" NAME="Long 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:04:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Long H, Zhou Y, Liao L, Pyakurel U, Wang Y, Lai W</AU>
<TI>Coronectomy vs. total removal for third molar extraction: a systematic review.</TI>
<SO>Journal of Dental Research</SO>
<YR>2012</YR>
<VL>91</VL>
<NO>7</NO>
<PG>659-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez_x002d_Cedrun-2011" MODIFIED="2012-11-12 19:54:36 +0000" MODIFIED_BY="[Empty name]" NAME="Lopez-Cedrun 2011" YEAR="">
<REFERENCE MODIFIED="2012-11-12 19:54:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>López-Cedrún JL, Pijoan JI, Fernández S, Santamaria J, Hernandez G</AU>
<TI>Efficacy of amoxicillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>6</NO>
<PG>e5-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacGregor-1973" MODIFIED="2012-11-12 19:54:47 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="MacGregor 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:54:47 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacGregor AJ, Hutchinson D</AU>
<TI>The effect of Nivemycin on pain and swelling following lower third molar removal</TI>
<SO>British Journal of Oral Surgery</SO>
<YR>1973</YR>
<VL>10</VL>
<NO>3</NO>
<PG>321-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacGregor-1975" MODIFIED="2010-07-11 12:31:05 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="MacGregor 1975" YEAR="1975">
<REFERENCE MODIFIED="2010-07-11 12:31:05 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacGregor AJ, Hutchinson D</AU>
<TI>The effect of sulfonamides on pain and swelling following removal of ectopic third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1975</YR>
<VL>4</VL>
<NO>5</NO>
<PG>184-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Majid-2010" MODIFIED="2012-11-12 21:05:01 +0000" MODIFIED_BY="[Empty name]" NAME="Majid 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-12 21:05:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Majid OW, Mahmood KW</AU>
<TI>Effect of submucosal and intramuscular dexamethasone on postoperative sequelae after third molar surgery: comparative study</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>49</VL>
<NO>8</NO>
<PG>647-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malkawi-2011" MODIFIED="2012-11-12 19:55:30 +0000" MODIFIED_BY="[Empty name]" NAME="Malkawi 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:55:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malkawi Z, Al-Omiri MK, Khraisat A</AU>
<TI>Risk indicators of postoperative complications following surgical extraction of lower third molars</TI>
<SO>Medical Principles and Practice</SO>
<YR>2011</YR>
<VL>20</VL>
<NO>4</NO>
<PG>321-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehlisch-2010a" MODIFIED="2012-11-12 19:55:59 +0000" MODIFIED_BY="[Empty name]" NAME="Mehlisch 2010a" YEAR="">
<REFERENCE MODIFIED="2012-11-12 19:55:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehlisch DR, Aspley S, Daniels SE, Southerden KA, Christensen KS</AU>
<TI>A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.</TI>
<SO>Clinical Therapeutics</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>6</NO>
<PG>1033-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehlisch-2010b" MODIFIED="2012-11-12 19:56:28 +0000" MODIFIED_BY="[Empty name]" NAME="Mehlisch 2010b" YEAR="">
<REFERENCE MODIFIED="2012-11-12 19:56:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehlisch DR, Aspley S, Daniels SE, Bandy DP</AU>
<TI>Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, modified factorial study.</TI>
<SO>Clinical Therapeutics</SO>
<YR>2010</YR>
<VL>32</VL>
<NO>5</NO>
<PG>882-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mishra-2012" MODIFIED="2012-11-12 21:05:29 +0000" MODIFIED_BY="[Empty name]" NAME="Mishra 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:05:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mishra H, Khan FA</AU>
<TI>A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain</TI>
<SO>Journal of Anaesthesiology, Clinical Pharmacology</SO>
<YR>2012</YR>
<VL>28</VL>
<NO>2</NO>
<PG>221-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1986" MODIFIED="2012-11-12 19:56:39 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Mitchell 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-11-12 19:56:39 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell R</AU>
<TI>Treatment of fibrinolytic alveolitis by a collagen paste (Formula K). A preliminary report</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1986</YR>
<VL>15</VL>
<NO>2</NO>
<PG>127-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1986a" MODIFIED="2012-03-28 15:25:05 +0100" MODIFIED_BY="[Empty name]" NAME="Mitchell 1986a" YEAR="1986">
<REFERENCE MODIFIED="2012-03-28 15:25:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell DA</AU>
<TI>A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery</TI>
<SO>British Dental Journal</SO>
<YR>1986</YR>
<VL>160</VL>
<NO>8</NO>
<PG>284-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nentwig-1985" MODIFIED="2012-11-12 19:56:53 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Nentwig 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-11-12 19:56:53 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nentwig GH, Kniha H</AU>
<TI>[Treatment of postsurgical bone infections] [German]</TI>
<SO>Fortschritte der Kiefer- und Gesichts-Chirurgie</SO>
<YR>1985</YR>
<VL>30</VL>
<PG>35-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neugebauer-2004" MODIFIED="2012-11-12 19:57:06 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Neugebauer 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-11-12 19:57:06 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neugebauer J, Jozsa M, Kubler A</AU>
<TI>[Antimicrobial photodynamic therapy for prevention of alveolar ostitis and post-extraction pain] [German]</TI>
<SO>Mund-, Kiefer- und Gesichtschirurgie</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>6</NO>
<PG>350-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neuner-1969" MODIFIED="2012-11-12 19:57:51 +0000" MODIFIED_BY="[Empty name]" NAME="Neuner 1969" YEAR="1969">
<REFERENCE MODIFIED="2012-11-12 19:57:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neuner O</AU>
<TI>Experiences with Apernyl in the treatment of and prevention of pain after extraction</TI>
<SO>Schweizerische Monatsschrift fur Zahnheilkunde</SO>
<YR>1969</YR>
<VL>79</VL>
<NO>5</NO>
<PG>630-5</PG>
<IDENTIFIERS MODIFIED="2012-03-29 10:16:13 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nordenram-1973" MODIFIED="2012-11-12 19:58:07 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Nordenram 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-11-12 19:58:07 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nordenram A, Sydnes G, Ödegaard J</AU>
<TI>Neomycin-bacitracin cones in impacted third molar sockets</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1973</YR>
<VL>2</VL>
<NO>6</NO>
<PG>279-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olson-1987" MODIFIED="2012-11-12 19:59:28 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Olson 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-11-12 19:59:28 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olson RAJ, Fridrich KL</AU>
<TI>Alveolitis sicca dolorosa following impacted mandibular 3rd molar surgical removal</TI>
<SO>Journal of Dental Research</SO>
<YR>1987</YR>
<VL>66</VL>
<NO>1 Suppl</NO>
<PG>174 (Abs No 542)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olusanya-2011" MODIFIED="2012-11-12 19:59:57 +0000" MODIFIED_BY="[Empty name]" NAME="Olusanya 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 19:59:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Olusanya AA, Arotiba JT, Fasola OA, Akadiri AO</AU>
<TI>Prophylaxis versus pre-emptive antibiotics in third molar surgery: a randomised control study</TI>
<SO>The Nigerian Postgraduate Medical Journal</SO>
<YR>2011</YR>
<VL>18</VL>
<NO>2</NO>
<PG>105-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pichler-2001" MODIFIED="2012-11-12 20:00:55 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Pichler 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-11-12 20:00:55 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pichler JR, Beirne OR</AU>
<TI>Chlorhexidine rinsing and dry socket after surgically extracting third molars</TI>
<SO>Journal of Dental Research</SO>
<YR>2001</YR>
<VL>80</VL>
<NO>Special Issue (AADR Abstracts)</NO>
<PG>222 (Abs No 1492)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Qi-2012" MODIFIED="2012-11-12 21:06:07 +0000" MODIFIED_BY="[Empty name]" NAME="Qi 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:06:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Qi D, May L, Zimmerman B, Peng P, Atillasoy E, Shelburne S et al</AU>
<TI>A randomized, double-blind, placebo-controlled, efficacy and safety study of acetaminophen 1000 mg and acetaminophen 650 mg in postoperative dental pain</TI>
<SO>Journal of Pain</SO>
<YR>2012</YR>
<VL>13</VL>
<NO>4 Suppl 1</NO>
<PG>S74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ritzau-1978" MODIFIED="2012-11-12 20:01:17 +0000" MODIFIED_BY="[Empty name]" NAME="Ritzau 1978" YEAR="1978">
<REFERENCE MODIFIED="2012-11-12 20:01:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ritzau M, Therkildsen P</AU>
<TI>Antifibrinolytic prevention of alveolitis sicca dolorosa</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1978</YR>
<VL>7</VL>
<NO>6</NO>
<PG>534-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanchis-2004" MODIFIED="2010-07-12 11:36:27 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Sanchis 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-07-12 11:36:27 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanchis JM, Sáez U, Penarrocha M, Gay C</AU>
<TI>Tetracycline compound placement to prevent dry socket: a postoperative study of 200 impacted mandibular third molars</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2004</YR>
<VL>62</VL>
<NO>5</NO>
<PG>587-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schatz-1987" MODIFIED="2010-09-09 09:26:25 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Schatz 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-09-09 09:26:25 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schatz JP, Fiore-Donno G, Henning G</AU>
<TI>Fibrinolytic alveolitis and its prevention</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1987</YR>
<VL>16</VL>
<NO>2</NO>
<PG>175-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schlund-1968" MODIFIED="2012-11-12 20:01:47 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Schlund 1968" YEAR="1968">
<REFERENCE MODIFIED="2012-11-12 20:01:47 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schlund A</AU>
<TI>[Experiences with "Terracortril Gel" in oral surgery] [German]</TI>
<SO>DDZ - das Deutsche Zahnarzteblatt</SO>
<YR>1968</YR>
<VL>22</VL>
<NO>2</NO>
<PG>82-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sorensen-1987" MODIFIED="2010-08-21 17:22:08 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Sorensen 1987" YEAR="1987">
<REFERENCE MODIFIED="2010-08-21 17:22:08 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sorensen DC, Preisch JW</AU>
<TI>The effect of tetracycline on the incidence of postextraction alveolar osteitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1987</YR>
<VL>45</VL>
<NO>12</NO>
<PG>1029-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swanson-1989" MODIFIED="2010-07-11 10:01:59 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Swanson 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-07-11 10:01:59 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swanson AE</AU>
<TI>A double-blind study on the effectiveness of tetracycline in reducing the incidence of fibrinolytic alveolitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1989</YR>
<VL>47</VL>
<NO>2</NO>
<PG>165-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sweet-1985" MODIFIED="2012-11-12 20:01:59 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Sweet 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-11-12 20:01:59 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sweet JB, Macynski AA</AU>
<TI>Effect of antimicrobial mouth rinses on the incidence of localized alveolitis and infection following mandibular third molar oral surgery</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1985</YR>
<VL>59</VL>
<NO>1</NO>
<PG>24-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Syrjanen-1981" MODIFIED="2010-07-13 12:06:26 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Syrjanen 1981" YEAR="1981">
<REFERENCE MODIFIED="2010-07-13 12:06:26 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Syrjanen SM, Syrjanen KJ</AU>
<TI>A new combination of drugs intended to be used as a preventive measure for the postextraction complications. A preliminary report</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1981</YR>
<VL>10</VL>
<NO>1</NO>
<PG>17-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-07-13 11:54:03 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Syrjanen SM, Syrjanen KJ</AU>
<TI>The effects on extraction wound healing of a new drug combination introduced for use in the prevention of post-extraction complications. A preliminary report</TI>
<SO>British Journal of Oral Surgery</SO>
<YR>1981</YR>
<VL>19</VL>
<NO>1</NO>
<PG>57-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Syrjanen-1981a" MODIFIED="2012-11-12 20:02:13 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Syrjanen 1981a" YEAR="1981">
<REFERENCE MODIFIED="2012-11-12 20:02:13 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Syrjanen SM, Syrjanen KJ</AU>
<TI>Prevention and treatment of post-extraction complications. A comparison of the effect of Alvogyl and a new drug combination on wound healing</TI>
<SO>Proceedings of the Finnish Dental Society</SO>
<YR>1981</YR>
<VL>77</VL>
<NO>6</NO>
<PG>305-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tjernberg-1979" MODIFIED="2012-11-12 20:02:35 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Tjernberg 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-11-12 20:02:35 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjernberg A</AU>
<TI>Influence of oral hygiene measures on the development of alveolitis sicca dolorosa after surgical removal of mandibular third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1979</YR>
<VL>8</VL>
<NO>6</NO>
<PG>430-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tong-2012" MODIFIED="2012-11-12 21:06:28 +0000" MODIFIED_BY="[Empty name]" NAME="Tong 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:06:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tong SE, Daniels SE, Black P, Chang S, Protter A, Desjardins PJ</AU>
<TI>Novel p38alpha mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>2012</YR>
<VL>52</VL>
<NO>5</NO>
<PG>717-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torres_x002d_Lagares-2010" MODIFIED="2012-11-12 20:03:09 +0000" MODIFIED_BY="[Empty name]" NAME="Torres-Lagares 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-11-12 20:03:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torres-Lagares D, Gutierrez-Perez JL, Hita-Iglesias P, Magallanes-Abad N, Flores-Ruiz R, Basallote-Garcia M et al</AU>
<TI>Randomized, double-blind study of effectiveness of intra-alveolar application of chlorhexidine gel in reducing incidence of alveolar osteitis and bleeding complications in mandibular third molar surgery in patients with bleeding disorders</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2010</YR>
<VL>68</VL>
<NO>6</NO>
<PG>1322-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vedtofte-1974" MODIFIED="2010-07-14 11:01:19 +0100" MODIFIED_BY="Zbys Fedorowicz" NAME="Vedtofte 1974" YEAR="1974">
<REFERENCE MODIFIED="2010-07-14 11:01:19 +0100" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vedtofte P, Ritzau M, Donatsky O</AU>
<TI>Use of propylic ester of p-hydroxy-benzoic acid after removal of impacted mandibular third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1974</YR>
<VL>3</VL>
<NO>6</NO>
<PG>394-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wen-2004" MODIFIED="2012-11-12 20:03:27 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Wen 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-11-12 20:03:27 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wen N, Han L, Lu HX, Mao TQ, Wang ZY, Liu HC</AU>
<TI>Protection of basic fibroblast growth factor on dry socket after mandibular impacted tooth extraction</TI>
<SO>Zhongguo Linchuang Kangfu</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>5</NO>
<PG>858-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yue-2012" MODIFIED="2012-11-12 21:06:54 +0000" MODIFIED_BY="[Empty name]" NAME="Yue 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:06:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yue Y, Christensen S, Buchanan W, Reed K, Collaku A, Otto J</AU>
<TI>Two randomized, double-blind, placebo-controlled efficacy studies assessing the efficacy and speed of onset of pain relief of Panadol Advancein post-surgical dental pain</TI>
<SO>Journal of Pain</SO>
<YR>2012</YR>
<VL>13</VL>
<NO>4 Suppl 1</NO>
<PG>S85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zanetta_x002d_Barbosa-1994" MODIFIED="2012-11-12 20:03:48 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Zanetta-Barbosa 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-11-12 20:03:48 +0000" MODIFIED_BY="Zbys Fedorowicz" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zanetta-Barbosa D, Candelas L, Rocha F, Marquez IM</AU>
<TI>A clinical study on the efficacy of two treatments for dry socket [Portuguese]</TI>
<TO>Estudo clínico da eficácia de dois tipos de tratamento para alveolite</TO>
<SO>Revista do Centro de Ciencias Biomedicas da Universidade Federal de Uberlandia</SO>
<YR>1994</YR>
<VL>10</VL>
<NO>1</NO>
<PG>35-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zuniga-2011" MODIFIED="2012-11-12 21:07:23 +0000" MODIFIED_BY="[Empty name]" NAME="Zuniga 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-11-12 21:07:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zuniga JR, Noveck RJ, Schmidt WK, Boesing SE, Hersh EV</AU>
<TI>Onset of action of diclofenac potassium liquid-filled capsules in dental surgery patients</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>9</NO>
<PG>1733-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-11-12 21:07:48 +0000" MODIFIED_BY="Zbys Fedorowicz">
<STUDY DATA_SOURCE="PUB" ID="STD-Babar-2012" MODIFIED="2012-11-12 21:07:48 +0000" MODIFIED_BY="[Empty name]" NAME="Babar 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-12 21:07:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Babar A, Ibrahim MW, Baig NJ, Shah I, Amin E</AU>
<TI>Efficacy of intra-alveolar chlorhexidine gel in reducing frequency of alveolar osteitis in mandibular third molar surgery</TI>
<SO>Journal of the College of Physicians &amp; Surgeons - Pakistan</SO>
<YR>2012</YR>
<VL>22</VL>
<NO>2</NO>
<PG>91-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2012-03-14 14:47:15 +0000" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-11-13 16:35:10 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-11-13 16:35:10 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alexander-2000" MODIFIED="2012-11-12 20:04:20 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Alexander 2000" TYPE="JOURNAL_ARTICLE">
<AU>Alexander RE</AU>
<TI>Dental extraction wound management: a case against medicating postextraction</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2000</YR>
<VL>58</VL>
<NO>5</NO>
<PG>538-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Antczak_x002d_Bouckoms-1990" MODIFIED="2012-11-12 20:04:53 +0000" MODIFIED_BY="[Empty name]" NAME="Antczak-Bouckoms 1990" TYPE="JOURNAL_ARTICLE">
<AU>Antczak-Bouckoms AA, Tulloch JF, Berkey CS</AU>
<TI>Split-mouth and cross-over designs in dental research</TI>
<SO>Journal of Clinical Periodontology</SO>
<YR>1990</YR>
<VL>17</VL>
<NO>7 Pt 1</NO>
<PG>446-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Beaudouin-2004" MODIFIED="2012-11-12 20:05:45 +0000" MODIFIED_BY="[Empty name]" NAME="Beaudouin 2004" TYPE="JOURNAL_ARTICLE">
<AU>Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC et al</AU>
<TI>Immediate hypersensitivity to chlorhexidine: literature review.</TI>
<SO>European Annals of Allergy and Clinical Immunology</SO>
<YR>2004</YR>
<VL>36</VL>
<NO>4</NO>
<PG>123-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blum-2002" NAME="Blum 2002" TYPE="JOURNAL_ARTICLE">
<AU>Blum IR</AU>
<TI>Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>3</NO>
<PG>309-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Caso-2005" MODIFIED="2012-11-12 20:06:11 +0000" MODIFIED_BY="[Empty name]" NAME="Caso 2005" TYPE="JOURNAL_ARTICLE">
<AU>Caso A, Hung LK, Beirne OR</AU>
<TI>Prevention of alveolar osteitis with chlorhexidine: a meta-analytic review</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>2005</YR>
<VL>99</VL>
<NO>2</NO>
<PG>155-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coulthard-2003" MODIFIED="2012-11-12 10:45:10 +0000" MODIFIED_BY="Blanaid JM Daly" NAME="Coulthard 2003" TYPE="COCHRANE_PROTOCOL">
<AU>Coulthard P, Esposito M, Renton TF, Worthington HV</AU>
<TI>Surgical techniques for the removal of mandibular wisdom teeth</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-11-12 10:45:10 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-11-12 10:45:10 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004345"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Edwards-2011" MODIFIED="2012-11-12 21:08:14 +0000" MODIFIED_BY="[Empty name]" NAME="Edwards 2011" TYPE="OTHER">
<AU>Edwards A</AU>
<TI>Dental patient, 30, 'turned blue and died after mouthwash led to fatal allergic reaction'</TI>
<SO>http://www.dailymail.co.uk/news/article-2037634/Sacha-Rumaner-turned-blue-died-swilling-mouthwash-led-fatal-allergic-reaction.html</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2012-11-12 20:06:54 +0000" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2012-11-12 20:07:31 +0000" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Epstein-2000" MODIFIED="2012-11-12 20:07:51 +0000" MODIFIED_BY="[Empty name]" NAME="Epstein 2000" TYPE="JOURNAL_ARTICLE">
<AU>Epstein JB, Chong S, Le ND</AU>
<TI>A survey of antibiotic use in dentistry</TI>
<SO>Journal of the American Dental Association</SO>
<YR>2000</YR>
<VL>131</VL>
<NO>11</NO>
<PG>1600-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fazakerley-1991" MODIFIED="2012-11-12 20:41:56 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Fazakerley 1991" TYPE="JOURNAL_ARTICLE">
<AU>Fazakerley M, Field EA</AU>
<TI>Dry socket: a painful post-extraction complication (a review)</TI>
<SO>Dental Update</SO>
<YR>1991</YR>
<VL>18</VL>
<NO>1</NO>
<PG>31-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fridrich-1990" MODIFIED="2012-11-12 20:42:39 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Fridrich 1990" TYPE="JOURNAL_ARTICLE">
<AU>Fridrich KL, Olson RAJ</AU>
<TI>Alveolar osteitis following surgical removal of mandibular third molars</TI>
<SO>Anesthesia Progress</SO>
<YR>1990</YR>
<VL>37</VL>
<NO>1</NO>
<PG>32-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gagari-1995" MODIFIED="2012-11-13 16:34:51 +0000" MODIFIED_BY="[Empty name]" NAME="Gagari 1995" TYPE="JOURNAL_ARTICLE">
<AU>Gagari E, Kabani S</AU>
<TI>Adverse effects of mouthwash use. A review</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>1995</YR>
<VL>80</VL>
<NO>4</NO>
<PG>432-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Garcia-2003" MODIFIED="2008-07-30 14:37:17 +0100" MODIFIED_BY="[Empty name]" NAME="Garcia 2003" TYPE="JOURNAL_ARTICLE">
<AU>Garcia AG, Grana PM, Sampedro FG, Diago MP, Rey JM</AU>
<TI>Does oral contraceptive use affect the incidence of complications after extraction of a mandibular third molar?</TI>
<SO>British Dental Journal</SO>
<YR>2003</YR>
<VL>194</VL>
<NO>8</NO>
<PG>453-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hedstrom-2007" MODIFIED="2012-11-12 20:43:08 +0000" MODIFIED_BY="[Empty name]" NAME="Hedstrom 2007" TYPE="JOURNAL_ARTICLE">
<AU>Hedstrom L, Sjogren P</AU>
<TI>Effect estimates and methodological quality of randomised controlled trials about prevention of alveolar osteitis following tooth extraction: a systematic review</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>2007</YR>
<VL>103</VL>
<NO>1</NO>
<PG>8-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-11-12 20:44:02 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<MD>Available from www.cochrane-handbook.org.</MD>
<IDENTIFIERS MODIFIED="2010-05-13 23:23:30 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Koerner-1994" MODIFIED="2012-11-12 20:44:21 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Koerner 1994" TYPE="JOURNAL_ARTICLE">
<AU>Koerner KR</AU>
<TI>The removal of impacted third molars. Principles and procedures</TI>
<SO>Dental Clinics of North America</SO>
<YR>1994</YR>
<VL>38</VL>
<NO>2</NO>
<PG>255-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kolokythas-2010" MODIFIED="2012-11-12 20:50:38 +0000" MODIFIED_BY="[Empty name]" NAME="Kolokythas 2010" TYPE="JOURNAL_ARTICLE">
<AU>Kolokythas A, Olech E, Miloro M</AU>
<TI>Alveolar osteitis: a comprehensive review of concepts and controversies</TI>
<SO>International Journal of Dentistry</SO>
<YR>2010</YR>
<VL>2010</VL>
<PG>249073</PG>
<IDENTIFIERS MODIFIED="2012-11-12 20:46:34 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Lodi-2012" MODIFIED="2012-11-12 10:42:05 +0000" MODIFIED_BY="Blanaid JM Daly" NAME="Lodi 2012" TYPE="COCHRANE_REVIEW">
<AU>Lodi G, Figini L, Sardella A, Carrassi A, Del Fabbro M, Furness S</AU>
<TI>Antibiotics to prevent complications following tooth extractions</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2012-11-12 10:42:05 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-11-12 10:42:05 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003811.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCaul-2001" MODIFIED="2012-11-12 20:51:57 +0000" MODIFIED_BY="[Empty name]" NAME="McCaul 2001" TYPE="JOURNAL_ARTICLE">
<AU>McCaul LK, Jenkins WM, Kay EJ</AU>
<TI>The reasons for the extraction of various tooth types in Scotland: a 15-year follow-up</TI>
<SO>British Dental Journal</SO>
<YR>2001</YR>
<VL>190</VL>
<NO>12</NO>
<PG>658-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Muhonen-1997" NAME="Muhonen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Muhonen A, Venta I, Ylipaavalniemi P</AU>
<TI>Factors predisposing to postoperative complications related to wisdom tooth surgery among university students</TI>
<SO>Journal of American College Health</SO>
<YR>1997</YR>
<VL>46</VL>
<NO>1</NO>
<PG>39-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nagendran-2009" MODIFIED="2012-11-12 20:52:23 +0000" MODIFIED_BY="[Empty name]" NAME="Nagendran 2009" TYPE="JOURNAL_ARTICLE">
<AU>Nagendran V, Wicking J, Ekbote A, Onyekwe T, Garvey LH</AU>
<TI>IgE-mediated chlorhexidine allergy: a new occupational hazard?</TI>
<SO>Occupational Medicine (Oxford, England)</SO>
<YR>2009</YR>
<VL>59</VL>
<NO>4</NO>
<PG>270-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Noroozi-2009" MODIFIED="2012-11-12 20:53:01 +0000" MODIFIED_BY="[Empty name]" NAME="Noroozi 2009" TYPE="JOURNAL_ARTICLE">
<AU>Noroozi AR, Philbert RF</AU>
<TI>Modern concepts in understanding and management of the "dry socket" syndrome: comprehensive review of the literature</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics</SO>
<YR>2009</YR>
<VL>107</VL>
<NO>1</NO>
<PG>30-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nusair-2007" NAME="Nusair 2007" TYPE="JOURNAL_ARTICLE">
<AU>Nusair YM, Younis MH</AU>
<TI>Prevalence, clinical picture, and risk factors of dry socket in a Jordanian dental teaching center</TI>
<SO>The Journal of Contemporary Dental Practice</SO>
<YR>2007</YR>
<VL>8</VL>
<NO>3</NO>
<PG>53-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reissner-2011" MODIFIED="2012-11-12 21:10:06 +0000" MODIFIED_BY="[Empty name]" NAME="Reissner 2011" TYPE="OTHER">
<AU>Reissner D, Khanam J</AU>
<TI>Briefing note -Death at the dentist</TI>
<SO>Available at www.charlesrussell.co.uk/UserFiles/file/pdf/Healthcare/Death_Dentist.pdf (accessed October 2012)</SO>
<IDENTIFIERS MODIFIED="2012-10-17 12:44:59 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2012-11-12 14:29:06 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 2011" TYPE="OTHER">
<AU>Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011</AU>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rood-1981" MODIFIED="2012-11-12 20:53:24 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Rood 1981" TYPE="JOURNAL_ARTICLE">
<AU>Rood JP, Danford M</AU>
<TI>Metronidazole in the treatment of dry socket</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1981</YR>
<VL>10</VL>
<NO>5</NO>
<PG>345-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rud-1970" MODIFIED="2012-11-12 20:53:46 +0000" MODIFIED_BY="Zbys Fedorowicz" NAME="Rud 1970" TYPE="JOURNAL_ARTICLE">
<AU>Rud J</AU>
<TI>Removal of impacted lower third molars with acute pericoronitis and necrotising gingivitis</TI>
<SO>British Journal of Oral Surgery</SO>
<YR>1970</YR>
<VL>7</VL>
<NO>3</NO>
<PG>153-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sharma-2009" MODIFIED="2012-11-12 20:54:14 +0000" MODIFIED_BY="[Empty name]" NAME="Sharma 2009" TYPE="JOURNAL_ARTICLE">
<AU>Sharma A, Chopra H</AU>
<TI>Chlorhexidine urticaria: a rare occurrence with a common mouthwash</TI>
<SO>Indian Journal of Dental Research</SO>
<YR>2009</YR>
<VL>20</VL>
<PG>377-9</PG>
<IDENTIFIERS MODIFIED="2012-11-12 20:54:14 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Silva-2006" MODIFIED="2008-07-30 14:37:24 +0100" MODIFIED_BY="[Empty name]" NAME="Silva 2006" TYPE="JOURNAL_ARTICLE">
<AU>Silva LJ, Poi WR, Panzarini SR, Rodrigues TS, Simonato LE</AU>
<TI>Clinical evaluation of an ointment with 10% metronidazole and 2% lidocaine in the treatment of alveolitis</TI>
<SO>Minerva Stomatologica</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>7-8</NO>
<PG>431-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweet-1978" NAME="Sweet 1978" TYPE="JOURNAL_ARTICLE">
<AU>Sweet JB, Butler DP</AU>
<TI>Predisposing and operative factors: effect on the incidence of localized osteitis in mandibular third-molar surgery</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1978</YR>
<VL>46</VL>
<NO>2</NO>
<PG>206-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turcotte-1997" MODIFIED="2012-11-12 20:54:42 +0000" MODIFIED_BY="[Empty name]" NAME="Turcotte 1997" TYPE="JOURNAL_ARTICLE">
<AU>Turcotte JY</AU>
<TI>[Alveolitis--current opinion] [French]</TI>
<SO>Journal (Canadian Dental Association)</SO>
<YR>1997</YR>
<VL>63</VL>
<NO>3</NO>
<PG>206-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Strydonck-2012" MODIFIED="2012-11-12 20:55:31 +0000" MODIFIED_BY="[Empty name]" NAME="Van Strydonck 2012" TYPE="JOURNAL_ARTICLE">
<AU>Van Strydonck DAC, Slot DE, Van der Velden U, Van der Weijden F</AU>
<TI>Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review</TI>
<SO>Journal of Clinical Periodontology</SO>
<YR>2012</YR>
<VL>39</VL>
<NO>11</NO>
<PG>1042-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vezeau-2000" MODIFIED="2012-03-20 15:27:00 +0000" MODIFIED_BY="[Empty name]" NAME="Vezeau 2000" TYPE="JOURNAL_ARTICLE">
<AU>Vezeau PJ</AU>
<TI>Dental extraction wound management: medicating postextraction sockets</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2000</YR>
<VL>58</VL>
<NO>5</NO>
<PG>531-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yengopal-2012" MODIFIED="2012-11-12 21:11:05 +0000" MODIFIED_BY="[Empty name]" NAME="Yengopal 2012" TYPE="JOURNAL_ARTICLE">
<AU>Yengopal V, Mickenautsch S</AU>
<TI>Chlorhexidine for the prevention of alveolar osteitis</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2012</YR>
<VL>41</VL>
<NO>10</NO>
<PG>1253&#8211;64</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2012-03-20 15:27:38 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-11-13 17:01:55 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-11-13 17:01:55 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-11-13 16:59:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alissa-2010">
<CHAR_METHODS MODIFIED="2012-11-13 09:52:55 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> A randomised, controlled, parallel-group (pilot) study.</P>
<P>
<B>Sample size calculation: </B>A priori sample size calculation suggested needed 34 in each group.</P>
<P>
<B>Sample size:</B> N = 23, suggesting 60% power.</P>
<P>
<B>Conducted in: </B>University Dental Hospital of Manchester, Manchester, UK. Patients recruited from consultation clinic.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> molars, premolars, canines and incisors, 17 (60.9%) extracted for dental caries and 5 (21.7%) endodontic failure. Extracted under IV sedation.</P>
<P>
<B>Recruitment period:</B> January 2005 to April 2008.</P>
<P>
<B>Funding source: </B>Not stated. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 09:54:46 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria: </B>
</P>
<UL>
<LI>Healthy adults over 18 years of age.</LI>
<LI>Patients with a demonstrable need for removal of at least one tooth, treated with local anaesthesia and intravenous sedation.</LI>
<LI>Patients able to consent (written) and willing to complete the requirements of the study protocol.</LI>
</UL>
<P>
<B>Exclusion criteria: </B>
</P>
<UL>
<LI>Pregnancy/nursing mothers/having childbearing potential and not using birth control measures.</LI>
<LI>Platelet dysfunction syndrome or critical thrombocytopenia.</LI>
<LI>Under treatment with NSAIDs including aspirin, antibiotics, systematic corticosteroids, anticoagulants or immunosuppressive drugs.</LI>
<LI>Diabetes mellitus.</LI>
<LI>Cardiovascular disease including a history of rheumatic fever, or other conditions requiring antibiotic prophylaxis.</LI>
<LI>Neoplasia or haematological malignancy.</LI>
<LI>Renal, hepatic or endocrine diseases.</LI>
<LI>Metabolic bone disease such as osteomalacia, hypocalcaemia or hypercalcaemia.</LI>
<LI>Participation in another trial.</LI>
</UL>
<P>
<B>Age group: </B>Mean = 30.5.</P>
<P>
<B>Platelet rich plasma (PRP) Group: </B>Number randomised 12; analysed 12.</P>
<P>
<B>Control Group: </B>Number randomised 11; analysed 7.</P>
<P>
<B>Number evaluated: </B>19.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 16:59:13 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: </B>Platelet rich plasma placed in extraction sockets versus control.</P>
<P>All patients were treated under IV sedation and blood drawn to manufacture the PRP produce before the surgical procedure and before IV sedation administered. All patients had a mucoperiosteal flap raised with two releasing incisions. Extraction with forceps to minimise trauma, elevators used as appropriate. All sockets carefully curetted to remove granulation tissue and/or periapical infections.</P>
<P>
<B>PRP Group (n = 12): </B>Platelet rich plasma placed in extraction sockets after extraction and curettage.</P>
<P>
<B>Control Group B (n = 11):</B> Nothing placed in control sockets. </P>
<P>
<B>Co-interventions and concomitant medication:</B> None stated. Co-codamol analgesic tablets (codeine phosphate 30 mg and paracetamol 500 mg).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:03:02 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Alveolar osteitis: assessed 1 week postoperative using Cheung et al 2001 (range).</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Quality of life. A statistically significant improvement associated with use of PRP was observed for two variables: bad taste in mouth (P = 0.03), food stagnation (P = 0.03) and borderline for change in di</LI>
<LI>Patient satisfaction: A high level of patient satisfaction in both groups, and no difference between groups.</LI>
</UL>
<P>
<B>Adverse outcomes: </B>
</P>
<UL>
<LI>No adverse events reported</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 16:59:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bai-2011">
<CHAR_METHODS MODIFIED="2012-11-13 16:59:28 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design: </B>Parallel RCT.</P>
<P>
<B>Sample size calculation:</B> Not clear that this was undertaken.</P>
<P>
<B>Study size</B>: 400 participants.</P>
<P>
<B>Conducted in:</B> Stomatological Center of Chinese PLA, the 306 Hospital of Chinese PLA, Beijing, China.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth: </B>Impacted mandibular third molar, local anaesthesia.</P>
<P>
<B>Recruitment period: </B>03/2009-06/2010.<BR/>
<B>Providers of care:</B> 1 surgeon.<BR/>
<B>Funding Source:</B> No funding.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:07:49 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Participants required to have their impacted mandibular third molar extracted were included.</LI>
<LI>Aged 18-50.</LI>
<LI>No acute pericoronitis within a week.</LI>
<LI>No antibiotics within 3 days before the extraction.</LI>
<LI>No contra-indications.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Acure pericoronitis within a week before the extraction.</LI>
<LI>Antibiotics administration within 3 days before the extraction.</LI>
</UL>
<P>
<B>Age group: </B>Mean 27.9.<B> </B>
</P>
<P>
<B>Number randomised in Group 1 = </B>200;<B> number analysed = </B>200.</P>
<P>
<B>Number randomised in Group 2 = </B>200; <B>number analysed = </B>200.</P>
<P>
<B>Number evaluated: </B>200.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:08:32 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: </B>Acellular dermis matrix versus control.</P>
<P>
<B>Group 1 (n = 200):</B> Acellular dermis matrix (1×1 cm) embedded into the extraction sockets.</P>
<P>
<B>Group 2 (n = 200):</B> Nothing embedded into the extraction sockets.</P>
<P>
<B>Co-interventions:</B> Extraction of the teeth (the detailed information was not reported).</P>
<P>
<B>Concomitant medication:</B> Not reported.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:09:16 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>When measured:</B> 1 week after the extraction.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence of postoperative alveolitis; disintegration of blood clot; haemorrhage rate; swelling rate (the exact measurement method was not reported); food residue rate; rate of red swollen gingiva.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None reported.</LI>
</UL>
<P>
<B>Adverse outcomes: </B>
</P>
<UL>
<LI>None reported.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-27 09:32:07 +0000" MODIFIED_BY="[Empty name]">
<P> Author contact failed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:15:47 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Burgoyne-2010">
<CHAR_METHODS MODIFIED="2012-11-13 12:15:47 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design: </B>Randomised parallel-group controlled trial.</P>
<P>
<B>Study size: </B>35.</P>
<P>
<B>Sample size calculation: </B>Not stated.</P>
<P>
<B>Prevention or treatment of dry socket: </B>Treatment.</P>
<P>
<B>Type of teeth: </B>Mandibular third molars, mandibular and maxillary molars and premolars.</P>
<P>
<B>Conducted in: </B>Department of Oral and Maxillofacial Surgery, School of Dentistry, Virginia Commonwealth University (Richmond, VA), USA.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:12:41 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Presenting with alveolar osteitis; diagnosed as pain of increasing severity 2 to 3 days post-extraction, absence of a clot in the socket.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Immunocompromised or on immunosuppressant drugs.</LI>
<LI>Steroids, nonsteroidal anti-inflammatory drugs within 4 hours of examination.</LI>
<LI>Allergy to eugenol, lidocaine, prilocaine, acetaminophen or codeine.</LI>
<LI>Medical conditions: Type 1/2 diabetes, glucose 6-phosphate dehydrogenase deficiency.</LI>
<LI>Pregnancy.</LI>
<LI>Drugs associated with drug induced methamglobinaemia.</LI>
</UL>
<P>
<B>Age: </B>
</P>
<P>Gauze strip group: mean = 33, range 19-53.</P>
<P>Topical anaesthetic gel: mean = 27, range 17-58.</P>
<P>
<B>Number randomised: </B>35.</P>
<P>
<B>Number analysed:</B> 35.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:13:00 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison: </B>Topical anaesthetic gel versus eugenol gauze strip.</P>
<P>
<B>Group 1 (n = 15): </B>2.5% prilocaine, 2.5% lidocaine (Oraqix; Dentsply Pharmaceutical, York, PA) thermosetting gel syringed into socket .</P>
<P>
<B>Group 2 (n = 20): </B>Eugenol on plain gauze into socket.</P>
<P>
<B>Co-interventions: </B>
</P>
<P>Extraction site irrigated with normal saline.</P>
<P>Prescription for 24 tablets of acetaminophen and codeine, 30 mg, taking 1 or 2 tablets every 4 hours if needed for pain. Details recorded quantity and frequency.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:13:13 +0000" MODIFIED_BY="[Empty name]">
<P>Self assessment 5, 10, 15 mins after first treatment, and then hourly whilst awake over 48 hours. Assessed at 48 hours and if still in pain re-treated.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Relief of pain associated with localized alveolar osteitis. Pain measured by VAS: no pain (0) to severe (10) compared at 24 and 48 hours.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None assessed.</LI>
</UL>
<P>
<B>Adverse effects: </B>
</P>
<UL>
<LI>None reported.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-21 14:49:33 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>The pain outcomes sought were to be assessed during waking hours but it was unclear why the investigators considered pain assessments not recorded while the patients slept as "missing data". "Two analyses were performed, one treating the missing data as ignorable and the other inputting pain scores of 0 during sleep". We used the one which ignored the missing data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:15:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delilbasi-2002">
<CHAR_METHODS MODIFIED="2012-11-13 12:15:54 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design: </B>Randomised, placebo-controlled, parallel-group study.</P>
<P>
<B>Sample size: </B>177.</P>
<P>
<B>Power calculation:</B> Not reported.</P>
<P>
<B>Conducted in: </B>Not stated (Authors based in Turkey and Japan).</P>
<P>
<B>Number of centres:</B> Not stated.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth: </B>Mandibular third molars.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source: </B>Not stated.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:15:22 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>At least 1 impacted mandibular third molar.</LI>
<LI>Patients in good health.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Patients who had pericoronitis or were taking antibiotics for other infections.</LI>
<LI>Women who were pregnant, breast-feeding, or using oral contraceptives.</LI>
</UL>
<P>
<B>Age Group 1</B>:<B> </B>24.1;<B> Group 2: </B>24.7;<B> Group 3: </B>24.2.</P>
<P>
<B>Number randomised:</B> 177.</P>
<P>
<B>Number analysed:</B> 177.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:16:34 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison:</B>
<BR/>
<B>Group 1 (n = 62): </B>Rinse with 15 mL of CHX solution (Klorhex; Drogsan) for 30 seconds just before tooth removal. Intraoperatively, 15 mL of CHX diluted with 15 mL of sterile saline was used as irrigation. The soft tissue was closed with 3/0 silk suture for transalveolar procedures. The day after surgery, the patients began home use of the CHX solution (15 mL for 30 seconds) twice daily for 7 days.</P>
<P>
<B>Group 2 (n = 56):</B> Similarly to Group 1. However, in addition to CHX solution, the patients in Group 2 were prescribed Aug-mentin (500 mg amoxicillin trihydrate, 125 mg clavulanic acid; SmithKline Beecham) twice daily for 5 days postoperatively.</P>
<P>
<B>Group 3 (n = 59):</B> Similarly to Group 1, except for the substitution of sterile saline solution (0.09 % NaCl) for CHX.</P>
<P>
<B>Co-interventions:</B> All 3 groups were instructed to use only 500 mg paracetamol (Minoset; Roche) for postoperative pain relief.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:18:40 +0000" MODIFIED_BY="[Empty name]">
<P>Assessment days 3 and 7 postoperatively.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Diagnosis of alveolitis osteitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None.</LI>
</UL>
<P>
<B>Adverse outcomes:</B>
</P>
<P>Adverse events reported for Group 1 n = 62. Allergy: n = 0. Staining of teeth: n = 4. Mucosal irritation: n = 0. Alteration in taste: n = 12. GIS complaints: n = 0. Bad taste: n = 8. No adverse reactions: n = 38. From Table IV page 303.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-29 22:12:29 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 10:23:48 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<CHAR_METHODS MODIFIED="2012-11-13 10:21:10 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> Randomised controlled double-blind split-mouth design.</P>
<P>
<B>Sample size:</B> 120.</P>
<P>
<B>Sample size calculation:</B> Not reported.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Bilaterally impacted mandibular third molars &#8211; under local anaesthetic.</P>
<P>
<B>Conducted in: </B>Department of Oral Surgery, Royal Dental College, Copenhagen, Denmark.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> No financial support received.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:21:31 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Bilateral impacted mandibular third molars without acute pericoronitis.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Not reported.</LI>
</UL>
<P>
<B>Mean age:</B> 23.2, range 14-58.</P>
<P>
<B>Number randomised: </B>120.</P>
<P>
<B>Number analysed:</B> 120.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:22:57 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Intervention (n = 120):</B> 4 AMCA (Tranexamic acid 40.0 mg) cones.</P>
<P>
<B>Control (n = 120):</B> 4 placebo (Lactose (n = 30) or Sorbitol (n = 90) 40 mg).</P>
<P>
<B>Co-interventions:</B>
</P>
<P>The surgical areas were irrigated with 50 ml sterile saline and closure of the wounds was accomplished with 2 silk sutures.</P>
<P>"Oral hygiene was secured by mouthrinses with chlorhexidine gluconate 0.2%, 3 times a day. The pains were alleviated with tablets containing 500 mg acetylsalicylic acid and 10 mg codeine phosphate." Frequency and quantity not reported.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:23:39 +0000" MODIFIED_BY="[Empty name]">
<P>Assessment carried out ''...4, 5 or 6 days (mean = 5 days) after the operation...''</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence of alveolitis sicca dolorosa.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>Foreign body reaction to the vehicle delivery system in the cones.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 10:23:48 +0000" MODIFIED_BY="[Empty name]">
<P>2 control groups, 2 teeth per patient.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 10:28:23 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Hermesch-1998">
<CHAR_METHODS MODIFIED="2012-11-13 10:25:09 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> Randomised, double-blind, placebo-controlled, parallel-group study.</P>
<P>
<B>Sample size</B>: 279.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Conducted in:</B> A military dental clinic (authors from San Antonio, Texas USA).</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Impacted mandibular third molar - under local anaesthesia with optional intravenous sedation. However, other third molars extracted concurrently.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not reported.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:26:46 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>At least 1 impacted mandibular third molar.</LI>
<LI>Over 18 years of age.</LI>
<LI>In good health.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Pericoronitis.</LI>
<LI>Medical conditions requiring antibiotic prophylaxis.</LI>
<LI>Participants taking antibiotics 2 weeks prior.</LI>
<LI>Pregnant or lactating females.</LI>
<LI>Allergy to chlorhexidine.</LI>
</UL>
<P>
<B>Number randomised: </B>279 0.12% CHX n = 140; placebo n = 139.</P>
<P>
<B>Number analysed:</B> 271 0.12% CHX n = 136; placebo n = 135.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:26:05 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 140):</B> 0.12% chlorhexidine gluconate rinse in 11.6% alcohol.</P>
<P>
<B>Group 2 (n = 139):</B> Placebo rinse containing 11.6% alcohol.</P>
<P>
<B>Co-interventions:</B>
</P>
<P>Prior to surgery: Daily rinse for 7 days, 15 ml of test product for 30 seconds b.i.d.</P>
<P>Postoperative: Daily rinse for 7 days,15 ml of test product 30 seconds b.i.d.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:27:54 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>3-4 days postoperatively telephone contact. Day 7 - clinical evaluation.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence or absence of alveolar osteitis.</LI>
<LI>Pain not relieved by analgesics.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not evaluated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>Collected and reported for both intervention groups, but unclear to what extent these were intervention related or essentially postoperative complications (Additional <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>).</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 10:28:23 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>NB: number above = patients, extractions: chlorhexidine 239, placebo 240. Randomisation at individual participant level but analysis of data at extraction site level.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 17:00:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<CHAR_METHODS MODIFIED="2012-11-13 12:16:17 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> A randomised parallel-group controlled trial.</P>
<P>
<B>Sample size: </B>73.</P>
<P>
<B>Sample size calculation:</B> Not reported.</P>
<P>
<B>Conducted in:</B> Faculty of Odontology at the University of Seville and the Oral and Maxillofacial Surgery service of the Virgen de Rocio University Hospitals, Seville, Spain.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention. </P>
<P>
<B>Type of teeth:</B> Mandibular third molars, under local anaesthesia. Difficulty index 4-7 Koerner scale.</P>
<P>
<B>Recruitment period:</B> From June - November 2005.</P>
<P>
<B>Funding source:</B> Laboratorios Lacer Barcelona Espan&#771;a, donated the chlorhexidine samples used in this study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 17:00:12 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Mandibular third molars; difficulty index 4-7 Koerner scale (<LINK REF="REF-Koerner-1994" TYPE="REFERENCE">Koerner 1994</LINK>), surgical extraction and suture.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Antibiotic or analgesic 4 days prior.</LI>
<LI>AIDs or any type of immuno-suppression.</LI>
<LI>Pregnant/lactating women</LI>
<LI>.Allergy to: CHX, articaine, paracetamol or ibuprofen.</LI>
<LI>Patients requiring simultaneous extraction of 2 third molars.</LI>
<LI>Any jaw associated pathology.</LI>
<LI>Operation times &gt; 30 minutes.</LI>
<LI>Non co-operative patients (psychic-motor dysfunction).</LI>
</UL>
<P>
<B>Age:</B> 18-60 years, mean 29.</P>
<P>
<B>Gel Group 1:</B> randomised 41; analysed 39.</P>
<P>
<B>Mouthrinse Group 2:</B> randomised 32; analysed 31.</P>
<P>
<B>Number randomised: </B>73.</P>
<P>
<B>Number analysed: </B>70.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:32:58 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparisons:</B> Chlorhexidine bio-adhesive gel versus mouthrinse.</P>
<P>
<B>Group 1 (n = 41):</B> 0.2% chlorhexidine bio-adhesive gel, placed in wound after extraction then self applied to the wound b.i.d. (day 1-7) beginning same day as intervention.</P>
<P>
<B>Group 2 (n = 32):</B> 0.12% chlorhexidine mouthrinse b.i.d. (day 1-7) beginning same day as intervention.</P>
<P>
<B>Co-interventions: </B>Ibuprofen 600 mg tds, paracetamol 500 mg with codeine 14.05 mg tds.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:33:38 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Subjects evaluated on the 3rd and 7th day postoperatively.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Incidence of alveolar osteitis day 1 to day 3.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not reported.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<P>
<B>Quote:</B> " tolerance to the treatment defined as the frequency that patients developed one or more adverse effects .. assessed on a verbal score 1 (max tolerance) to 5 (max intolerance) during the 3rd and 7th postoperative day" page 443.</P>
<P>
<B>Comment: </B>"Tolerance" was not defined in the report nor the type of "adverse effects" which might constitute maximum intolerance, and the relevant data reported in Table 1 were not readily interpretable.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 10:33:46 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>November 2012: Communication from Dr Torres-Lagares confirmed that <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK> &amp; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK> were separate studies each involving a different group of participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:16:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Huang-2011">
<CHAR_METHODS MODIFIED="2012-11-13 12:16:26 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Parallel-group RCT.</P>
<P>
<B>Sample size: </B>80.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.<BR/>
<B>Type of teeth: </B>Impacted mandibular third molar, local anaesthesia with lidocaine.</P>
<P>
<B>Conducted in:</B> Department of Stomatology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Recruitment period: </B>05/2008-07/2010.<BR/>
<B>Providers of care:</B> Not reported.</P>
<P>
<B>Funding source:</B> Scientific plan of Cantoon Provience.</P>
<P> </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 10:39:24 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Participants required to have their impacted mandibular third molar extracted were included; 1) aged 18-45; 2) horizontal impacted third mandibular molar on X-ray; 3) agreed to participate and could be followed-up.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Have contra-indication and could not be followed-up.</LI>
</UL>
<P>
<B>Number Randomised: </B>80.</P>
<P>
<B>Number evaluated:</B> 80.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 10:39:38 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 40):</B> Acellular dermis matrix (2×2.5 cm) embedded into the extraction sockets.</P>
<P>
<B>Group 2 (n = 40):</B> Nothing embedded into the extraction sockets.</P>
<P>
<B>Co-interventions:</B> Extraction of the teeth via flap elevation, bone removing and tooth splitting.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 10:40:16 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>When measured:</B> 1 week after the extraction.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence of postoperative alveolitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None.</LI>
</UL>
<P>
<B>Adverse outcomes: </B>
</P>
<UL>
<LI> None reported.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-27 09:33:12 +0000" MODIFIED_BY="[Empty name]">
<P> Author contact failed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 17:00:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaya-2011">
<CHAR_METHODS MODIFIED="2012-11-13 12:16:31 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Randomised parallel-group controlled trial.</P>
<P>
<B>Study size:</B> 104.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Conducted in:</B> Department of Oral and Maxillofacial Surgery, Atatürk University Faculty of Dentistry, Turkey.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Treatment.</P>
<P>
<B>Type of teeth:</B> Mandibular permanent first molar.</P>
<P>
<B>Recruitment period:</B> 18-months, January 2008 to July 2009.</P>
<P>
<B>Funding source:</B> Not reported.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 17:00:59 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>18 years or older.</LI>
<LI>The ability to understand verbal and written instructions.</LI>
<LI>Previously diagnosed, but untreated AO in the mandibular permanent first molar extraction socket.</LI>
</UL>
<P>
<B>Exclusion criteria: </B>
</P>
<UL>
<LI>Previous radiotherapy.</LI>
<LI>Any medical condition that could affect AO treatment (e.g. bone pathologic features, vascular or hematologic disorders, diabetes mellitus).</LI>
<LI>The use of antibiotics.</LI>
<LI>Pregnancy or lactation.</LI>
<LI>An allergy to iodine, eugenol, or paracetamol.</LI>
<LI>Patients who smoked, used oral contraceptives, were menstruating, or would require a surgical flap to remove the tooth were excluded.</LI>
</UL>
<P>
<B>Number randomised: </B>104.</P>
<P>
<B>Number evaluated: </B>104.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:13:55 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 26): </B>Curettage and irrigation alone.</P>
<P>
<B>Group 2 (n = 26):</B> Curettage and irrigation followed by alvogyl applied directly to the socket.</P>
<P>
<B>Group 3 (n = 26):</B> Curettage and irrigation followed by SaliCept patch applied directly to the socket.</P>
<P>
<B>Group 4 (n = 26):</B> Curettage and irrigation followed by LLLT irradiation.</P>
<P>
<B>Co-interventions: </B>Patients were allowed 500 mg of acetaminophen as a rescue medication, as required, and were instructed to record how many times daily the medication was used. Additional follow-up visits were organized through the department, as necessary.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:14:19 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Pain (VAS) - assessed each morning for 1 week.</LI>
<LI>Alveolar osteitis &#8211; days 3 and 7.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not stated.</LI>
</UL>
<P>
<B>Adverse outcomes:</B>
</P>
<UL>
<LI>Not stated.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:16:36 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Kjellman-1973">
<CHAR_METHODS MODIFIED="2012-11-13 12:16:36 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> A randomised parallel-group controlled trial.</P>
<P>
<B>Sample size: </B>100.</P>
<P>
<B>Sample size calculation:</B> Not reported.</P>
<P>
<B>Conducted in:</B> Department of Oral Surgery at Södersjukhuset Stockholm, Sweden.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Impacted mandibular third molars, degree of difficulty unspecified, under local anaesthesia.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:15:06 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria: </B>
</P>
<UL>
<LI>Impacted mandibular third molars.</LI>
</UL>
<P>
<B>Exclusion criteria: </B>
</P>
<UL>
<LI>Cases that have required relatively major operations on bone tissue.</LI>
</UL>
<P>
<B>Number randomised:</B> 100.</P>
<P>
<B>Number evaluated:</B> 100.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:15:25 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 50):</B> Apernyl cone, consisting of acetylsalicylic acid and p-oxybenzoic acid (preservative) inserted immediately after extraction.</P>
<P>
<B>Group 2 (n = 50):</B> Placebo without acetylsalicylic acid inserted immediately after extraction.</P>
<P>
<B>Co-interventions: </B>Concomitant pain medication unreported.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:15:48 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Assessments performed on days 1, 2 and 4 postoperatively.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>The occurrence of postoperative periosteitis "dry socket".</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not evaluated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>Pain and burning sensation.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-15 08:52:27 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Inadequately reported, sparse trial details and incomplete and largely unusable data.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:16:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Larsen-1991">
<CHAR_METHODS MODIFIED="2012-11-13 12:16:41 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> A randomised parallel-group controlled trial.</P>
<P>
<B>Sample size: </B>150.</P>
<P>
<B>Sample size calculation:</B> None reported.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Impacted mandibular third molars.</P>
<P>
<B>Conducted in:</B> Not stated.</P>
<P>
<B>Number of centres:</B> Not stated.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Procter and Gamble Co, Cin- cinnati, OH.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:17:25 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Bilaterally impacted mandibular third molars.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Acute infection.</LI>
<LI>Participants on antibiotics.</LI>
<LI>Those requiring prophylaxis.</LI>
</UL>
<P>
<B>Number randomised:</B> 150.</P>
<P>
<B>Number analysed:</B> 139.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:19:58 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 72):</B> 0.12% chlorhexidine gluconate 15 mL for 30 seconds a day for 1 week prior to surgery and 1 week after.</P>
<P>
<B>Group 2 (n = 67):</B> Placebo rinse (identical appearance).</P>
<P>
<B>Concomitant medication:</B>
<BR/>
</P>
<P>Preoperative 8 mg dexamethasone IV.</P>
<P>Postoperative 325 mg acetaminophen plus 30 mg codeine prn.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:17:59 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Assessment 1 week postoperative or earlier if pain.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence of dry socket.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Adverse effects: </B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:18:05 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Sponsored by Procter and Gamble Co, Cincinatti, OH.</P>
<P>Randomisation was by patient but analysis by sites which will narrow the confidence intervals slightly.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:17:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Metin-2006">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:01 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Randomised, parallel-group, controlled, double-blind, single-centre trial.</P>
<P>
<B>Sample size</B>: 99.</P>
<P>
<B>Sample size calculation</B>: Not reported.</P>
<P>
<B>Conducted in:</B> Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ondokuz, Mayis, University of Samsun, Turkey.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Impacted mandibular third molars, under local anaesthesia.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not reported.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:19:23 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Patients requiring surgical removal of impacted mandibular third molars.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Acute infection.</LI>
<LI>Pericoronitis.</LI>
<LI>Patients using antibiotics or requiring antibiotic before treatment.</LI>
</UL>
<P>
<B>Number randomised: </B>99.</P>
<P>
<B>Number analysed:</B> 99.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:20:18 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: </B>Pre &amp; post op chlorhexidine rinse versus post op only.</P>
<P>
<B>Group 1 (n = 46):</B> Rinsed with chlorhexidine 0.2% 15 ml for 30 seconds twice per day for both 1 week prior to and 1 week after surgery.</P>
<P>
<B>Group 2 (n = 53):</B> Rinsed with chlorhexidine 0.2% 15 ml for 30 seconds twice per day for 1 week after surgery.</P>
<P>
<B>Co-interventions:</B>
</P>
<P>After removal of the teeth, the surgical sites were rinsed with 10 ml of sterile saline solution, and the soft tissue was closed and sutured with 3-0 silk suture.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:21:56 +0000" MODIFIED_BY="[Empty name]">
<P>On the 7th day (or on preceding days if pain was present), the extraction sites were evaluated.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Incidence of alveolar osteitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not evaluated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<P>Altered taste and numbness page 3. Numbness in the tongue reported in Group 1 and Group 2 45.6% and 13.2%. However, disturbance of taste sensation was seen in 56.5% of the patients in Group 1 and in 11.3% of the patients in Group 2.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-13 02:05:26 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:17:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1984">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:15 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> Randomised, parallel-group, placebo-controlled, double-blind trial.</P>
<P>
<B>Sample: </B>64.</P>
<P>
<B>Conducted in:</B> Oral Surgery Department Newcastle Dental Hospital, UK.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Treatment.</P>
<P>
<B>Type of teeth:</B> No tooth specified.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not reported.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:24:46 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>A diagnosed dry socket.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Number randomised: </B>64, 1 lost to follow-up but group allocation not stated.</P>
<P>
<B>Group (Metronidazole): </B>Randomised not reported; 6 lost to follow-up; analysed 26 (18%).</P>
<P>
<B>Group (Orabase placebo):</B> Randomised 32; 3 lost to follow-up; analysed 29 (10%).</P>
<P>
<B>Number analysed:</B> 55.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:25:23 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison: </B>Metronidazole (10%) versus Orabase alone.</P>
<P>
<B>Group 1 (n = 26):</B> Metronidazole (10%) in carboxymethylcellulose gelatin (Orabase) paste.</P>
<P>
<B>Group 2 (n = 29):</B> Orabase paste alone.</P>
<P>Dressing syringed into the sockets.</P>
<P>
<B>Co-interventions: </B>Warm saline irrigation at presentation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:25:47 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Review at 2 days post-intervention initially and then re-application dressing where necessary and review until cure.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Absence of pain.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Treatment time in days.</LI>
<LI>Number of visits to effect resolution.</LI>
<LI>Extraction time to start of treatment.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>Not reported.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-15 12:08:37 +0100" MODIFIED_BY="Zbys Fedorowicz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:17:21 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Ragno-1991">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:21 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> A randomised, controlled, double-blind, parallel-group study.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Conducted in:</B> Department of Oral and Maxillofacial Surgery, Walter Reed Army Medical Centre, Washington D.C..</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Mandibular third molars, under intravenous sedation and local anaesthesia.</P>
<P>
<B>Operator:</B> Resident surgeon for 8 years.</P>
<P>
<B>Recruitment period:</B> July 1987 to April 1989.</P>
<P>
<B>Funding source:</B> Not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:28:13 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>&gt;18 years of age.</LI>
<LI>Negative medical history.</LI>
<LI>Not taking any medication apart from birth control pill.</LI>
<LI>2 mandibular third molars for extraction.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Not stated.</LI>
</UL>
<P>
<B>Mean age: </B>Not reported.</P>
<P>
<B>Intervention Group: </B>Number randomised 40; analysed 40.</P>
<P>
<B>Control Group: </B>Number randomised 40; analysed 40.</P>
<P>
<B>Number randomised: </B>40 patients, but sites not (80).</P>
<P>
<B>Number analysed: </B>40 patients, but sites not (80).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:28:49 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparisons:</B>
</P>
<P>On the day of surgery patients first rinsed with 15 ml of designated solution, teeth were then extracted, surgical sites irrigated with 15 ml of designated solution and soft tissue closed and sutured. The day after surgery patients began home use of solutions.</P>
<P>
<B>Group 1 (n = 40; 80 surgical sites):</B> 0.12% CHX rinse, 15 ml twice daily for 7 days postoperatively.</P>
<P>
<B>Group 2 (n = 40; 80 surgical sites): </B>Placebo rinse, 15 ml twice daily for 7 days postoperatively.</P>
<P>
<B>Co-interventions: </B>None stated.</P>
<P>
<B>Concomitant interventions: </B>None stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:30:34 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Postoperative examination on days 3 and 7.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Alveolar osteitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Postoperative questionnaire day 7, though not reported but presume it relates to adverse events associated with mouthrinse.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<P>There were no allergic reactions to the chlorhexidine rinse. 3 participants reported bad taste, 1 reported stomach upset page 526 but no staining noted.</P>
<P>1 person in the control had a severe surgical reaction which in the author's opinion was not attributable to the medication</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:30:39 +0000" MODIFIED_BY="[Empty name]">
<P>On the day of the procedure patients first rinsed with 15 ml of their assigned solution for 30 seconds, after the procedure the sites were rinsed with 15 ml of the same solution.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:17:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reekie-2006">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:29 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Randomised, parallel-group, double-blind, placebo-controlled study.</P>
<P>
<B>Sample size: </B>302.</P>
<P>
<B>Sample size calculation: </B>Undertaken.</P>
<P>
<B>Conducted in:</B> 3 dental practices in the UK.</P>
<P>
<B>Number of centres:</B> 3.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Routine non-surgical extraction of 1 or more molar or premolar tooth under local anaesthetic.</P>
<P>
<B>Recruitment period:</B> 2000-2003.</P>
<P>
<B>Funding source:</B> This study was supported by a grant from the Oral and Dental Research Trust.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:32:37 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Non-surgical extraction of 1 or more molar/premolar tooth under local anaesthetic.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Grade 3 mobile teeth.</LI>
<LI>Participants on warfarin, nicoumalone, phenytoin, fluocil, lithium and cimetidine.</LI>
<LI>Pregnant/breast feeding women.</LI>
<LI>Participants with intellectual impairment.</LI>
</UL>
<P>
<B>Number randomised:</B> 302.</P>
<P>
<B>Number analysed:</B> 27.</P>
<P>Only patients calling back with pain were examined and assessed. It was assumed all others did not have dry socket.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:33:24 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: </B>Metronidazole 25% gel versus placebo gel.</P>
<P>
<B>Group 1 (n = 152):</B> 0.25 ml of 25% metronidazole gel (62.5 mg).</P>
<P>
<B>Group 2 (n = 150):</B> Placebo gel (KY jelly).</P>
<P>Gel syringed into socket immediately after dental extraction.</P>
<P>
<B>Mean age: </B>49.5, SD 14.77 (range 19 to 93).</P>
<P>
<B>Co-interventions: </B>Not stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:34:08 +0000" MODIFIED_BY="[Empty name]">
<P>Assessment made only on participants with severe pain and who phoned the surgery. Only patients with the classical signs of dry socket were reported.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Presence of dry socket.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None assessed or reported.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>Not selected as an outcome but were reported (<I>see</I> Notes).</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:34:24 +0000" MODIFIED_BY="[Empty name]">
<P>Adverse events:</P>
<P>Reported: 1 participant with nausea and vomiting, 2 complained of a bitter taste. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:17:42 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Ritzau-1977">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:42 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design: </B>Randomised, parallel-group, double-blind, placebo-controlled study.</P>
<P>
<B>Sample size: </B>45.</P>
<P>
<B>Sample size calculation:</B> Not reported.</P>
<P>
<B>Conducted in: </B>Royal Dental College in Aarhus, Denmark.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth: </B>Impacted mandibular third molars.</P>
<P>
<B>Recruitment period:</B> February to May 1974.</P>
<P>
<B>Funding source: </B>Not stated.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:36:32 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Partially and totally impacted mandibular third molars.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Mean age: </B>27 range (17 to 61 years).</P>
<P>
<B>Number randomised:</B> 45.</P>
<P>
<B>Number analysed:</B> 45.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:37:34 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison: </B>Propylic ester of p-hydroxybenzoic acid versus placebo.<BR/>
<B>Group 1 (n = 24): </B>Propylic ester of p-hydroxybenzoic acid inserted in each socket.</P>
<P>
<B>Group 2 (n = 21):</B> Placebo tablet gel inserted in each socket.</P>
<P>
<B>Co-interventions:</B> Postoperative analgesic tablets containing 10 mg of codeine phosphate, 500 mg of acetyle acid, and 70 mg of magnesium oxide were prescribed, and the number of tablets consumed was recorded.</P>
<P>Experimental substance or placebo inserted into postoperative socket immediately after removal of impacted third molar.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:46:10 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Assessment day 7 postoperatively. Patients also assessed if they returned in pain at any point - the day of return was noted.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Occurence of alveolitis sicca dolorosa.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Pain.</LI>
</UL>
<P>
<B>Adverse outcomes:</B>
</P>
<UL>
<LI>Haematoma and rash.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-10-19 20:23:53 +0100" MODIFIED_BY="Zbys Fedorowicz"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 15:25:56 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Shi-2003">
<CHAR_METHODS MODIFIED="2012-11-13 12:17:59 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> A randomised, parallel-group, controlled trial.</P>
<P>
<B>Sample size: </B>274.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Impacted wisdom teeth.</P>
<P>
<B>Conducted in:</B> Not stated (appears to be 4th Medical University, Xi, Shaanxi China).</P>
<P>
<B>Number of centres:</B> Not stated.</P>
<P>
<B>Recruitment period:</B> November to April 2001.</P>
<P>
<B>Funding source:</B> Not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:47:53 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Impacted wisdom tooth.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>History of acute pericoronitis in 10 days.</LI>
<LI>&lt;18 and &gt;65 years of age.</LI>
<LI>Smoking more than 3 cigarettes.</LI>
<LI>Oral contraceptives.</LI>
<LI>Contraindication of tooth extraction.</LI>
</UL>
<P>
<B>Number randomised:</B> 274.</P>
<P>
<B>Number analysed:</B> Not fully reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 15:25:56 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 92):</B> Shahaosan.</P>
<P>
<B>Group 2 (n = 86): </B>Yunnan white drug.</P>
<P>
<B>Group 3 (n = 96): </B>Blank control.</P>
<P>
<B>Co-interventions: </B>None stated.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:48:36 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Assessments 5-7 days post-extraction. Quote: "incidence and intensity of dry socket in each group were observed and evaluated by scores."</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Incidence of dry socket.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Self assessed POSSE (Postoperative Symptom Severity Scale) global assessment to include pain and "influence of daily life". Time and frequency of assessment unreported.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>No report of any assessment.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:48:41 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>3 different colour capsules, unclear if both A and B are active interventions. Unclear if this was systemic or topical and method and timing of administration not reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:18:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<CHAR_METHODS MODIFIED="2012-11-13 12:18:07 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Randomised controlled "...prospective, parallel, single-blind clinical trial".</P>
<P>
<B>Sample size: </B>30.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Conducted in:</B> Faculty of Odontology of the University of Seville, Spain.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> 1 or 2 impacted mandibular third molars, under local anaesthesia.</P>
<P>
<B>Recruitment period:</B> September to December 2001.</P>
<P>
<B>Funding source:</B> Not stated.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:50:33 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>1 or 2 mandibular impacted third molars; difficulty index 4-7 Koerner scale (<LINK REF="REF-Koerner-1994" TYPE="REFERENCE">Koerner 1994</LINK>).</LI>
<LI>No symptoms 10 days pre-surgery.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Contra-indications for the intervention.</LI>
<LI>AIDS.</LI>
<LI>Smokers.</LI>
<LI>Immunodepressed patients.</LI>
<LI>Pregnant/lactating women.</LI>
<LI>Women taking oral contraceptives.</LI>
<LI>Allergies to: CHX, lidocaine or paracetamol.</LI>
<LI>Extraction of both wisdom teeth at one visit.</LI>
<LI>Bone pathology.</LI>
<LI>Having ingested any medication 4 days preoperatively.</LI>
</UL>
<P>
<B>Number randomised: </B>30.</P>
<P>
<B>Number analysed:</B> 30.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:51:10 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 17):</B> 10 ml of 0.2% CHX bio-adhesive gel applied intra-alveolar post-extraction.</P>
<P>
<B>Group 2 (n = 13): </B>No intrasocket medication.</P>
<P>
<B>Co-interventions:</B>
</P>
<P>''All the patients took, as postoperative treatment, 14.05 mg codeine phosphate and 500 mg of paracetamol on demand...''</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:51:21 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear if assessed on days 3 and 7 postoperatively.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Development of alveolar osteitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:51:38 +0000" MODIFIED_BY="[Empty name]">
<P>November 2012: Communication from Dr Torres-Lagares confirmed that <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK> &amp; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK> were separate studies each involving a different group of participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 11:54:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<CHAR_METHODS MODIFIED="2012-11-13 11:53:11 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> A randomised, controlled, parallel-group, double-blind study.</P>
<P>
<B>Sample size:</B> 103.</P>
<P>
<B>Sample size calculation: </B>Not reported.</P>
<P>
<B>Conducted in:</B> Faculty of Dentistry of the University of Seville, Spain.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth: </B>Impacted mandibular third molars - under local anaesthesia.</P>
<P>
<B>Recruitment period:</B> January-June 2003.</P>
<P>
<B>Funding source: </B>Laboratorios Lacer, Barcelona, Spain, donated the medication used in this study.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:54:06 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>1 or 2 mandibular impacted third molars; difficulty index 4-7 Koerner scale (<LINK REF="REF-Koerner-1994" TYPE="REFERENCE">Koerner 1994</LINK>).</LI>
<LI>No symptoms 10 days pre-surgery.</LI>
<LI>Aged 18-60 years of age.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>Contra-indications for the intervention.</LI>
<LI>AIDS.</LI>
<LI>Smokers.</LI>
<LI>Immunodepressed patients.</LI>
<LI>Pregnant/lactating women.</LI>
<LI>Women taking oral contraceptives.</LI>
<LI>Allergies to: CHX, lidocaine or paracetamol.</LI>
<LI>Extraction of 2 molars at once.</LI>
<LI>Bone pathology.</LI>
<LI>Having ingested any medication 4 days preoperatively.</LI>
</UL>
<P>
<B>Number randomised: </B>103.</P>
<P>
<B>Number analysed:</B> 94.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:54:43 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparisons: </B>0.2% CHX bio-adhesive gel versus no application.</P>
<P>
<B>Group 1 (n = 49):</B> 10 ml of 0.2% CHX bio-adhesive gel applied intra-alveolar post-extraction.</P>
<P>
<B>Group 2 (n = 45):</B> Placebo gel - excipient containing.</P>
<P>
<B>Co-interventions:</B>
</P>
<P>All the patients took, as postoperative treatment, 14.05 mg codeine phosphate and 500 mg of paracetamol on demand.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-13 10:44:57 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Developement of alveolar osteitis.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-13 11:54:53 +0000" MODIFIED_BY="[Empty name]">
<P>No clear statement of when follow-up was done.</P>
<P>November 2012: Communication from Dr Torres-Lagares confirmed that <LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>; <LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK> &amp; <LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK> were separate studies each involving a different group of participants.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 11:57:19 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Trieger-1991">
<CHAR_METHODS MODIFIED="2012-11-13 11:56:39 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Study design:</B> Split-mouth randomised controlled trial.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Mandibular bony third molar impactions.</P>
<P>
<B>Conducted in:</B> Setting unreported.</P>
<P>
<B>Number of centres:</B> Not stated.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> "This study was made possible with a grant from Upjohn, Kalamazoo, Mich."</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:56:48 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Bilateral mandibular third molar bony impactions.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>No antibiotics 2 weeks prior.</LI>
</UL>
<P>
<B>Number randomised:</B> 172 sites in 86 patients.</P>
<P>
<B>Number analysed:</B> Unclear.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 11:57:06 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>
<B>Comparison:</B>
</P>
<P>
<B>Group 1 (n = 86):</B> Gelfoam square saturated with 1 ml clindamycin phosphate solution (150 mg/ml).<BR/>
<B>Group 2 (n = 86):</B> Gelfoam square saturated with saline placebo.</P>
<P>
<B>Co-interventions: </B>Comcomitant analgesic medication allowed but no details reported.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 11:57:19 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not clear when assessments were made and by whom.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Dry socket.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>Not reported.</LI>
</UL>
<P>
<B>Adverse events:</B>
</P>
<UL>
<LI>Unreported and unclear if assessed.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-13 10:56:46 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>We assume there were no drop-outs but study poorly reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-13 12:01:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Eeden-2006">
<CHAR_METHODS MODIFIED="2012-11-13 11:58:23 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Study design:</B> Randomised controlled, split-mouth trial.</P>
<P>
<B>Sample size: </B>19.</P>
<P>
<B>Sample size calculation:</B> Not reported.</P>
<P>
<B>Conducted in:</B> Military Hospital in South Africa.</P>
<P>
<B>Number of centres:</B> 1.</P>
<P>
<B>Prevention or treatment of dry socket:</B> Prevention.</P>
<P>
<B>Type of teeth:</B> Bilateral impacted mandibular third molars of similar difficulty assessed clinically and radiologically. Carried out under general anaesthesia.</P>
<P>
<B>Recruitment period:</B> Not stated.</P>
<P>
<B>Funding source:</B> Not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-13 11:58:52 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Bilateral impactions of similar levels as determined by clinical and radiographic examination.</LI>
<LI>No pericoronal infection.</LI>
<LI>No antibiotics.</LI>
<LI>No anti-inflammatory medication prior to surgery.</LI>
<LI>No associated co-morbidity.</LI>
</UL>
<P>
<B>Exclusion criteria:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Mean age:</B> 21.4 years (16-32 range).</P>
<P>
<B>Number randomised:</B> 19.</P>
<P>
<B>Number analysed:</B> 19.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-13 12:00:18 +0000" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: </B>Covomycin D versus inert gel foam carrier.</P>
<P>
<B>Group 1 (n = 19):</B> 1 mm Covomycin D (2.0 mg chloramphenicol, 5.0 mg neomycin sulphate and 0.5 mg dexamethasone) delivered within an inert gel foam carrier.</P>
<P>
<B>Group 2 (n = 19):</B> Inert gel foam carrier - 1 ml normal saline.</P>
<P>
<B>Co-interventions:</B>
</P>
<P>Analgesic/anti-inflammatory medication 6 hourly when necessary (Myprodol®).</P>
<P>Oral antibiotic medication (amoxicillin 500 mg 8 hourly or in penicillin allergic patients erythromycin 500 mg 6 hourly) for 5 days.</P>
<P>A 0.2% chlorhexidine gluconate mouthrinse 6 hourly for 5 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-13 12:01:13 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Pain scores were recorded at 6-hour intervals from the day of surgery until day 6. The patients were examined clinically on day 6.</P>
<P>
<B>Primary outcome measures:</B>
</P>
<UL>
<LI>Development of alveolar osteitis, diagnostic criteria.</LI>
</UL>
<P>
<B>Secondary outcome measures:</B>
</P>
<UL>
<LI>None stated.</LI>
</UL>
<P>
<B>Adverse effects:</B>
</P>
<P>Some of the events may be attributable to intervention or could be normal sequelae of operation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-13 10:58:15 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AO = alveolar osteitis; CHX = chlorhexidine; RCT = randomised controlled trial.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-11-12 21:26:35 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-10-10 14:15:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Akota-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-10 14:15:38 +0100" MODIFIED_BY="[Empty name]">
<P>The intervention used was an impregnated gauze drain which was specifically excluded from this review. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:16:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Sukhun-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:16:47 +0000" MODIFIED_BY="[Empty name]">
<P>3 analgesics taken systemically to assess their ability to control pain after extraction. They were not local measures.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:16:52 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Altman-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:16:52 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:16:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Annibali-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:16:58 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT. Consensus statement on management of third molars.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:14 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Anonymous-1966">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:14 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not an RCT. Translated from the Japanese by Prof Ken Yaegaki,<I> </I>Nippon Dental University Department of Oral Health, Tokyo, Japan.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arakeri-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:18 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket not defined.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arenaz_x002d_Bua-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:21 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket not defined, general comments on sequelae.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:25 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Banach-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:25 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not an RCT (translated from Polish).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-10 15:07:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baqain-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-10 15:07:49 +0100" MODIFIED_BY="[Empty name]">
<P>The intervention was surgical (flap design) which was specifically excluded from the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-10 14:16:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bello-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-10 14:16:20 +0100" MODIFIED_BY="[Empty name]">
<P>The intervention was wound closure techniques excluded from this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:38 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Berwick-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:38 +0000" MODIFIED_BY="[Empty name]">
<P>Drop-outs substituted making trial results invalid.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:43 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Betts-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:43 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Evaluated the efficacy of lidocaine jelly for the alleviation of pain experienced during the instrumentation of extraction sites diagnosed with alveolar osteitis. Assessment of pain related to instrumentation only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bezerra-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:46 +0000" MODIFIED_BY="[Empty name]">
<P>Systemic amoxicillin antibiotic not local intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:17:49 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Birke-1970">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:17:49 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not an RCT (translated from German).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:01 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Bloomer-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:01 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "In a consecutive manner, 1 of the 2 lower third molar sockets was packed on each patient. Sockets were packed in a series of 25 on 1 side then changed to a series of 25 on the opposite side throughout the series, totaling 100 patients."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bloomer-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:10 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT. Expert opinion/commentary.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brignardello-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:33 +0000" MODIFIED_BY="[Empty name]">
<P>Study about techniques, not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:38 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Butler-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:38 +0000" MODIFIED_BY="[Empty name]">
<P>The interventions were lavage techniques which are excluded from this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:43 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Butylin-1977">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:43 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Cohort study. Translated from the Russian by Vasiliy Vlassov.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-13 23:08:29 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Bystedt-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-16 10:47:07 +0100" MODIFIED_BY="Zbys Fedorowicz" NOTES="&lt;p&gt;Bystedt is prevention of poet extraction complications? did we agree in protocol to exclude systemic interventions&lt;/p&gt;" NOTES_MODIFIED="2010-07-16 10:47:07 +0100" NOTES_MODIFIED_BY="Zbys Fedorowicz">
<P>Interventions were systemic antibiotics.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Christensen-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:48 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT. Expert opinion/commentary.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:18:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cooper-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:18:53 +0000" MODIFIED_BY="[Empty name]">
<P>Pain study not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 11:59:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Daniels-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 11:59:21 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket not defined. Pain management study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:19:07 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Field-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:19:07 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "The trial was 'open' and on arrival extraction cases were consecutively allocated to one of three groups."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:19:23 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Fotos-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:19:23 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "70 randomly selected healthy patients" page 383, "each subject was treated at one extraction site with a saline solution whereas the other site received CHX" page 384.<BR/>Comment: No evidence of randomisation of participants to intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:19:36 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Garibaldi-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:19:36 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "Patients were assigned in sequential (A, B, C, A, B, C, etc) order."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:19:45 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Goldman-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:19:45 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>CCT non-randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:02 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldsmith-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:02 +0000" MODIFIED_BY="[Empty name]">
<P>Intervention involved surgical techniques which are excluded from the review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goyal-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:05 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket, instrument evaluation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:09 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Hall-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:09 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not an RCT. Expert opinion/commentary.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haraji-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:18 +0000" MODIFIED_BY="[Empty name]">
<P>Interventions were envelope versus modified triangular flap designs, which are excluded from this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hill-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:27 +0000" MODIFIED_BY="[Empty name]">
<P>Pain study, not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-13 10:58:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hooley-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-13 10:58:39 +0000" MODIFIED_BY="[Empty name]">
<P>No clinical diagnosis of dry socket made, only used pain.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:36 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Johnson-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:36 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>CCT non-randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:20:43 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Jolley-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:20:43 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "The purpose of this was to determine the effectiveness of the gel in controlling pain from ill-fitting dentures after extractions and in other situations" page 72.<BR/>Comment: Not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jovanovic-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:07 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT (after contact with author).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:10 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Julius-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:10 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Not an RCT. Split-mouth where all left hand sides received intervention and all right hand sides received the control.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-11 13:13:33 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Keskitalo-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-11 13:13:33 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "Alternate patients were treated with Apernyl cones."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kirk-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:18 +0000" MODIFIED_BY="[Empty name]">
<P>Definition of dry socket not provided.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-12 10:45:19 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Krekmanov-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-12 10:45:19 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Only systemic interventions.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:22 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Krekmanov-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:22 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Unsure if randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:36 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kudiyirickal-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:36 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT, not dry socket, looks at oral facial infections.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lao-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:39 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:39 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Long-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:43 +0000" MODIFIED_BY="[Empty name]">
<P>The intervention was a surgical technique which is excluded from this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lopez_x002d_Cedrun-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:47 +0000" MODIFIED_BY="[Empty name]">
<P>Systemic antibiotics, not a local intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-21 17:45:28 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-MacGregor-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-21 17:45:28 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Outcomes specified were pain and swelling, no clinical diagnosis of dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:21:59 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-MacGregor-1975">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:21:59 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "Successive patients were entered in to the trials...arrangements were made that there was an equal distribution of experiments and controls."<BR/>Comment: No evidence of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:22:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Majid-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:22:14 +0000" MODIFIED_BY="[Empty name]">
<P>No definition of dry socket in report. Study refers to generalised sequelae.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:22:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malkawi-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:22:22 +0000" MODIFIED_BY="[Empty name]">
<P>Cross sectional study, not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:22:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehlisch-2010a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:22:30 +0000" MODIFIED_BY="[Empty name]">
<P>No definition of dry socket. Study refers to pain management.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehlisch-2010b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:04 +0000" MODIFIED_BY="[Empty name]">
<P>No definition of dry socket. Study refers to pain management.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mishra-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:05 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket, dental pain.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:11 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Mitchell-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:11 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "They were allocated into groups according to a predetermined protocol."<BR/>Comment: Inadequate method of sequence generation, quasi-randomised CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1986a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:14 +0000" MODIFIED_BY="[Empty name]">
<P>Systemic intervention, not a local intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 14:43:00 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Nentwig-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 14:43:00 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Study unobtainable.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:26 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Neugebauer-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:26 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Participants "randomised into two groups". Randomisation at participant level but allocation of intervention 'split-mouth' at extraction socket level.<BR/>Comment: Open allocation. CCT.<BR/>Translated from the German language by Mona Nasser.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Neuner-1969">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:40 +0000" MODIFIED_BY="[Empty name]">
<P>Study to treat pain and there is no mention that it is an RCT (German translation).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-21 17:25:35 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Nordenram-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-21 17:25:35 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Outcomes reported were "post-operative complications": pain/swelling/infection but with no independent assessments of classical 'dry socket'.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:56 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Olson-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:56 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Abstract only, insufficient information for inclusion.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:23:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olusanya-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:23:59 +0000" MODIFIED_BY="[Empty name]">
<P>Systemic antibiotics, not a local intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:11 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Pichler-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:11 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Abstract only, insufficient information for inclusion.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Qi-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:16 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket, pain management study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-23 11:43:44 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ritzau-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-23 11:43:44 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear if RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:21 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Sanchis-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:21 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "We divided the cases into a group of 100 patients who underwent extraction...."<BR/>Comment: Non-randomised controlled (no treatment) study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-09-15 09:55:47 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Schatz-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-09-15 09:55:47 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Age range of a group of participants outside the inclusion criteria and no subgroup data reported. Open allocation sequence.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 14:43:29 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Schlund-1968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 14:43:29 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Study unobtainable.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:28 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Sorensen-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:28 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "Patients were randomly selected and divided so that approximately half would receive.........."<BR/>Comment: Non-RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:34 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Swanson-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:34 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "One hundred impacted lower third molars were to be operated. They were to be included in the study in the random order in which they came to the surgery by routine booking methods."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:40 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Sweet-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:40 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "The rinses were chosen by a random-selection technique."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-07-13 11:32:33 +0100" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Syrjanen-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-07-13 11:32:33 +0100" MODIFIED_BY="Zbys Fedorowicz">
<P>Controlled study, non-RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-11-17 12:15:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Syrjanen-1981a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-11-17 12:15:41 +0000" MODIFIED_BY="[Empty name]">
<P>Does not measure dry socket as an outcome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:48 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Tjernberg-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:48 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "Patients referred to the department for the surgical removal of a partially erupted, lower third molar were randomly distributed into two pools."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tong-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:51 +0000" MODIFIED_BY="[Empty name]">
<P>Not dry socket.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torres_x002d_Lagares-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:54 +0000" MODIFIED_BY="[Empty name]">
<P>Patients in the study have bleeding disorders.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:24:58 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Vedtofte-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:24:58 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "The cones were packed in randomly numbered packets and the code was unknown to the investigators."<BR/>Comment: Inadequate method of randomisation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:25:50 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Wen-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:25:50 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Quote: "The method of random-digit dialling was adopted to divide groups."<BR/>Translated from the Chinese by Dr Nian Fang. "Patients were divided into 2 groups Group A and Group B, with complete randomization according to the visit order....."<BR/>Comment: Suggestive of quasi-randomisation.<BR/>Inconsistencies between the English abstract and the translated version of the Chinese paper and lack of clarity in the methodology as reported did not provide any degree of confidence that adequate measures had been taken to satisfactorily randomised the participants or to conceal the allocation sequence in this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:25:55 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yue-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:25:55 +0000" MODIFIED_BY="[Empty name]">
<P>No dry socket, pain management study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-11-12 21:26:11 +0000" MODIFIED_BY="Zbys Fedorowicz" STUDY_ID="STD-Zanetta_x002d_Barbosa-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-11-12 21:26:11 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>Following email communication with the principal investigator, "the first patient was decided by a coin toss and the following was always allocated by alternation in the other group."<BR/>Comment: CCT quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 11:58:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zuniga-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 11:58:46 +0000" MODIFIED_BY="[Empty name]">
<P>Dry socket not defined. Pain management study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CCT= Controlled clinical trial; RCT = randomised controlled trial.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-11-07 09:59:29 +0000" MODIFIED_BY="Zbys Fedorowicz" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Babar-2012">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-03-14 14:47:15 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-11-13 17:01:55 +0000" MODIFIED_BY="Zbys Fedorowicz">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-11-13 12:01:25 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:03:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>
<B>Quote:</B> "A computer-generated randomization schedule was created by a statistician" page 127.</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:10:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>
<B>Quote:</B> "The participants were randomized into intervention group (n = 200) and control group (n = 200)."</P>
<P>
<B>Comment:</B> The detailed methods of randomisation were not clearly reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:13:38 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>
<B>Quote:</B> "control or experimental group by use of a randomization table" page 145.<BR/>
</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:19:17 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>
<B>Quote:</B> "...were randomly allocated into 3 groups."</P>
<P>
<B>Comment:</B> No information relating to randomisation process. Insufficient information to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:23:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>
<B>Quote: </B>"An equal distribution of AMCA/Tplacebo between right and left side was ensured by randomization corresponding to 120 consecutive numbers."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:28:48 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>
<B>Quote:</B> "Each subject was then randomized to a treatment group within these strata."<BR/>
<B>Comment: </B>Method of sequence generation not reported. Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:33:56 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>
<B>Quote: </B>"Randomly classified into two groups by means of a simple allocation system using a computer program."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:11:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>
<B>Quote: </B>"The participants were randomized into two groups with 40 in each group."</P>
<P>
<B>Comment:</B> The detailed methods of randomisation were not clearly reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:14:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>
<B>Quote:</B> "The patients were randomly assigned&#8230;"</P>
<P>
<B>Comment: </B>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:16:01 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>
<B>Quote:</B> "...with the help of a randomising procedure..."</P>
<P>
<B>Comment: </B>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:18:28 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>
<B>Quote:</B> "using a computer software routine supplied by the sponsor ..." " Within strata subjects were randomly assigned into two groups."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:22:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "Patients were randomly assigned into two groups."</P>
<P>
<B>Comment: </B>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:25:55 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>
<B>Quote:</B> "The patients were randomly allocated to the test or placebo group and the operator was unaware of the code breaker."</P>
<P>
<B>Comment: </B>Insufficient information on which to base a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:30:48 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>
<B>Quote: </B>''The patients within each group were randomly assigned.'.<BR/>
</P>
<P>
<B>Comment:</B> Insufficient information to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:34:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>
<B>Quote: </B>"Blinding and randomisation was achieved by the manufacturer ....The syringes were allocated a code number derived from a random number sequence."</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:46:18 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>
<B>Quote:</B> "PEPH or placebo were inserted at random selection...."</P>
<P>
<B>Comment:</B> Insufficient information to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:48:52 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>
<B>Quote: </B>"patients with extraction of impacted tooth were randomly divided into 3 groups."</P>
<P>
<B>Comment:</B> Insufficient information to establish the method of sequence generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:51:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "The aforementioned allocation into one group or another was carried out by computer before the start of the study."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:55:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>
<B>Quote: </B>''The random assignment was carried out by means of a random number list."</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:57:28 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>
<B>Quote</B>: "...according to a randomized distribution."</P>
<P>
<B>Comment: </B>Insufficient information to make a clear judgement if the sequence generation was adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 12:01:25 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "...preselected on a random basis by the flip of a coin."</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-11-13 17:01:55 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:03:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>
<B>Quote:</B> "The randomization codes were enclosed in sealed, opaque and sequentially numbered envelopes. The patients allocation to either group was revealed by the investigator just before venous cannulation on the day of the patient&#8217;s appointment for the extraction."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:10:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>Insufficient reporting to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:13:47 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-15 23:05:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:24:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>
<B>Quote: </B>"The code was unknown to the author during the study and first broken when all the patients had been treated."<BR/>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:28:58 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>
<B>Quote: </B>"Each bottle was labelled with a unique subject number, which allowed for blinding of treatment assignment."</P>
<P>
<B>Comment:</B> Still unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:34:07 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>
<B>Quote:</B> "Having carried out the procedure the envelope corresponding to the patient code was opened."</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:11:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>It is not clear from the report how allocation concealment was achieved.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-11 13:32:05 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:16:05 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-07 12:19:09 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>Insufficient information to make a judgement of Yes or No.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:22:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:26:05 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>
<B>Quote: </B>"The patients were randomly allocated to the test or placebo group and the operator was unaware of the code breaker."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:30:49 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>
<B>Quote:</B> "The pharmacist manufactured the placebo and maintained the code for patient assignments"...."Decoding of the patient assignments revealed..."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:34:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "Blinding and randomisation was achieved by the manufacturer ..The code constructed by the manufacturer and not broken until the end of the study."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:46:21 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>
<B>Quote:</B> '"...The code was unknown to the investigators."</P>
<P>
<B>Comment:</B> Probably done but randomisation unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:49:02 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Nothing reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 17:01:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> ''...an envelope was opened, in which it indicated whether the patient should receive the bio-adhesive gel or not."</P>
<P>
<B>Comment:</B> No mention of envelope nature (i.e. opaque or not) therefore unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:55:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>
<B>Quote:</B> ''The allocation of patients into one group or the other was carried out by computer before the start of the study. The gel was identifiable by a patient inclusion code number."</P>
<P>
<B>Comment: </B>Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:57:36 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Insufficient information to make a clear judgement if adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 12:01:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>No mention of this. Therefore, insufficient information to make a clear judgement if adequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-11-13 12:01:53 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:03:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>It was probably not possible to blind personnel and participants to group allocation. Strict study criteria required that participants would be blinded to group allocation as they will be involved in reporting of patients symptoms, however as operator is also involved in assessment of outcome, it is unclear the impact of performance bias has on study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:10:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>Insufficient reporting to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:13:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>Participants blinded to allocation and to what they received. Personnel were not blinded to interventions. Strict study criteria required that personnel would be blinded to group allocation as they will be involved in reporting of patients symptoms, however as operator is also involved in assessment of outcome, it is unclear the impact of performance bias has on study. Detail from the study is insufficient to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:19:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>Participants in antibiotic group would not have been blinded to intervention, though personnel were blinded to group allocation. Interventions were in identical bottles, a third operator separate to clinicians undertaking the surgery and doing the assessment, as both personnel and participants would be involved in outcome assessment, unclear impact on performance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-15 12:06:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:29:31 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>
<B>Quote: </B>"Each bottle was labelled with a unique subject number, which allowed for blinding of treatment assignment."</P>
<P>Both the placebo and active interventions were identical in appearance and therefore participants were blinded to group allocation, however it is not clear how bottle labelling ensured blinding of personnel. Strict study criteria required that participants and personnel would be blinded to group allocation, however as operator is also involved in assessment of outcome, it is unclear the impact of performance bias has on study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 10:34:20 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>Participants could not be blinded to group allocation, nor could operators. Strict study criteria required that participants and personnel would be blinded to group allocation as they will be involved in reporting of patients symptoms, however as operator is also involved in assessment of outcome, it is unclear the impact of performance bias has on study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:11:53 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>Participants were not blinded to group allocation (placebo received no intrasocket intervention), personnel were not blinded to group allocation. Strict study criteria required that participants and personnel would be blinded to group allocation as they will be involved in reporting of patients symptoms, however as operator is also involved in assessment of outcome, it is unclear the impact of performance bias has on study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-15 11:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-15 20:36:20 +0100" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:18:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>Patients were unaware of group allocation, personnel were unaware of group allocation. Active and placebo were identical in appearance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:22:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>Participants may have known their group allocation, it is not clear if personnel knew group allocation. A strict study criteria require that participants and personnel are blinded to group allocation but unclear reporting and unclear impact on performance bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:26:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>The test and control pastes were packaged in identical 2 ml syringes. Participants and personnel are blinded to group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:31:00 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>Not clear that participants and personnel are blinded to group allocation. Strict study criteria require that participants and personnel are blinded to group allocation, though impact on performance bias is unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:34:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>Participants and personnel were blinded to group allocation. Placebo and intervention gel had identical appearance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:46:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>Patients and personnel were blinded to group allocation. Intervention and placebo were identical in appearance.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:49:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:52:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>Patients did not know allocation but operators would have. Strict study criteria required that participants and personnel were blinded to allocation, but unclear the impact on performance bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:55:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>
<B>Quote:</B> "Neither the patient nor the operator knew group allocation, the code list was kept in a sealed enveloped and was not opened until after the study. Placebo did not contain active ingredient."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 11:57:45 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-11-13 12:01:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>Participans were blinded to group allocation. Personnel were blinded to group allocation but as they were not involved in assessment of outcomes, unlikely to have impact.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-11-13 12:02:04 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 10:03:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>While the criteria for dry socket are clear, it is unclear who and how they made the judgement. Insufficient information to permit judgement of 'high' or 'low' risk, therefore unclear risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 10:10:49 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>Insufficient reporting to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-15 09:03:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>It is not clear who made outcome assessment, if it was the operator given the low numbers in the trial s/he could remember group allocation, but insufficient information to form a judgement of high risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-15 12:01:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-15 12:06:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 10:29:48 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>All diagnoses were made by one of two attending clinical examiners involved in this study, without knowledge of treatment assignment. However it is not clear how bottle labelling ensured blinding of assessors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 10:34:49 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>
<B>Quote: </B>"All clinical assessment was carried out by a single blind investigator previously trained on diagnostic criteria."</P>
<P>
<B>Comment:</B> Probably done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:12:12 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>It is not clear whether assessors were blinded to group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-15 11:59:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-15 20:36:23 +0100" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Not mentioned and no information to suggest this was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:18:45 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>Unclear who made the assessment of outcome, while operators were blinded to allocation and appearance of placebo was identical, unlikely that they would have known group allocation when making assessment, however insufficient information to make a judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:22:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>It would appear that operators made the assessment of the outcome. It is possible that they may have become aware of group allocation, but there is insufficient information</P>
<P>
<B>Quote:</B> "The same examiners made all the diagnoses."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:26:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>Operator unaware of group allocation and code only broken after study was complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:31:04 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>Not clear who assessor was, not clear blinded to group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:34:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>Code was not broken until after the study, assessors were blinded to group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:46:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>Patients and personnel were blinded to group allocation. Intervention and placebo were identical in appearance, code for group allocation not broken until after the study completed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:49:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:52:24 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>Operators detecting presence of dry socket could have remembered group allocation potential for high risk.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:55:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>
<B>Quote:</B> "Operator did not know group allocation. The code list was kept in a sealed enveloped and was not opened until after the study."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 11:57:46 +0000" MODIFIED_BY="Blanaid JM Daly" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-11-13 12:02:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "..patients were examined clinically by an independent surgeon blinded to the site of intrasocket medication."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-11-13 12:02:14 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 10:03:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>In relation to alveolar osteitis, 2 patients from the control group did not attend any of the scheduled appointments following tooth extraction, and given the low event rate it is unclear whether this may introduce a bias. There was no loss in the intervention group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-08 16:50:04 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>None of the participants were reported to have dropped out. All outcomes in relation to dry socket fully reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-22 09:22:00 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>Outcomes assessments not carried out during periods of sleep were considered as "missing data".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 10:19:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>No drop-outs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-13 10:35:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>All participants accounted for in analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 10:29:56 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>Participants not included in final analysis reported (n = 8) and reasons for exclusion provided. Equal numbers in both intervention groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 10:35:08 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>The drop-outs/losses to follow-up were reported. Similar numbers in both groups, 2 in gel group, 1 in rinse group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:12:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>None of the participants dropped out.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-03-07 15:39:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>All participants accounted for in analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:16:12 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Very limited data, reported as graph plots. Insufficient information to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:18:47 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="NO" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>No data available for drop-outs (11): unreported from which groups, when and the reasons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:22:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>All randomised participants included in the outcome evaluation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:26:26 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>1 drop-out reported but not clear from which group, all other drop-outs fully reported. Unlikely to have had large impact on data analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:31:07 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>No patient lost to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:35:10 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>Only patients with pain and who phoned the surgery were "offered an appointment the same day to see a dentist".</P>
<P>
<B>Comment: </B>Incomplete outcome data and judged as potentially at high risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:46:38 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>No losses to follow-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:49:04 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-13 00:04:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>All patients completed the protocol and analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:55:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>Number of patients not included in final check-up visit stated, not included in analysis: 5 patients (1 in the control group and 4 in the test group) did not have their final check-up visit.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 11:57:47 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-11-13 12:02:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>All patients were accounted for at day 6.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-11-13 11:57:47 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 12:29:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>The report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:10:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>All the outcomes in relation to dry socket were reported clearly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-19 08:41:41 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>Although the study protocol was unavailable, the report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-29 22:25:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>The report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-20 04:34:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>Although the study protocol was unavailable, the report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:30:05 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="NO" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>271 participants 973 third molars extracted, 51.7% (239 CHX, 240 placebo) were mandibular molars, no data were reported for the non-mandibular molars.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 19:02:03 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>Although the study protocol was unavailable, the report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:12:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>All the outcomes were reported clearly.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-11 13:32:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>The report appears to be free of selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-07 09:17:55 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Although the protocol was unavailable all of the outcomes specified in the methods section appear to have been reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 19:19:31 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>Although the study protocol was unavailable, the report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-08 17:01:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>Although the protocol was unavailable all of the outcomes specified in the methods section appear to have been reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-15 12:09:11 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>Although the study protocol was unavailable, the report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:31:16 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>Postoperative questionnaire completed day 7, no data reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:35:31 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>Only patients with pain and who phoned the surgery were "offered an appointment the same day to see a dentist".</P>
<P>
<B>Comment:</B> Incomplete outcome data and judged as potentially at high risk of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 04:42:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>The report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:49:05 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 04:56:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>The report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-20 05:45:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>The report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:57:47 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 05:08:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>The report appears to be free of selective reporting of the outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-11-13 17:00:32 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-15 12:29:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alissa-2010">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:11:04 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bai-2011">
<DESCRIPTION>
<P>Although the authors reported the gender and the age, the difficulties of the extraction and the detailed information of the tooth impaction were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-19 08:42:17 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Burgoyne-2010">
<DESCRIPTION>
<P>Appears to be free of other bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-29 22:25:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Delilbasi-2002">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-20 04:34:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gersel_x002d_Pedersen-1979">
<DESCRIPTION>
<P>Appears to be free of other bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 10:30:09 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="NO" STUDY_ID="STD-Hermesch-1998">
<DESCRIPTION>
<P>Randomisation at individual participant level but analysis of data at extraction site level.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 19:05:04 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Hita_x002d_Iglesias-2008">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 17:00:32 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Huang-2011">
<DESCRIPTION>
<P>Authors stated that the gender and the age in each group were similar at baseline, but the difficulties of the extraction and the detailed information of the tooth impaction were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-11 13:32:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaya-2011">
<DESCRIPTION>
<P>The study appears to be free of other sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-09-07 09:37:30 +0100" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Kjellman-1973">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:18:53 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="NO" STUDY_ID="STD-Larsen-1991">
<DESCRIPTION>
<P>Participants were stratified then randomised but subsequent analyses were at tooth level. Although we know how many sites were available for analysis we only know the baseline number of patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-13 02:27:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Metin-2006">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-01 22:15:22 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="YES" STUDY_ID="STD-Mitchell-1984">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 04:44:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ragno-1991">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:35:42 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reekie-2006">
<DESCRIPTION>
<P>
<B>Quote:</B> "Where more than one extraction was needed only one was randomly chosen to be included in the study."</P>
<P>
<B>Comment:</B> Unclear if this would constitute an element of selection bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 04:44:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1977">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:49:05 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Shi-2003">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 04:56:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-20 05:45:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Lagares-2006a">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-13 11:57:48 +0000" MODIFIED_BY="Zbys Fedorowicz" RESULT="UNKNOWN" STUDY_ID="STD-Trieger-1991">
<DESCRIPTION>
<P>Very limited data reported, unable to make a clear judgement.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-10-19 05:08:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Eeden-2006">
<DESCRIPTION>
<P>Appears to be free of other potential sources of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-10-09 19:17:49 +0100" MODIFIED_BY="Zbys Fedorowicz" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-11-13 17:17:11 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2012-11-13 17:17:11 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2012-03-22 10:51:43 +0000" MODIFIED_BY="Grade Profiler">Chlorhexidine rinse for the management of dry socket</TITLE>
<TABLE COLS="7" ROWS="13">
<TR>
<TD COLSPAN="7">
<P>
<B>Chlorhexidine rinse for the management of dry socket</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Patients with the management of dry socket<BR/>
<B>Intervention:</B> Chlorhexidine rinse<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control<SUP>2</SUP>
</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Chlorhexidine rinse</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Presence of dry socket</B>
<BR/>agreed diagnostic criteria.<BR/>Follow-up: median 7 days</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.58 </B>
<BR/>(0.43 to 0.78)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>750<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>158 per 1000</B>
<BR/>(129 to 234)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>10 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>6 per 1000</B>
<BR/>(4 to 8)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>28 per 1000</B>
<BR/>(22 to 38)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Three trials were assessed as being at high risk of bias and one at unclear risk of bias.</P>
<P>
<SUP>2</SUP> The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%).</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2012-11-13 17:16:57 +0000" MODIFIED_BY="Grade Profiler" NO="2" READONLY="YES">
<TITLE MODIFIED="2012-03-22 10:52:29 +0000" MODIFIED_BY="Grade Profiler">Chlorhexidine gel for the management of dry socket</TITLE>
<TABLE COLS="7" ROWS="3">
<TR>
<TD COLSPAN="7">
<P>
<B>Chlorhexidine gel for the management of dry socket</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Patients with the management of dry socket<BR/>
<B>Intervention:</B> Chlorhexidine gel<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk<SUP>
<B>2</B>
</SUP>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Chlorhexidine gel</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>Presence of dry socket</B>
<BR/>agreed diagnostic criteria.<BR/>Follow-up: median 7 days</P>
</TD>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Study population</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>
<B>RR 0.42 </B>
<BR/>(0.21 to 0.87)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>133<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="6" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>300 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>126 per 1000</B>
<BR/>(63 to 261)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Low</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>10 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>4 per 1000</B>
<BR/>(2 to 9)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" ROWSPAN="1">
<P>
<B>Moderate</B>
</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>50 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>21 per 1000</B>
<BR/>(10 to 44)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> One trial was assessed as being at low risk of bias and the other at high risk of bias. Both were conducted by the same research team.</P>
<P>
<SUP>2</SUP> The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2012-11-13 11:29:38 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-11-12 21:32:07 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-11-12 21:30:02 +0000" MODIFIED_BY="[Empty name]">Results for treatment of dry socket (single studies)</TITLE>
<TABLE COLS="4" ROWS="3">
<TR>
<TH VALIGN="TOP">
<P>Comparison</P>
</TH>
<TH VALIGN="TOP">
<P>Data</P>
</TH>
<TH VALIGN="TOP">
<P>Effect (95% CI)</P>
</TH>
<TH VALIGN="TOP">
<P>P-value</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Anaesthetic gel versus eugenol (<LINK REF="STD-Burgoyne-2010" TYPE="STUDY">Burgoyne 2010</LINK>).</P>
<P>Pain at 48 hours.</P>
</TD>
<TD VALIGN="TOP">
<P>Anaesthetic gel</P>
<P>N = 15, mean = 2.49, SD = 2.51</P>
<P>Placebo</P>
<P>N = 20, mean = 2.69, SD = 2.46</P>
</TD>
<TD VALIGN="TOP">
<P>Mean difference</P>
<P>-0.20 (-1.87 to 1.47)</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>0.81</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Metronidazole versus placebo (<LINK REF="STD-Mitchell-1984" TYPE="STUDY">Mitchell 1984</LINK>).</P>
<P>Duration of treatment.</P>
</TD>
<TD VALIGN="TOP">
<P>Metronidazole</P>
<P>N = 26, mean = 5.35, SD = 3.52</P>
<P>Placebo</P>
<P>N = 29, mean = 8.52, SD = 8.52</P>
</TD>
<TD VALIGN="TOP">
<P>Mean difference</P>
<P>-3.17 (-1.04 to -5.300)</P>
</TD>
<TD VALIGN="TOP">
<P>0.004</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI = confidence interval; SD = standard deviation.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2012-11-12 21:38:14 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-02-15 14:19:28 +0000" MODIFIED_BY="[Empty name]">Results for prevention of dry socket (single studies)</TITLE>
<TABLE COLS="4" ROWS="16">
<TR>
<TH VALIGN="TOP">
<P>
<B>Comparison</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Data</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>RR/OR (95% CI)</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>P-value</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Acellular dermal matrix patch versus no treatment</P>
<P>(<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>)</P>
</TD>
<TD>
<P>Patch 1/200</P>
<P>No patch 15/200</P>
</TD>
<TD>
<P>RR 0.07 (0.01 to 0.50)</P>
</TD>
<TD>
<P>0.008</P>
</TD>
</TR>
<TR>
<TD>
<P>Rinsing with chlorhexidine both pre- and post-extraction versus rinsing just post-extraction</P>
<P>(<LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>)</P>
</TD>
<TD>
<P>Pre &amp; post 3/46</P>
<P>Post 6/53</P>
</TD>
<TD>
<P>RR 0.58 (0.15 to 2.17)</P>
</TD>
<TD>
<P>0.42</P>
</TD>
</TR>
<TR>
<TD>
<P>Inserting chlorhexidine gel into the socket versus rinsing with chlorhexidine</P>
<P>(<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>)</P>
</TD>
<TD>
<P>Gel 3/40</P>
<P>Rinse 8/32</P>
</TD>
<TD>
<P>RR 0.30 (0.09 to 1.04)</P>
</TD>
<TD>
<P>0.06</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Glucocorticosteroid antibiotic agent (post) versus normal saline</P>
<P>(<LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Split-mouth</P>
<P>CS only = 0</P>
<P>NS only = 3</P>
<P>Both = 0</P>
<P>Neither = 16</P>
<P>Total N = 19</P>
</TD>
<TD VALIGN="TOP">
<P>OR (exact)  0 (0 to 2.42)</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>0.25</P>
</TD>
</TR>
<TR>
<TD>
<P>Clindamycin phosphate antibiotic solution patch versus saline patch</P>
<P>(<LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>)</P>
</TD>
<TD>
<P>Split-mouth</P>
<P>CP only = 0</P>
<P>S only = 7</P>
<P>Both = 0</P>
<P>Neither = 79</P>
<P>Total N = 86</P>
</TD>
<TD>
<P>OR (exact) 0 (0 to 0.69)</P>
</TD>
<TD>
<P>0.016</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Metronidazole gel (post) versus placebo gel</P>
<P>(<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Met 8/152</P>
<P>Placebo 15/150</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.53 (0.23 to 1.20)</P>
</TD>
<TD VALIGN="TOP">
<P>0.13</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Apernyl versus placebo</P>
<P>(<LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Apernyl 1/50</P>
<P>Placebo 4/50</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.25 (0.03 to 2.16)</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>0.21</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Platelet rich plasma versus control</P>
<P>(<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>PRP 0/12</P>
<P>Control 2/9</P>
</TD>
<TD VALIGN="TOP">
<P>RR = 0.15 (0.01 to 2.86)</P>
</TD>
<TD VALIGN="TOP">
<P>0.21</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Tranexamic acid versus placebo</P>
<P>(<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Split-mouth</P>
<P>AMCA Y, placebo Y = 3</P>
<P>AMCA  Y, placebo N = 6</P>
<P>AMCA N, placebo Y = 3</P>
<P>AMCA N, placebo N = 108</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.67 (0.30 to 1.48)</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>0.51</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>P-hydroxybenzoic acid versus placebo</P>
<P>(<LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>P-hydro 0/24</P>
<P>Placebo 5/21</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.08 (0.00 to 1.37)</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>0.08</P>
</TD>
</TR>
<TR>
<TD>
<P>Heal-all tissue patch versus no treatment</P>
<P>(<LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>)</P>
</TD>
<TD>
<P>Patch 0/40</P>
<P>No patch 6/40</P>
</TD>
<TD>
<P>RR 0.08 (0.00 to 1.32)</P>
</TD>
<TD>
<P>0.08</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Partial versus total wound closure</P>
<P>(<LINK REF="STD-Bello-2011" TYPE="STUDY">Bello 2011</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Partial 6/40</P>
<P>Total 4/42</P>
</TD>
<TD VALIGN="TOP">
<P>RR 1.58 (0.48 to 5.17)</P>
</TD>
<TD VALIGN="TOP">
<P>0.45</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Chinese herbs Shahaosan versus placebo</P>
<P>(<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Shah 1/92</P>
<P>Placebo 8/96</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.13 (0.02 to 1.02)</P>
</TD>
<TD VALIGN="TOP">
<P>0.05</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Chinese herbs Yunnan versus placebo</P>
<P>(<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Yunn 2/86</P>
<P>Placebo 8/96</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.28 (0.06 to 1.28)</P>
</TD>
<TD VALIGN="TOP">
<P>0.10</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Chinese herbs Shahaosan versus Yunnan</P>
<P>(<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>)</P>
</TD>
<TD VALIGN="TOP">
<P>Shah 1/92</P>
<P>Yunn 2/86</P>
</TD>
<TD VALIGN="TOP">
<P>RR 0.47 (0.04 to 5.06)</P>
</TD>
<TD VALIGN="TOP">
<P>0.53</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CI = confidence interval; RR/OR = risk ratio/odds ratio.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2012-11-13 11:29:38 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-03-21 14:42:21 +0000" MODIFIED_BY="[Empty name]">Adverse events reported in included studies for prevention of dry socket</TITLE>
<TABLE COLS="3" ROWS="19">
<TR>
<TH VALIGN="TOP">
<P>
<B>Author/study</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Intervention</B>
</P>
</TH>
<TH VALIGN="TOP">
<P>
<B>Adverse events</B>
</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Alissa-2010" TYPE="STUDY">Alissa 2010</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Platelet rich plasma.</P>
<P>Patients all given co-codamol to take postoperatively if needed.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Bai-2011" TYPE="STUDY">Bai 2011</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Acellular dermal matrix.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Delilbasi-2002" TYPE="STUDY">Delilbasi 2002</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.2% chlorhexidine rinse.</P>
<P>Paracetamol for postoperative pain relief. Patients rinsed with 15 ml of chlorhexidine solution "just before tooth removal" (page 302). Intraoperatively the surgical site was irrigated with 15 ml of chlorhexidine solution diluted with 15 ml of saline. The day after surgery patients began rinsing with 15 ml chlorhexidine, twice daily for 7 days.</P>
</TD>
<TD VALIGN="TOP">
<P>Adverse events reported for Group 1 n = 62.</P>
<P>Allergy: n = 0.</P>
<P>Staining of teeth: n = 4.</P>
<P>Mucosal irritation: n = 0.</P>
<P>Alteration in taste: n = 12.</P>
<P>GIS complaints: n = 0.</P>
<P>Bad taste: n = 8.</P>
<P>No adverse reactions: n = 38.</P>
<P>From Table IV page 303.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Gersel_x002d_Pedersen-1979" TYPE="STUDY">Gersel-Pedersen 1979</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>AMCA cones versus lactose cones.</P>
<P>All had 0.2% chlorhexidine 3 times a day.</P>
</TD>
<TD VALIGN="TOP">
<P>Foreign body reaction to the vehicle delivery system in the cones.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Hermesch-1998" TYPE="STUDY">Hermesch 1998</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.12% chlorhexidine rinse. Participants in the experimental group rinsed for 30 seconds twice per day with 15 ml chlorhexidine 7 days preoperatively. On day of surgery supervised rinse before anaesthesia and surgery. Participants suspended rinsing for the remainder of the day and recommenced the next day.</P>
</TD>
<TD VALIGN="TOP">
<P>Adverse events: Group 1 CHX n = 136 and Group 2  placebo n = 135.</P>
<P>Paraesthesia reported: CHX 9, placebo 5.</P>
<P>Infection: CHX 4, placebo 3.</P>
<P>Trismus: CHX 0, placebo 5.</P>
<P>Gingivitis: CHX 1, placebo 3.</P>
<P>Glossitis: CHX 2, placebo 2.</P>
<P>Abnormal healing: CHX 1, placebo 3.</P>
<P>Nausea: CHX 0, placebo 4.</P>
<P>Sinusitis: CHX 1, placebo 3.</P>
<P>Headache: CHX 1, placebo 2.</P>
<P>Dysphagia: CHX 0, placebo 2.</P>
<P>Edema (head &amp; neck): CHX 1, placebo 1.</P>
<P>Haemorrhage (prolonged): CHX 1, placebo 1.</P>
<P>Pain: CHX 1, placebo 1.</P>
<P>Pharyngitis: CHX 1, placebo 1.</P>
<P>Rash: CHX 1, placebo 1. </P>
<P>There were single site observations of each of the following: asthenia, bronchitis, cyst, depression, contact dermatitis, dyspepsia, ecchymosis, fever, herpes simplex, hypalgesia, back pain, rhinitis, stomatitis, and tenosynovitis. All but 2 cases of paraesthesia had resolved by end of study, one in each treatment group. From Table VII page 384.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Hita_x002d_Iglesias-2008" TYPE="STUDY">Hita-Iglesias 2008</LINK>
<B> </B>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>Chlorhexidine 0.2% gel versus 0.12% chlorhexidine mouthrinse. Participants in the 0.2% chlorhexidine gel group had the gel placed in the socket during surgery and then they were required to apply the gel to the socket twice a day (morning and night-time) for 7 days beginning on the same day as the surgery. Patients in the rinse group rinsed twice a day (morning and night-time) for 7 days beginning on the same day as the surgery.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Huang-2011" TYPE="STUDY">Huang 2011</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Intradermal matrix.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Kjellman-1973" TYPE="STUDY">Kjellman 1973</LINK>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Apernyl as alveolar.</P>
</TD>
<TD VALIGN="TOP">
<P>Pain and burning sensation page 200.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Larsen-1991" TYPE="STUDY">Larsen 1991</LINK>
<B> </B>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.12% chlorhexidine rinse versus placebo.</P>
<P>All patients received 8 mg dexamethasone (glucocorticoid) IV prior to surgery. Participants were required to rinse twice per day for 30 seconds using 15 ml of the solution for 7 days prior to the surgery. On the day of the surgery they rinsed with the solution immediately prior to surgery (using 15 ml) and postoperatively patients were instructed to begin rinsing the day following surgery.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse reactions page 954.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Metin-2006" TYPE="STUDY">Metin 2006</LINK>
<B> </B>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.2% chlorhexidine rinse 7 days preoperatively and 7 days postoperatively (group I)  versus 7 days postoperatively only (group II).</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>Altered taste and numbness page 3. Numbness in the tongue reported in group I and group II 45.6% and 13.2%. However, disturbance of taste sensation was seen in 56.5% of the patients in group I and in 11.3% of the patients in group II.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Ragno-1991" TYPE="STUDY">Ragno 1991</LINK>
<B> </B>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.12% chlorhexidine rinse. Participants rinsed immediately before surgery, the surgical was irrigated intraoperatively and starting the day after the surgery participants were asked to rinse with solution twice daily (15 ml) for 7 days postoperatively.</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>There were no allergic reactions to the chlorhexidine rinse. 3 participants reported bad taste, 1 reported stomach upset page 526 but no staining noted.</P>
<P>1 person in the control had a severe surgical reaction which in the author's opinion was not attributable to the medication.<B> </B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.25 ml of 25% metronidazole gel intrasocket intervention.</P>
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>1 participant with nausea and vomiting, 2 complained of a bitter taste.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Ritzau-1977" TYPE="STUDY">Ritzau 1977</LINK>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>PEPH (p-hydroxybenzoic acid).</P>
</TD>
<TD VALIGN="TOP">
<P>Haematoma and rash.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Shi-2003" TYPE="STUDY">Shi 2003</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Artemisia desertorum spreng (Shahaosan, Yunnan).</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Torres_x002d_Lagares-2006" TYPE="STUDY">Torres-Lagares 2006</LINK>
<B> </B>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.2% chlorhexidine gel intrasocket versus placebo.</P>
<P>Participants in the 0.2% chlorhexidine gel group had the gel placed in the socket during surgery. Note only 1 application of bio-adhesive gel during surgery.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Torres_x002d_Lagares-2006a" TYPE="STUDY">Torres-Lagares 2006a</LINK>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>0.2% chlorhexidine gel intrasocket versus placebo.</P>
<P>Participants in the 0.2% chlorhexidine gel group had the gel placed in the socket during surgery. Note only 1 application of bio-adhesive gel during surgery.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Trieger-1991" TYPE="STUDY">Trieger 1991</LINK>
</P>
</TD>
<TD VALIGN="TOP">
<P>Gelfoam clindamycin.</P>
</TD>
<TD VALIGN="TOP">
<P>No adverse events reported.</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-van-Eeden-2006" TYPE="STUDY">van Eeden 2006</LINK>
</P>
<P>
<I>
<B> </B>
</I>
</P>
</TD>
<TD VALIGN="TOP">
<P>Gelfoam covomycin.</P>
<P>0.2% chlorhexidine advised postoperatively every 6 hours for 5 days.</P>
</TD>
<TD VALIGN="TOP">
<P>Some of the events may be attributable to intervention or could be normal sequelae of operation.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>CHX = chlorhexidine.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-11-12 21:15:04 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-11-12 21:15:04 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Prevention of dry socket</NAME>
<DICH_OUTCOME CHI2="3.197260597237637" CI_END="0.7757229402912682" CI_START="0.43143725787730136" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.578511692389862" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="102" I2="6.169675296660708" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.1102933650665855" LOG_CI_START="-0.36508235299372405" LOG_EFFECT_SIZE="-0.23768785903015477" METHOD="MH" MODIFIED="2012-10-10 12:03:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3621999629459115" P_Q="1.0" P_Z="2.553564547994882E-4" Q="0.0" RANDOM="YES" SCALE="2.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.005739764756103413" TOTALS="YES" TOTAL_1="382" TOTAL_2="368" WEIGHT="100.0" Z="3.6568271419544858">
<NAME>Chlorhexidine rinse versus placebo</NAME>
<GROUP_LABEL_1>Chlorhexidine rinse</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours chlx rinse</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7189970321031112" CI_START="0.4542303519527924" EFFECT_SIZE="0.8836405529953917" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.2352751268660202" LOG_CI_START="-0.34272384932104205" LOG_EFFECT_SIZE="-0.05372436122751095" MODIFIED="2012-02-21 09:26:23 +0000" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="0.33951945975335635" STUDY_ID="STD-Delilbasi-2002" TOTAL_1="62" TOTAL_2="59" VAR="0.11527346355121094" WEIGHT="18.50988261326813"/>
<DICH_DATA CI_END="0.9626422587567195" CI_START="0.39983870501823005" EFFECT_SIZE="0.6204044117647058" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="40" LOG_CI_END="-0.016535077271148856" LOG_CI_START="-0.3981151677911236" LOG_EFFECT_SIZE="-0.20732512253113622" MODIFIED="2012-02-10 13:55:39 +0000" MODIFIED_BY="[Empty name]" ORDER="2" O_E="0.0" SE="0.22414203402334423" STUDY_ID="STD-Hermesch-1998" TOTAL_1="136" TOTAL_2="135" VAR="0.05023965141612201" WEIGHT="40.01364794033645"/>
<DICH_DATA CI_END="0.7518197765054178" CI_START="0.21155207837237971" EFFECT_SIZE="0.39880952380952384" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="28" LOG_CI_END="-0.1238862544213426" LOG_CI_START="-0.6745827036287302" LOG_EFFECT_SIZE="-0.3992344790250364" MODIFIED="2012-02-10 13:55:39 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.3234818202558073" STUDY_ID="STD-Larsen-1991" TOTAL_1="144" TOTAL_2="134" VAR="0.10464048803601042" WEIGHT="20.29294727961556"/>
<DICH_DATA CI_END="0.9292735303476837" CI_START="0.26902735506354475" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="20" LOG_CI_END="-0.031856433223062315" LOG_CI_START="-0.5702035581049001" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-02-10 13:55:39 +0000" MODIFIED_BY="[Empty name]" ORDER="3" O_E="0.0" SE="0.316227766016838" STUDY_ID="STD-Ragno-1991" TOTAL_1="40" TOTAL_2="40" VAR="0.10000000000000003" WEIGHT="21.183522166779856"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.2746465802661303" CI_END="0.8675274354147625" CI_START="0.2051708421868354" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4218901925196084" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.06171678182719548" LOG_CI_START="-0.6878843588483523" LOG_EFFECT_SIZE="-0.3748005703377739" METHOD="MH" MODIFIED="2012-11-12 21:15:04 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6002317573256344" P_Q="1.0" P_Z="0.018959681135653137" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="63" WEIGHT="100.0" Z="2.3463227615258266">
<NAME>Chlorhexidine gel versus placebo/no treatment</NAME>
<GROUP_LABEL_1>Gel</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours gel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.128265932945285" CI_START="0.1545558668525782" EFFECT_SIZE="0.5735294117647058" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.32802589335740373" LOG_CI_START="-0.810914504716878" LOG_EFFECT_SIZE="-0.24144430567973713" MODIFIED="2012-03-21 10:11:46 +0000" MODIFIED_BY="[Empty name]" ORDER="14" O_E="0.0" SE="0.6690192276747295" STUDY_ID="STD-Torres_x002d_Lagares-2006" TOTAL_1="17" TOTAL_2="13" VAR="0.4475867269984916" WEIGHT="22.70046023206067"/>
<DICH_DATA CI_END="0.8956100525250544" CI_START="0.15899713273740285" EFFECT_SIZE="0.37735849056603776" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.04788104044845717" LOG_CI_START="-0.7986107074251585" LOG_EFFECT_SIZE="-0.4232458739368078" MODIFIED="2012-03-21 10:11:46 +0000" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.0" SE="0.4409823225538995" STUDY_ID="STD-Torres_x002d_Lagares-2006a" TOTAL_1="53" TOTAL_2="50" VAR="0.19446540880503146" WEIGHT="77.29953976793932"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-11-13 17:01:56 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-11-07 12:29:30 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzkAAANFCAYAAABY8jKjAAA9y0lEQVR42u3di5KrSK4F0P7/n+4b
03HPjMcDpKRU8vJaEY7uU7Z5JAK0y5j66+8Pf/31l4eHx8bjbmwTD4937MsALOqVPhsmYD9U3Cnc
AM/elwFYfrx3wIcnNEb2VbAfASDkwKuaI/sq2JcAEHJAyAHsSwBCDnDX5si+CvYnAIQcEHIA+xOA
kAMIOWBfBkDIAY2RpgzsywAIOaAx0pSB/QmAS0LO0V+KHv0l6Tf8penqckfGddUybv37z89m53v0
/tFyvKGxuWvIWf2X3TP1vPf/Z4/fE485jjfnbUMhB+CHQ87RyWwv1ESff3vTceZ0M9vwzHkJOX9f
NvZnj9ve8z75crwRcgC4VcipNDUzIefzN3/f04l+WnT03F4DfjS/vcY98pvy0fuOnh8t62h8tl5f
mW9kubPLMbvNI3V1tMyjZXpiyKks0+x2z45xd91Xa8Xx5h3HGyEHgGUhpysYfZ/cZoJU9pOmzGUX
o/lll7NzWbueyy53tNGa2Qbdy5xthp8ScjKXqnWMYfT5lftopVYcb95zvBFyAJgKOZnfeM+GnNlm
rLNZzs6vszHvaA5WNB3ZMT9rG5x5GeVTPsmZ+YSqc4zPvuS16/jgeHP/442QA0A55FR/k9j1/NZv
qK9sOjKhr/Kb08x6djUdM/MVcu4Rcqqv7aq3q0NO5/HB8eY5xxshB4ByyImeFDru7DP7W9uzmo7K
c7O/sT3zN6ud4yHk3DfkrAwfZ4acan073jz/eCPkALA05HTdulTTIeQIObV5d9TtE0POysvLHG+E
HAB+OOR0/m2GjoZ3xW+J7/JF4LOaju4bD6wOOTNfin9ryKneiWvF82eGnM7Lyxxv7n+8EXIAKIWc
z5PM3vdzRtdXZ+76lLk18d7z2eUfze/oxHvFLV2PmoPR7XwjyzV7S9fIayNN6Bm3N35TyImMWecY
ZsZ4Zd1XtrXjzXuON0IOAOWQAy8p8lc0RvZVsD8BIOSgcRFyAPsTgJAD72heMpduCTkg5AAg5IDG
SFMG9mUAhBzQGGnKwL4MgJADGiNNGdifABByQMgB7E8AQg4g5IB9GQAhBzRGmjKwLwPw8JCz8i/D
O+HUxsW4CTmRv1j/tnF7wjpjXwZAyHHCMS62h5Aj5ODYCsD6kPP9BxW3GoutP7qY/fnntI/+iOPo
jzzOvLdzWpn1HM1vNC7f08gsuxP980POVq1Fa6ayf46Cxl5tRWozuh9V1rm6X3YdF0bjlz0uzB4P
cewD+NmQs9fAZE/amddHGvjK/CIN2mjdq8uRXc+ZccmOoQbo+SEnul2zNdix/1Xm2TW/jv3y7seF
2eOvfdmYAAg5wZPC6CQ80wTMzG825Kwel65mb7bR4j0hp6MOupv4VXW/avlWLu/Z44OQAyDkFBqh
vUtK9qYbfX3lkpDRz6OXcMxOa3Y9hRyNkZDTG3KO9tvodp29HK1zfEbHIZerCTkAQk4x5MxeIjbz
+kyTNHsym/2Nr5CjMRJy7vdJzux2vdv4aOiFHAAaQs4dLie5Y8i5stkTcoQcIUfI0dAbEwAabzwQ
eX70+pkvzd/1xgOVy9Wq8+v4sjZCTtf+9/bv5DzluKChF3IAhJyNk0D0FtJbJ9nR7VC7b398x1tI
R5upjmv9Z2/zy3NDzmibznxfrut4kB3LzPdNsrVfDQF3OS5U5oeQAyDk4ETPY0KOsQL1CYCQ46Tu
RC/kqC3sywYBQMjhTSd2l7EIOWoL+7IaBRByACEH7MsACDmgMdKUgX0ZACEHNEaaMrA/ASDkgJAD
2J8AEHJAyAH7MgBCDthhhBywLwMg5IDGSFMG9mUAhBzQGGnKwP4EgJADQg5gfwJAyAEhB+zLAAg5
oDHSlIF9GQAhBzRFmjKwLwNwyrHeAR+e0xjZV8F+BICQAy0N0V32EfsqvGNfBuCEkOPgD88JFfZV
8AsCAIIh57uB8vDwuHdTZPt4eLxjXwbghJCD3zoC9l0AEHLQKAH2XQAQctAogX0XABByNEqAfRcA
EHI0SoB9FwCEHDRKgH0XAIQcNEpg37XvAoCQg0YJ7LsAgJCjUQLsuwCAkKNRAuy7ACDkoFEC7LsA
IOSgUQL7LgAg5KBRAvsuACDkaJQA+y4AIORolAD7LgAIOWiUAPsuAAg5aJTAvgsACDlolMC+CwAI
ORolwL4LAAg5GiXAvgsAQg7nNkoeHh7PfAAAQg78XIAFAEDIASEHAAAhB4QcAAAhBxByAACEHEDI
AQAQckDIAQBAyAEhBwAAIQeEHAAAIQcQcgAAhBxAyAEAEHJAyAEAQMiBh4ab7wcAAEIOCDkAAAg5
cMegAwCAkANCDgAAQg4IOQAAQg4g5AAACDlAPOgAACDkgJADAICQo5n+y8PDI/gAAIQcHhBugNx+
AwAIOWjUwL4DAAg5aNTA/gMACDlo0sD+AwAIOZo0wD4EAEIOGjSwDxkEABBy0KCBfQgAEHLQoIF9
CAAQctCggX0IABByNGj/9dzRX3jPPv/EZnDlMn+OyVlj0zmfz2l1TVeNAABCDssatL3QEn3+Lc3f
qnW4aqxWhZxfDgxCDgAIOfxIyMk2fp+faHxPJ/pp0dFze6HiaH57YST6qdTe/Lc+4Yq8LrL8o/Gp
bMPRMmTHKbu+MzUg5AAAQo6QE35tpEHOXKo2aqKjjXV2+Y7mt9VsR8duZtmryz9ahtH6ZMco8v+z
4bjj9UIOACDkCDmbjfFsIJgNBdGGeea93Z9OrQ45lW07+2lcJeR0jkv3NhFyAAAh5wdDTiTYRL88
Xwklo8u5zgw5R6EvEhKzIae67k8IOZlxGX0q6HI1AEDIoS3kdD6f/eTnqpAzs3yzn+Rkt9tdQ87M
uNwxcAg5ACDk8JCQMxs6Vl2u9pSQs+I7OW8IOau/YyPkAABCDm13V1vRtK++8cBofp03HqhcrpZd
/o5lOPvGA5UxduMBAEDIodygzd66N3t3te5liNyCeTS9rltIR5v97C2kZ5YhuowrbyG9NR23kAYA
hBw0aKgN4wQACDlo0FAbxgkAEHI0aKgNjBMACDlo0MA+BAAIOWjQwD4EAAg5aNDAPgQACDlo0MA+
BADO54ZAgwbYhwBAyEGDBvYhAEDIQYNmPVFbAICQgwZNI4raAgCEHA3a/s//9d/P1/z59/fPI+/Z
msfWtEbLNFqO7+c1ogg5AICQo0E7DDGj4HH078i0IsFrtByjdQEhBwAQcn4w5GR/NgpF0ZDT/V6N
KEIOACDkaNBCl5eNLjNbGXIyy6ERRcgBAIQcDVopKHSGnM9/Ry6bm112EHIAQMhByBFyQG0BgJDD
+0LOqsvVupdDI4qQAwAIOULO7s9Ht5DO/PvoNtDV5fh+XiOKkAMACDkaNMA+BABCDho0sA8BAEIO
GjSwDwEAQg4aNLAPAQBCDho0sA8BAEKOBg2wDwGAkIMGDexDAICQgwYN7EMAgJCDBg3sQwCAkIMG
DexDAICQo0ED7EMAIOSgQQP7EAAg5KBBA/sQACDkoEED+xAAIOSgQQP7DwAg5GjUAPsOAAg5aNTg
pfuM/QYAhBw0beCXAgCAkMN1YcfDw2P7AQAIOUBD8AQAQMgBIQcAACEHhBwAACEHEHIAAIQcQMgB
ABByQMgBAEDIASEHAAAhB4QcAAAhBxByAACEHEDIAQAQckDIAQBAyAEhBwAAIQeEHAAAIQcQcgAA
hBxAyAEAEHJAyAEAQMgBIQcAACEHhBwAACEHEHIAAIQcQMgBABByQMgBAEDIASEHAAAhB4QcAAAh
BxByAACEHEDIAQAQckDIAQBAyAEhBwAAIQeEHAAAIQcQcgAAhBxAyAEAEHJAyAEAQMgBIQcAQMgB
zgk33w8AAIQcEHIAABBy4I5BBwAAIQeEHAAAhBwQcgAAhBxAyAEAEHKAeNABAEDIASEHAAAhh/s3
+x6/80Ddq3sAhBxe3+Txe9td3at7dQ+AkIMTPra9dce2B0DIwQkf2996Y/sDCDngZI/tb72x/QGE
HHCyRw1YZ9QAgJCDE71BUAPWGTUAgJCDEz1qwDqjBgAQcnCiRw1YZ9QAgJADTvSoAeuMGgAQcqDp
RD/6S+HZ55/YVPxCIyTkrK17NWEdARByuMmJfq95iz7/liZCs6fuM3Uf2S/UhHUEEHLgRc1eZDm+
f/ud+a350XN7AexofnvB7cm/odfs3SvkqHt1DyDkwMUn+myzl7ls56ghiy5DZfmO5rfVCL6xSRJy
+uo+Oy91r+4BhBy44EQ/+o1wtDGKNHvZn81Mr3t+mr3fDDmVT1rUvboHEHLgps3eViM3+xvto0Zx
q2k8u9nLNK+avXescyTAqHt1D4CQw4tCTufzKy4DWtHsvbFJEnL6g5C6V/cACDnc8EQ/23ytulxN
s6fZO2Odz/rOjrpX9wBCDtwo5ES+ozPbuK3+AvZofr6A/ZshJ/Nc9qYB6l7dAwg5cINmr3ob28j7
o2Fr5a10R9Pz3YTfC/ejOwOqe3UPgJCDEz1qwDqjBgCEHHCiRw1YZ9QAgJADTvSoAeuMGgAQcsCJ
HiEHdQ+AkIMTPWrAOqMGABBycKJHDVhn1ACAkANO9KgB64waABBywIkeNTD6my7qHjUAIOTgRI8a
eGTI2fvDmOoeNQAg5OBEb71/YCz2gsFbH0+ptavf7xgAgJCDE731NhY3Wae7fJIj5Kh7AIQcbnSi
P/qt995z358K7DWdo6b0aJrZ92+9V4PzGyFntu5HwWivxo9eM1qWUa2qdXUPIORA8USfadS2Gr3R
PCrN48z7Mw2wGlD3kVrK7BNdtarW1T2AkAPNzV71uY6Qs/J5NSDkdIccta7uARByuOmJPnL5TbRJ
HH0/Ivv9ic73qwEhJ1pLn6+p7BNdn2qqdXUPIORAw4m+8lvr6Dwqz2e+RK7x0+xlQk7kvVeGHLWu
7gGEHBByNH6avbaQc8fL1dS6ugcQcqDY7FW+ZL2ysfNlbM3eWSFn5Y0HRpebufGAugcQcqD5RD9z
C+mj11dvIT0KYW6rq9nrrvvuW0hHatEtpNU9gJADTvSoAeuMGgAQcsCJHiEHdQ+AkIMTPWrAOqMG
ABBycKJHDVhn1AAAjro40aMGrDNqAEDIASd61IB1Rg0ACDngRI+Qg7oHQMjBiR41YJ1RAwAIOTjR
owasM2oAQMgBJ3rUgHVGDQAIOeBEjxqwzqgBACEHJ3rUgHVGDQAg5OBEjxqwzqgBAIQcnOhRA9YZ
NQAg5IATPba/9cb2BxBywAkf2966Y9sDCDk44fNj2/zXt7u6V/cACDk4+aO5V/eoewCEHJ7b9Hm8
94G6V/cACDnwAw0uAABCDgg5AAAIOSDkAAAIOYCQAwAg5ABCDgCAkANCDgAAQg4IOQAACDkg5AAA
CDmAkAMAIOQAQg4AgJADQg4AAEIOCDkAAAg5IOQAAAg5gJADACDkAEIOAICQA0IOAABCDgg5AAAI
OSDkAAAIOYCQAwAg5ABCDgCAkANCDgAAQg4IOQAACDkg5AAACDmAkAMAIOQAQg4AgJADQg4AAEIO
CDkAAAg5IOQAAAg5gJADACDkAEIOAICQA0IOAABCDgg5AABCDiDkAAAIOYCQAwAg5ABCDgCAkANC
DgAAQg4IOQAAQg4g5AAACDmAkAMAIOSAkAMAgJADQg6/WS8eHh4eHh4e44eQA0IODwk3AEC+x3IG
BSEHNQIAQg6ggUWNAMBdz6HOpKCBRY0AgJADaGBRIwBw1/OoMyloYFEjACDkABpY1AgACDmABhY1
AgBCDmhgUSMAgJADGlheWyNHf925UmeZPzr6X39/YPCerjpfsb/8z1/FLqz/248zV79/pk4ry/PG
GgAhBxByeESNbP1872eROsvW4ltDzhv33TeFnI5p3bkeASEHhByEnMHP/v33AQIh5PsTodH0oyFn
79Omo5+PplH9dOtz3famufWeo2lF5ns0neyYjbbJaFmjdRMdk8i6VgJ0pmZG9b+3P1S27aieHN9B
yAGcBFkccjJ1FmnQKiGnc9qVT4y2muToskWfy6xPJBR2jE3nsna+v1LvmUAdDTnV8crWEyDkgAYW
kjXS+Z2cN4Sc0byzv/2PjulMY74q5HQua+fzK0POd5DZ+m9nbc+uKyDkgJCDGplosO4YckaXoM38
lrx6uddMcIiuT/bSwY6x6Q4xR8sn5Dimg5ADOCHyqpATbXwz30vpXI8zP8mp7vcrxmb1JzWdjb+Q
Awg5IOQg5Nwq5MxMe8V83hhy7ni5mpDjmA5CDuCEyCNDztGnM3e98UD35WpvvPFA5FO3p9x4IFPL
1ZDTeWkeIOSAkIMa2TtwL7rxwPf0Z8PH7C2k96ZTXebI64/m+dRbSFfWufsW0pVbml8VcjLjWglk
gJADQg5qBNQ0gJADTvaoEVDTgJADONmjRgBAyAE0sKgRABByAA0sagQAhBzQwKJGAAAhBzSwqBEA
EHIADSxqBACEHEADixoBACEHNLCgRgBAyAENLGoEABByQAOLGgEAIQfQwKJGAEDIATSwqBEAEHJA
AwtqBACEHNDAokYAACEHNLCoEQAQcgANLGoEAIQcQAOLGgEAIQc0sBCtkX8O3F+P7vq6qkZXzDcz
zdVjd/X6PfGYF33vnWrWMR6EHNDAQqJGIj8XcoScXws5V9Zrdl8FhBwQclAjyZ9vfcIT+U3z3ns6
lmOvMfx+/ujTqb3pR957tK6RaYyWKzLes+sdnV9k/CNBLLvtRu8d1eDs2OzNLzOu1X1UyAEhB3Dy
Y1HIiTR8Rw3mVqNaDTlH888uS3b6o2lWxqI6dh3bJhpOj/49U19dY7e6Jqp1shemMsHo7E/uACEH
hBxeWSPZ39JXmshs479qXtnpz06ze+xWh5zK8lSb8plx7h7j2Zo4c18FhBzQwEKyRqKXZ7095Bz9
Fj57yVzHtJ8aco5CdEfI6dp+Qg4g5ICQww/UyOpPI0aXr10dcjLvqV5W1bE8V4SczPZbte2OLoGs
jHF3yHG5Ggg5gJDDhTVSubuakLPmUyshp3a5Wsc27w45q47njvUg5IAGFk4KOdFLtJ4ccqI3HoiM
RXasr77xwEzIedONB4QccB61B4KQw4NqJPLHQI9uxXvULGduO11tOLPLHg15lVtIbzXUq24hXZ1+
Zn4dDfedbiFdrQkhBxByQMhBjahbNWXdjDcIOYCTH5o21JR1s7+AkAM4+fHIGln1F+Ox/d68zwBC
DmhgQY0AgJADGljUCAAg5IAGFjUCAEIOoIFFjQCAkANoYFEjACDkgAYW1AgACDmggUWNAABCDmhg
USMAIOQAGljUCAAIOYAGFjUCAEIOaGBBjQCAkAMaWNQIACDkgAYWNQIAQg6ggUWNAICQA2hgUSMA
IOSABhY1AgAIOaCB5Qdq5J8D99eju74+p/GL9Vpd/9Fr7z6WM8u3et2ePv1fqsOj5c7O+8zt8n08
/fx3dDk6l1evIOSAkMPP1Ejk590hx7YQcoQcddi13Hcd5zsup+OwkANCDkLOx28bvz/h2XrP1gl9
7z1Hr92b9t5zo3XZmm90XpGgt/Vb2tGnYZn1Hy1zdiyj67s1745pRLfvUd1FXluZfve6jX5jX5nv
2+owMp3o8ahynKjW5+h4s/Xp+Og42jG2R+uTPTYg5ICQwytDTqYRiTZPkddGpjUTcjJNX6ZRzaxH
dv2jyxwJn7PjtXrMM3U0Wz9nrdvMp6hvr8NsyJmpi9X1mT12Veaz4hiHkANCDq+tkdFv92Yby9mT
9sw6zoSAmcCVXeczxrJjvLLbYWYe1ct9qtPvrqdV3yN5ax3u/bey/pmQ01k/XSGnc3mFHCEHhBzU
yN9/hy+X6GyIIjc+6LxcLfKeyKVC1ffOXiY3M5arQk51+Y+2b/a385nLu54Qcn6tDu8YcjL1eVbI
ORpbIUfIASEHNZJ4/dmf5FTXoyPkVC6fyTYxs83PyrGsTG9m+Wfrrqt5XB1yRrVTrcs31eFdQ073
9p8NOWfs0wg5IOTw+Bqp3F3trSEn0zDOjMmqy0+uCDndlwh2NLNPDzm/WodCjpAj5ABCDrcKOZHL
aa648cDspRxHd1uamXd2rK688UC2rmaWv6OZzVza9ZSQ8/Y6nA0EVwWVmdqrzsd3coQc0MBC8qSf
/U5M9naoZ9xCOjvf7HJHgmFk3pWxuvIW0h1jXr1Fb+SPJ87cmrfjFtLVhrM6pm+tw0wgqI5NxzFh
5jhXmU/lFtLRsUPIASEHNQLYD0HIAZw4USOA/RCEHMCJEzUC72yO7IMg5AAaWNQIAAg5oIEFNQIA
Qg5oYFEjAICQAxpY1AgACDmABhY1AgBCDqCBRY0AgJADGliI10i2du50K9zIX/u+yz7WtWx3WI4r
t/+Z2xxAyAEhhx+okbvV2ZnLc9dg99SwVm4wNubv+AcIOaCBRY3s/vzP//9pJr+fy/x8a3p7Pxs1
sNH5bs0/umxH+1Bl3avjvDXt0XSOtvPMGEXqKDOOHfUr5ABCDmhgIR1yMk31qOHcm97RazJN/EwA
GK1rtLmvvH9mnGfHJxuSIuucHcetRzYgOgYCQg4IOZD6JKcz5GTDwkzDO7MuZ4ecSiPfvY5dIWf1
8UjIAYQc0MDC60LO0eViQs7c85lPVa4IOdEQ7BgICDkg5KBGHhNyOi7rEnLy81kVcjLBKjNtx0BA
yAEhBzXyiJCz+js5Qs75ISfdUARDkWMgIOSAkIMaeWTI+dXL1aI3HoiMzxO/k5OtYwAhB4QchJzp
YBC53XEl5HxPf2t5Zm8hnWnwu28hnVnvyvjMjpGQAyDkgJCDGkEdWSZAyAGc5FEjqCO1DQg5gJM8
agS1pK4BIQc0HagRNQIAQg5oYFEjAICQAxpY1AgACDmABhY1AgBCDqCBRY0AgJADGljUCAAg5IAG
FjUCAM6jzqSggUWNAICQA2hgUSMAIOQAGljUCAAIOaCBRY0AAEIOaGBRIwAg5AAaWNQIAAg5gAYW
NQIAQg7Y8ex2qBEAEHJAA4saAQCEHNDA8q4ayf78rBr952Ty/+/JvPfztd/vu3o/+Vynt+zXM8t4
5/U7qqMV63nVWIzmu/W88w1CDiDk8IiQc0Yjc0Vzf6f9orIsQs47jqmVIHGH0H30vHMOQg4g5HD7
kLP1/Na/Px/RBupo+lvT2/r51m/V95Zl6/nsMkTmM1rn0Tplxyy6PJnpZ7bvaJz2ftY9Jpn5Zutk
NK3qWGVDTqX2qseD7HHBOQchBxByeE3IyX7Ss9cUZhvUo6Y58t6ZdYo21tV1qoxZZHrRn3duj67p
di/zijqqjFWlbrK1t/XoOHdklx2EHEDI4VYhZ6ax62j4VzTO3Q34mSGnsjzVhnRm2bPfgZodk1U1
tirkzK7H6mO8kANCDgg5CDmNDejRb56FnP6Q8z3u3SEncglc9NOoVcvcFXKy6yTkgJADCDlcGHL2
mtarG34hp/7dicj8ZkNO9Htds8etVSFmNvDPBJSOkONyNRByQMhBjQg5Qk5zyOlcZyHHJzkg5ABO
NrSHnH8fyG9844FfCDnZGw2cFRxXj3F1mUc3ath6/51vPCDkgJADONnQHHKOmrXVt5DuDjldyxBt
CDPTy4xZR7N5p1tIj5Ynu8x743X3W0gLOSDkAEIOagTbdnnzbvupORBywAkHNYJtK+QIOSDkAE44
qBGaTri26+NDztP2TzWHkAM46aBGAEDIATSwqBEAEHLAjqeBRY0AgJADGljUCAAg5IAGFjUCAEIO
oIFFjQCAkANoYFEjACDkgAYW1AgACDmggUWNAABCDmhgUSMAIOQAGljUCAAIOYAGFjUCAEIOaGBB
jQCAkAMaWNQIACDkgAYWNQIAQg6ggUWNAICQA2hgWVQj2Z/fof7+OdHsPCKvn5nen5+tXuc77dN3
XpYVyzY7zaNa5D3H0Ctr7/N1Z9XaGesv5ABCDq0h56iZv2vImTkRZ95/1boKOc8MOY7FzrO/EnJ+
tQaMAgg5PCjkRJrHvU84Ip+kjF73uQyR34JHQ0olzFSmHVn+zKdJmfGPvD8S9LLbN7rdt8YnErCj
8zxj7GeWb/T+zmWd2c6Vscwue2fNz273UU1maq9zebPT6zhWzO57K47xQg4g5HBKyBmdkCuhZNTs
Vj9tmf0NZzXkdI7fVoNx5vsj08+O29F4da7riullazlTX3fbztlmeqYmZtdldiyzdb16ftVt2bUv
X73+Qg4g5LAk5HSeOLPL03lJ2VUhJ7tPrgwhq5evo6E9K3B1j82KwH+XOphZtzPG8ax1OSMgRGv5
6mP1mesv5ABCDo8NOUeXQmQbpMiNAjpDTsdvsavrP1rXrgYjOv3MTR8qISezrk8LOd/rmBnXrk9q
OqffVRMrljX7/sp+sDp0RZal+1h9xfoLOYCQw9KQ8/nvFSfOVY1mxx3iVoecqy8H7Fy+md8GV8Yi
u+3vHnKu2s4rpt9VE2cua9d+fvanrWeEnKvWX8gBhBweGXLObjRnmrIVIeeOzWn3JWJCjpDz9JBz
5vdZKvvY6pBz5foLOYCQw/KQ8+8D+eLfDq74Ts6q8LOigbnyxgMdz8+M6Z2/k/OmGw+ceQOKK248
sDrcnnW51uyyrNqGLlcTckDI4XUh5+iEN/ouweHJYeLWt7MhZeb21J0NU+T2q9nx757+1vp13EI6
8+9orc3eijc6zczyhRqlE241XhnbbB1X97OzlzVziWt0P+ha3uqydNX71esv5ABCDmoE25vXbmc1
i5ADODmgRrC9efQfVVSzCDmAhgY1gu3Nq7Zz9vI2EHLAiQ7UCAAIOaCBRY0AAEIOaGBRIwAg5AAa
WNQIAAg5gAYWNQIAQg5oYEGNAICQAxpY1Ij1aZjvleMd+Wv0R38xHQAhBzSwqBEh51YBp/KHFh1D
AIQc0PDxqho5+oN8R3+w78+/o+/PTDs6763liDT8lXWK/vHCyjh1buOjsXIMARByQMjh9TUSCQ9H
z2fen5129PlRuFm5TpFxHk1zFMIiwWg07pFpOY4ACDkg5PDKkBNp2Geej74308iPAsSqcDWzXt37
bGY8zlomACEHEHL4uZAT+YQh8mX5bMjJfgn/7iGn6/I0xxEAIQeEHISc5k9yMs175yc5s+vcHXIy
l6tVw4qQAyDkgJCDkHNyyMl+J+dNISd90p38dMpxBEDIASGHV4ecld9fmX2v7+TUtnX0cjbHEQAh
B4QcXlMjHbdxHoWT2VtIH4WNbFM/s05dl4+dGXIiY+04AiDkgJCDGuFVY60+AIQc0KCgRhByAIQc
QIOCGjHelhVAyAE0KagRABByQAMLagQAhBzQwKJGAAAhBzSwqBEAEHIADSxqBACEHEADixoBACEH
NLCgRgBAyAENLGoEABByQAOLGgEAIQfQwKJGAEDIATSwqBEAEHJAAwtqBACEHNDAokYAACEHNLCo
EQAQcgANLGoEAIQcQAOLGgEAIQc0sKiRcN1kf373mr/7/vG9fPZnx8Qn1VLXPO42ne5l6Viuu0yj
c77/BIePx533YyEHnNB5cMj587NMKLJ/2H8RmO0H91+/KwNO9hx019DqaA1ODjykRvZOKEcnms/X
fP989Bu5vee3njuq66PliSzT7LJuLUNlelvv23p/57hWmpPRdEfLddTsZNchMq+jMZyZ9uz4VsYs
Oo2jWurejpV9cTReo089otu0e//JLv9o/KvHjey6ZY/31WNEdJ5CDiDk8IiQEzkRZd6zd/KOhpzs
tDPTG43dinVfOa7VmplZrqMxnW14nzK+lXlVpjHaj2bX/4xtUVnPFds3u0+sPA5VgmBkftn133pU
z0EzPxNyQMiBJSFntvnqPGHPNETVZelctzOn3XVcmR3zmW3fOQZnjm/HtM6u9ewydW2LK6eTrZcr
j0Ody7e6n6h8J0fIAYQcWhrWSuB5asg5+m1kJeTMTG9lyPlevieHnNntVf0Esmt87xpysrV7h3AS
3aZ3Dzmzx6FoSLhryPFJDiDkIOQ0h5zKWGXGo6sxPbNJu3PIWXXZzp2b4LNCzuy55aqQE3nv0z7J
yR5nOy+XjE7D5WqAkIOQI+QIOSeso5Aj5PxiyOn6Ts5Z/YSQAwg5XFIjmWuhzwg52RsPnNX4nbXu
Z0w7WzOd8+28KcVTxtd3cuo3DBht86tCzpXfDZw5Zgo5Qg4IOQg5yT8iWv3uw/f7M81G5nsH1WVd
ue4dt5DOjGu2LmZuPZxpDqu3F+8Yg1XjOzuvyjRG+9Bsfc2Ghsqtn7umU/1UujLfFcehrmPmXULO
aAyEHEDI4ZU1oq5/Y4xtZ7CvPWGZhRxw4EKNtCyfuhZyACFHyAEHLnh0jVTu2IPaBN65v91tWYUc
cCBAjQDA686jzqSggUWNAICQA2hgUSMAIOQAGljUCAAIOaCBRY0AAEIOaGBRIwAg5AAaWNQIAAg5
gAYWNQIAQg789A7nDygi5ACAkANCDkIOACDkwAOCDgg5ACDkgJCDkAMACDkg5CDkAICQAwg5CDkA
IOQAGljUCAAIOaCBBTUCAEIOty4oD4+mh5BzTvi5y1ivXo431dRV67I1X4EcEHJ4fbgBTamQI+S8
N+CcWZcAQg4aUdTWD4acP///2Xxu/ezz31uN6ta/t14bXabRfPamHfkUL7Mee/Pcm29lXnvTy0xr
tByj2jga1+56FHIAIQeNKKiv5SFnL6BEm/+j/882uJH5HC3baFtn1iPyfHZZjtblKBDOLldkDLLT
qF4eml02ACEHTSior3TIyQaBmZCTbchnp312yJmZ12xgmqmLM78nI+QAQg6aUFBjtwk5R7+5P7ps
bHTJWubSrF8OOaNPTqKfqAg5AEIOGlDUmJDz9/ynLXuvj8xLyMnX78xyRafhcjVAyAENKGpMyAmE
nO4QIuSsCTmr9kXnAkDIQQMKauzSkFP9Tk7mZ1dfrpa91O7KmxgIOQBCDhpQ1JiQk2xuO24hnZ1P
pdmfuYV0ZP7dt5DO/LvjFtJCDoCQw40a0ErjFW22tl6fXe5KY3GXZj17t6snNiRCDty7NtQrIOTw
cyfcowCTDR6dv0V8a8h5Y1Mi5ICQAyDkcJuTW+YuTDMhZ+sTn9nvIRxNe/Tz0TRm/6L70d2Rorem
XXU5jQbKOvNb9aFWASGHnz3ZrrgL1Oi5rpDTOe2OL1bPfOH5rD8AqYmyzgAg5CDkCDmheXf8XZKO
kKPht84AIOQg5DT9Abszgkh02tG/YF5pXKt/MX4m5HT9RXYNv3UGACEHIScwrco8KiEnGi6qd3qb
XY8zP8m5UwMu5AAAQg6vCjnVWyKffbnaivkIOUIOACDk8LKQk2n0oncPWxVyVtx4oPtyNTceEHIA
QMiBhSHns4kffQckeuvlo+nPho/ZW0jvTae6zJHXH83TLaSFHAAQckAzhhqzzgAg5KAZAzVmnQFA
yEEzBkKO/QoAhBw0Y6gx6wwACDloxlBj1hkAhBzQjKHGrDMACDloxkCNWWcAEHLQjMF7a6zyd58A
ACEHDShq7PYhJ/NHZQEAIQcN6OXrPvpt/crlycw38769165s0P9Mby8YvPVx5b53tD2v2ufPmO/W
un7W36p5PHXstqYroANCDkLOi9f9inHpmGc1HK1cd5/kHAe/X9nHz16OM4PBU9fjrGMAgJDD7Rr9
o99Mdzx35XSPTvB7jeve9L8/raiM6ei373vLvvX/2XkcfdqyKky9IeRU13mvBjP/ztTjqHY69pvR
PnpU013Hgeh6V48l2elGli+7/1SmkQ3ZQg4g5PDakDO6jCHboN9xupkmNTL9zKVi0dARWfbRcmTn
EflE4tdDzuw6z4acai3N1MvsfnP2ceAOx6jseEePGZnwW/1lhaADCDm8uhnLnMxnTtpXTLc75FTG
uho0ul+b+Q5HtvkRcnK19R1kMp+grG7ou/fRlceB7HpXl+3s8ez8Ho2QAwg5/GzIGV16UbmcZPRb
xhXTvUvIiS6jkCPkREJOtpbuFnJWHAe6Qk70WCLkAAg5vKwZqzzX2SBX7yp2ZciJPn+nkDNqtIWc
+DpH7sYWDTkrLts6M+SsPr7MhJyzLnVbEXJcrgYIOfB3/Ts5Qo6QI+T07Fd7438Ucjq/k3NFyDlj
utWQs/o7OatDzorjK4CQw2ubsZlLNn7lxgOVsb77jQeEnL79auY7KdE7ld15v6nWdHV9uo4lLlcD
EHJ4Ucj5PLnP3oL16Lk73kL6qJGI3h43MqZ3vIV09L1CzrUhJ1sTkddVai9y3KhOd+V3crLTj45n
5Tgh5AAIOZwccrDdhBz7le1pXwcQcnAC5ZRtJOTYr36p9uz/6hcQcsDJ7K07+8RfOO+Ytxr7zXW+
svY4v55sY0DIwckT1Jh1BgAhB80Yasw6AwBCDpox1Jh1BgAhBzRjqDHrDABCDhpQUGPWGQCEHDRj
oMasMwAIOWjGUGPWGQAQctCMocasMwAIOaAZQ41ZZwAQctCMgRqzzgAg5KAZAzVmvwIAIQfNGOrL
egMA3+dQZ1I0ZKgt6w4AQg5oxlhdU79eV/YrAKj3Ds6iaErR3NuvAOBVvYOzJ0uaMg+P6gP7lYeH
h4eHx2zvoKMAn1QAALyr3zIEIOQAAAg5gJADACDkAEIOAICQA0IOAABCDgg5AABCDiDkAAAIOYCQ
AwAg5ICQYxAAAIQcEHIAABByQMgBABByACEHAEDIAYQcAAAhB4QcAACEHBByAAAQckDIAQAQcgAh
BwBAyAGEHAAAIQeEHAAAhBwQcgAAEHJAyAEAEHIAIQcAQMgBhBwAACEHhBwAAIQcEHIAABByQMgB
ABByACEHAEDIAYQcAAAhB4QcAACEHBByAAAQckDIAQAQcgAhBwBAyAE+ws33AwAAIQeEHAAAhBy4
Y9ABAEDIASEHAAAhB4QcAAAhBxByAACEHCAedAAAEHJAyAEAQMg5o1n18PDwOOsBAAg5y8MNwNnH
HgBAyNFkAI4/ACDkoMkAHIMAQMjRYAA4BgGAkKPBAHAcAgAhR3MBOA4ZBAAQcjQXgOMQAAg5aC4A
xyEAEHI0FwCOQwAg5LymuYj+dfLZBqWjwfmcxqqGqWu6V4/Xym15Vq3ObO/v1z+twT5z+c8aGyEH
AIScU5qLrZ/v/exuIefJwfIJ739Crb65oX56SBNyAEDIuXXI+fPvaIOy9anQ1qdF0XnvvefotUdB
bbQeW/OoTHf0KURmXSvrF/0kJ7KOmXll1zUybnuvz/x8NC6R6WZr/mg+R+M+Wv5IDVRrNfM6IQcA
hJxbhpzZQBQNSKPnoq/PXMqUnfdRs1uZ7uzydb5/Zh2jgaW6rNFx66ifTPiYGY/ofLK1NROkq7Xa
GUyEHAAQcl4RcqIBqLMZjj4fDQDV6a5q/CvPr3pvx/SqISe7XtXnKuPRMZ+V+0vXviLkAICQ84iQ
0/Fl9cwlMZ0hZ+sRWa6nhJyj9XtiyImsS/Tyr8iYZJ4b1VJHza8IOdV9oLqvCDkAIOTcPuRkmv/K
fM/+JKcjzN35k5zMWN4t5FQuncpONzrP1d87ycyne3+ZCfMrgomQAwBCzqkhpyMECTlCzsrt2h0S
hBwhBwCEnBeHnI5L2SKNWfQSmcrzK288UJ3uzI0Fzr7xwEy9zK5L9XK1ynyq4XDmu2ZXhhw3HgAA
IecnQ07m+wcd38k5ulXuUeN69S2kI8119nsOd7uFdGZbd65LtOHO1k/lluXRsc7WViVMzd5y3S2k
AUDI+dmQA+rL+BgHABByNBegvoyPcQAAIUdzgfr6zXExNuoEAIQczQXgOAQAQg6aC8BxCACEHM0F
gOMQAAg5mgsAxyEAEHI0FwCOQwAg5GguAMchABByKDYX2b/u/pZm6cx1PWNeV267ru2Rmc4TanVm
Ga9Yv9XzFHIAQMg5pbnY+vnbm0ch537zrrxfyBFyAEDIEXJaQs6f575/6370adD3e/bmmXn/1mtH
n0h9PzdquGbX6Wg6lXE8er4yj671jX4SWN1uke0X3R6Z6UfH5ui9o/2rc0xm9zshBwCEnNeEnGoj
WGnkjp6feX90GqP16Fyn0fSq4zizjlv/XrkNZ9ctM35H61YJ+7PjvmK63TWa3SeEHAAQch4XcqLf
yYl+8jPbzGWe75rGmdOrjONoutkguHobrQw5XTWyqhYq2yc7Jtn5zdawkAMAQs7jQs5swze6jOyM
kDOzDHcJOUfrsPe6rpDTvQ2fFHKOgn5HyOnab0bLLeQAgJAj5DSGnJUNalcD+4SQk902Kz/JuTqk
dLy/+l2TroB39H2XyjrP1IOQAwBCzs+EnO7mX8hZF3Jmvhsi5FwXcjrX+ez9SsgBACFHyDloplb/
xvmKGw+cEXKyNxboDDl3vlwte6OByvQ7wuWZNx6YvVzNjQcAQMh5Tcj5bG6qNx4YTaPrFtJ7r4+u
x4pbSFfGuDqOo+mM5hH5d8etkLvGM7vus431nW4hXRnT6i8H3EIaAIScV4acN88b1J9tAQBCjuZC
Y4Pax7YAACFHc6Gx4Y41r/YchwBAyNFcADgOAYCQo7kAcBwCACFHcwE4DgEAQo7mAnAcAgAhB80F
4DgEAEKO5gLAcQgAhJwXNBd7rxn9tfe3NlMasvjYXD1W2dp8wradWca7rp99CgCEnFObi70mMfoz
IUc9PWlZhBx1AwBCzsub0j/PdYScz2l9vu7o06Dv9+zNM/P+rdeOPpH6fi4aDKvrlHl9dlyPPpWb
Xf6t9229v2tsRusZmc7R8kaXJzP96FhEtnl2+935k1chBwCEnNObi66QU23Wjp6feX90GqP16Fyn
7Lhlx3XUqHdvk+7tNbPtRu/fCwWZgBittUrdrZiukAMAQo6Qs9OAZz6RmG1SO5/vmsYTpreyST5r
2qtDTlf9rF726HgLOQAg5Ag5zQEl+vrRZWRnhJyZZbhryMms09ElTbPb5JdDzvd4doecrn1KyAEA
IUfIWdSQrmhCu5rUJ4ac6DbtHo+3h5xRyIjObzbkdG4/IQcAhBwhR8gRcoScy0NO5zoLOQAg5Ag5
i0NO940HKiFn9Y0HsuM2MwbdP3tzyMneaKAy/RXj6MYDACDk0BRyPpvC6o0HRtPouoX03uuj67Hi
FtLZRj4zvei2mdkmo2A6cwvpTH1mp5fZttWbCozqrVp3lW1wNP5CDgAIOT8dciybMcB2MZ4AIORo
LjQ+xsB2wXgCgJCjudD4GIP7bw/bRJ0DgJCjuQBwHAIAIUdzATgOAQBCjuYCcBwCACEHzQXgOAQA
Qo7mAsBxCACEHM0FgOMQAAg5mgvAcQgAnCsNgeYCcBwCACFHcwHgOAQAQo7mAsBxCACEHM0FgOMQ
AAg5mgvAMQgAhBw0GYDjDwAIOZoMgPOOO449ACDkaDiA1xxvAAAh5/Sw4+Hh4bHqAQAIOXD7YAwA
gJADQg4AAEIOCDkAAEIOIOQAAAg5gJADACDkgJADAICQA0IOAABCDgg5AABCDiDkAAAIOYCQAwAg
5ICQAwCAkANCDgAAQg4IOQAAQg4g5AAACDmAkAMAIOSAkAMAgJADQg4AAEIOCDkAAEIOIOQAAAg5
gJADACDkgJADAICQA0IOAABCDgg5AABCDiDkAAAIOYCQAwAg5ICQAwCAkANCDgAAQg4IOQAAQg4g
5AAACDmAkAMAIOSAkAMAgJADQg4AgJADnBNuvh8AAAg5IOQAACDkwB2DDgAAQg4IOQAACDkg5AAA
CDmAkAMAIOQA8aADAICQA0IOAABCzqjR9PDw8PilBwAIOS8PNwC/ePwDACHHCR7AMRAAhBwneADH
QQAQcpzcARwHAUDIcXIHcCwEACEHQMgxCAAIOU7sAI6FACDkOLEDOBYCgJDjxA7gWAgAQk77iX2m
AehoHj6nsaoZ6Zru7HRWvv/Jjdz3ss/UxNG0nj4Wmn/rCQBCTuDE/q/X3CnkvL1Zuvr9TxzX2ZDz
psCH/QYAhJzBif3P85kw9P0b9u+fb01rq2nbe8/Ra/emHQlqW/OoTHf0CUNmXSvrFw0DkXXMzCu7
rnvjlq2jvWlmfj4au8h0s/tFZH+bGYuj5ajWc7ZehBwAEHJud2LPXA6UafRHzfBeU1UJEZnfeG81
kpXpzi5f5/tn1jEaWKrLumrMZ+oiGj5mxiw6n+z6zoTtaj2/KRgIOQAIOUJOS6PX0ZBVplVd3+h0
uxv/medXvbdjeqsa8cq8ZuZTvYxuVSg5u56FHAAQch5zYq/8xjZzuUtnyNl6RJbrKSHnaP2eGHKq
61IJOdF5ZZ4b1VvHfrEi5FT3E5erAYCQ84oTe+U38t0NWSbkdDUyT/kkZ2ZbXR1yzrikajbIfP67
+/Ksmfl071Mzgf+NwUDIAUDI+YGQU/mNtZAj5Jz5/Irv5Ag5Qg4ACDk/dGJfeeOByKVEV9x4oKPh
7lzXyvRXhpzZdVl5uVplWaoBcub7aFeGHDceEHIAEHKEnMnv5BzdBveoKb36FtKRxjn7HYa73UI6
G2a71qXSiB+9N1NjlduaR7dHtv4qYWr2tuxuIS3kACDkCDmgfoyh7QAAQo4TO+oHY2g7AICQ48SO
+vmpsTN+ahkAhBwndgDHQgAQcpzYARwLARBynNgBhBwAEHKc2AEcCwFAyHFiB3AsBAAhx4kdwLEQ
AISc4ol91Yn/CQ1FxzJGp5F53Vljt7o2rqqtz+fPrkONtJADAELOxSf2lSf9Xwk5Twicbws5mlnU
BQAIOeHn/vz7+9OEvU8X/vx87/XRn4+Wf+8938ubWcbv94/GZzSN0esi2yI7Znvb62jamfE7WrfI
ssxsn6PxG4353nRm6+VoeY7mHZ1fdlmy+5KQY5wAEHJef2I/apqO/h1pQo8CVKbpiMzjaD7RZRyN
UXQes+ucfX+mEZ8dv+q26Ng+2TE/eu3M8oz2l9n5de9fCDkACDlCTqBxmmnCupqOmaa0GlCiwWR2
nSshp3N+syFnZvpdIeeMdVixfh3TRsgBQMgRchpCztYjMt+uS9YyjfXo/dXL0DKXqwk5uRr6fE13
UKouT2fIGdVVdGw070IOAAg5jSEnO9/Id0I6P03Kvn90+Vp2HM64XO3pIScacM8KObP7VtcnQx3L
gjECQMgRchaHnFXfyel8Xsi5V8i5w+VqQo6QAwBCzo+HnMrlX9mgNLsMlZBz5xsPZLf/1d9nufrG
A6tCSfc+4sYDQg4ACDkXhJzPhjL6fYGjW/0eLX/k9sCRZZxpaq/4Tk5kjKM1EH1/JEBUppWd5spb
SFdrujvkjOrFLaSFHAAQcgondif9c8fEeIOQAwBCjpAj5AD2PwAQcnIndif+/4yDgANCDgAIOU7s
AI6FACDkOLEDOBYCgJDjxA7gWAgAQo4TO4BjIQBCjhM7gGMhAAg5TuwAjoUAIOQ4sQM4FgKAkOPE
DuBYCABCji0OOPA7FgIg5DixAzgWAoCQ48QO4FgIAEKOEzuAYyEACDlO7ACOhQAg5AAIOQAg5Dix
AzgWAoCQ48QO4FgIAELOJSf2fz33+biyeficxqpmpGu6s9NZ+f4nN3Lfyz5TE0fTevpYaP6tJwAI
OTsn9q2fV5uA7pDz9mbp6vc/NZD/0hg9PaQJOQAg5Dwm5Gx96rP1aVBk2kfvOXrt3rQjn0ZtzaMy
3dEnDJl1raxfNAxE1jEzr+y67o1bto72ppn5+WjsItPN7hdH8+kYi6PlqNZztl6EHAAQcm5/Ys/8
Jn0USiLN93dTVQkRmd94bzWSlenOLl/n+2fWMRpYqsu6asxn6iIaPmb3i8h8sus7E7ar9fymYCDk
ACDkCDltAWi2IatMKxoAqtPtbvxnnl/13o7prWrEK/Oamc+K/aIjvJ9Vz0IOAAg5jz2xVy/LOSPk
bD0iy/WUkHO0fk8MOdV1qYSc6Lwyz43qrWO/WBFyqvuJy9UAQMh55Ym9cvI/67fOnV84f8onOZmx
vFvIOeOSqtkg8/nv7suzZubTvU/NBP43BgMhBwAh54dCTscd1YQcIWfF8yu+kyPkCDkAIOS8/MQ+
832dbEN5xxsPdDTcnetamf7KkDO7LisvV6ssSzVAznwf7cqQ48YDQg4AQs7PhZzu7x4c3Qb3qCm9
+hbSkcY5+x2Gu91COtPoda5LpRE/em+mxiq3NY9uj2z9VcLU7G3Z3UJayAFAyPnJkAPqxxjaDgAg
5DixozHEGNoOACDkOLGjfn537IyfWgYAIceJHcCxEACEHCd2AMdCAIQcJ3YAIQcAhBwndgDHQgAQ
cpzYARwLAUDIcWIHcCwEACGneGJfdeJ/QkPRsYzRaWRe1zl2mWndeZvNLNvK986O2VX73+fzb93u
Qg4AQs6PhpyVJ/1fCTlPCJxCzu+FnLc0/EIOAAg50yHnz7+/P03Y+3Thz8/3Xh/9+Wj5997zvbyZ
Zfx+/2h8RtMYvS6yLbJjtre9jtZhbxm35jOqh8iYZ7ZHZpyPtk+l5qo1drT9I9trpoaPxmRUl3vT
md2nImNbGTMhBwCEnNCJ/ah5Ofp3punMNKmZZTwKX5VlHI1RdB6z61xt7KNjmB2vatiY3R6rp5sZ
98yYVeu1a90ydXn02pnliYxt57YTcgBAyEk34Csby2rTMdNwVQNKtImbXefZQDE7XtXfolfGqnOc
u0NOddqV5Zh9TyXknLEOK9ZPyAEAIeeUkLP1iMy365K1TNM4en/1MrTM5WpvCjmjS4w6PgXael1k
+0Zr8Skh52jdPl/THZSqy9O5fkIOAAg5p4ec7Hwj33fo/DQp+/7R5WvVxvxtIScbhrpCTuTywUpz
+7RPco7G5oyQM3v86QqgQg4ACDmXh5xV38lZ0dQLOfWmfGXIWdUoPznk3OFyNSEHAIScV4ecyuVf
2aA0uwyVkHPnGw9cHXKiYzo7/ytvPHC3kLP6xgMd67BqHxZyAEDIWRpyPhuW6PcyRreS3VvOyK1v
I8s407Bd8Z2cyBh3h5zI9sncEjizPplxPlr27DaZne/M9srW8Fm3kK7u97P14hbSACDkTJ/YnfTP
HRPjDf4AKgAIOUKOkAMv25+EHAAQcpaf2J34/zMOAg6s27dW72P2QQCEHCEH4OfCFgAIOU7sAI6F
ACDkOLEDOBYCgJDjxA7gWAgAQo4TO4BjIQAIOQBCDgAIOU7sAI6FACDkOLEDOBYCgJDjxA7gWAgA
Qo4TO4BjIQAIOQBCDgAIOU7sAI6DACDkOMEDOAYCgJDjBA/Qduxz/ANAyHGyB3jNMQ8AhJwfCzse
Hh4eb34AwK/5Pzw2eCvaa+F5AAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-11-13 17:01:56 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-11-13 17:01:56 +0000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAWkAAAPLCAIAAAASUu/VAAA2D0lEQVR42u3dsY7lRNrG8ZY22aCD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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-11-12 21:13:59 +0000" MODIFIED_BY="Zbys Fedorowicz">
<APPENDIX ID="APP-01" MODIFIED="2012-11-12 21:13:16 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="1">
<TITLE MODIFIED="2012-11-12 21:12:52 +0000" MODIFIED_BY="[Empty name]">MEDLINE (OVID) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-11-12 21:13:16 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>1.    Dry socket/<BR/>2.    ("alveolar osteitis" or "alveolar ostitis").mp.<BR/>3.    (alveolalgia or "alveolar periostitis" or "alveolitis sicca dolorosa").mp.<BR/>4.    ((septic adj4 socket*) or "necrotic socket osteomylitis" or "fibrinolytic alveolitis").mp.<BR/>5.    ("dry socket$" or dry-socket$ or (infect$ adj5 socket$)).mp.<BR/>6.    or/1-5<BR/>7.    exp Tooth Extraction/<BR/>8.    ("dental extraction$" or (tooth adj3 extract$) or (teeth adj3 extract$) or (teeth adj3 remov$) or (tooth adj3 remov$)).mp.<BR/>9.    ((dental or oral) and (surgery or surgical)).mp.<BR/>10.  or/7-9<BR/>11.  6 and 10</P>
<P>The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the<I> Cochrane Handbook for Systematic Reviews of Interventions, v</I>ersion 5.1.0 (updated March 2011) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>1. randomized controlled trial.pt.<BR/>2. controlled clinical trial.pt.<BR/>3. randomized.ab.<BR/>4. placebo.ab.<BR/>5. drug therapy.fs.<BR/>6. randomly.ab.<BR/>7. trial.ab.<BR/>8. groups.ab.<BR/>9. or/1-8<BR/>10. exp animals/ not humans.sh.<BR/>11. 9 not 10</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-11-12 21:13:33 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="2">
<TITLE MODIFIED="2012-11-12 21:13:33 +0000" MODIFIED_BY="Zbys Fedorowicz">The Cochrane Oral Health Group's Trials Register search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-11-01 15:08:46 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>The register was searched via the Cochrane Register of Studies, using the following search strategy:</P>
<P> #1        (("dry socket*" or "alveolar osteitis" or "alveolar ostitis" or alveolagia or "alveolar periostitis" or "alveolitis sicca dolorosa" or dry socket*  or "septic socket*" or "necrotic socket osteomylitis" or "fibrinolytic alveolitis")) AND (INREGISTER)<BR/>#2        ((infect* and socket*)) AND (INREGISTER)<BR/>#3        (#1 or #2) AND (INREGISTER)<BR/>#4        (extract* or remov* or surg*) AND (INREGISTER)<BR/>#5        (#3 and #4) AND (INREGISTER)</P>
<P>Previous searches were conducted using the following strategy on the ProCite version of the register (to January 2012):</P>
<P>
<B> </B>(("dry socket*" or "alveolar osteitis" or "alveolar ostitis" or alveolagia or "alveolar periostitis" or "alveolitis sicca dolorosa" or dry-socket*  or "septic socket*" or "necrotic socket osteomylitis" or "fibrinolytic alveolitis" or (infect* and socket*)) AND (extract* or remov* or surg*))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-11-12 21:13:52 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="3">
<TITLE MODIFIED="2012-11-12 21:13:52 +0000" MODIFIED_BY="Zbys Fedorowicz">Cochrane Central Register of Controlled Trials (CENTRAL) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-11-01 15:09:00 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>#1        MeSH descriptor Dry Socket this term only<BR/>#2        ("alveolar osteitis" in All Text or "alveolar ostitis" in All Text)<BR/>#3        ((septic in All Text near/4 socket* in All Text) or "necrotic socket osteomylitis" in All Text or "fibrinolytic alveolitis" in All Text)<BR/>#4        (alveolalgia in All Text or "alveolar periostitis" in All Text or "alveolitis sicca dolorosa" in All Text)<BR/>#5        ("dry socket*" in All Text or dry-socket* in All Text or (infect* in All Text near/5 socket* in All Text))<BR/>#6        (#1 or #2 or #3 or #4 or #5)<BR/>#7        MeSH descriptor Tooth Extraction explode all trees<BR/>#8        ("dental extraction*" in All Text or (tooth in All Text near/3 extract* in All Text) or (teeth in All Text near/3 extract* in All Text) or (teeth in All Text near/3 remov* in All Text) or (tooth in All Text near/3 remov* in All Text))<BR/>#9        ((dental in All Text or oral in All Text) and (surgery in All Text or surgical in All Text))<BR/>#10      (#7 or #8 or #9)<BR/>#11      (#6 and #10) </P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-11-12 21:13:59 +0000" MODIFIED_BY="Zbys Fedorowicz" NO="4">
<TITLE MODIFIED="2012-11-12 21:13:59 +0000" MODIFIED_BY="Zbys Fedorowicz">EMBASE (OVID) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-17 16:14:22 +0000" MODIFIED_BY="Zbys Fedorowicz">
<P>1.    Dry socket/<BR/>2.    ("alveolar osteitis" or "alveolar ostitis").mp.<BR/>3.    (alveolalgia or "alveolar periostitis" or "alveolitis sicca dolorosa").mp.<BR/>4.    ((septic adj4 socket*) or "necrotic socket osteomylitis" or "fibrinolytic alveolitis").mp.<BR/>5.    ("dry socket$" or dry-socket$ or (infect$ adj5 socket$)).mp.<BR/>6.    or/1-5<BR/>7.    exp Tooth Extraction/<BR/>8.    ("dental extraction$" or (tooth adj3 extract$) or (teeth adj3 extract$) or (teeth adj3 remov$) or (tooth adj3 remov$)).mp.<BR/>9.    ((dental or oral) and (surgery or surgical)).mp.<BR/>10.  or/7-9<BR/>11.  6 and 10</P>
<P>The above subject search was linked to the Cochrane Oral Health Group filter for EMBASE via OVID:</P>
<P>1. random$.ti,ab.<BR/>2. factorial$.ti,ab.<BR/>3. (crossover$ or cross over$ or cross-over$).ti,ab.<BR/>4. placebo$.ti,ab.<BR/>5. (doubl$ adj blind$).ti,ab.<BR/>6. (singl$ adj blind$).ti,ab.<BR/>7. assign$.ti,ab.<BR/>8. allocat$.ti,ab.<BR/>9. volunteer$.ti,ab.<BR/>10. CROSSOVER PROCEDURE.sh.<BR/>11. DOUBLE-BLIND PROCEDURE.sh.<BR/>12. RANDOMIZED CONTROLLED TRIAL.sh.<BR/>13. SINGLE BLIND PROCEDURE.sh.<BR/>14. or/1-13<BR/>15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/<BR/>16. HUMAN/<BR/>17. 16 and 15<BR/>18. 15 not 17<BR/>19. 14 not 18</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;4 studies included in quantitative synthesis (meta-analysis) for chlorhexidine rinses&lt;/p&gt;&lt;p&gt;2 studies included in quantitative synthesis (meta-analysis) for intrasocket chlorhexidine gel&lt;/p&gt;" WIDTH="314">
<FLOWCHARTBOX TEXT="&lt;p&gt;21 studies included in qualitative synthesis: 3 reported on treatment of dry socket and 18 reported on prevention of dry socket&lt;/p&gt;" WIDTH="281">
<FLOWCHARTBOX TEXT="&lt;p&gt;102 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="144">
<FLOWCHARTBOX TEXT="&lt;p&gt;395 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;395 records after duplicates removed&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;622 records identified through database searching&lt;/p&gt;" WIDTH="195"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;5 additional records identified through other sources&lt;/p&gt;" WIDTH="203"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;293 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;81 full-text articles excluded, of which:&lt;/p&gt;&lt;p&gt;Study not related to dry socket (n = 1)&lt;/p&gt;&lt;p&gt;Studies unavailable or abstract only available with insufficient information to include (n = 4)&lt;/p&gt;&lt;p&gt;No definition of dry socket supplied (n = 11)&lt;/p&gt;&lt;p&gt;Not an RCT/inadequate method of sequence generation/allocation concealment (n = 45)&lt;/p&gt;&lt;p&gt;Wrong interventions, comparisons or other inclusion criteria (n = 18)&lt;/p&gt;&lt;p&gt;Irrelevant outcomes (n = 1)&lt;/p&gt;&lt;p&gt;Awaiting classification (n=1)&lt;/p&gt;" WIDTH="457"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>